Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3001467	s-afluust	U/l (u/l)	2299	2870	0.00%
3001467	luusto-is	U/l (u/l)	915	1039	0.00%
3001467	afosluusto	U/l (u/l)	555	630	0.00%
3001467	s-afluust	— (—)	458	488	100.00%	Distribution not available
3001467	afosluusto	— (—)	178	190	100.00%	Distribution not available
3001467	s-afluust	U/l_______ (u/l)	147	164	0.00%
3001467	s-afosluu	U/l (u/l)	97	105	0.00%
3001467	s-luust	U/l (u/l)	91	100	0.00%
3001467	afosluu	U/l (u/l)	76	90	0.00%
3001467	alkalinenfosfataasi(afos)	U/l (u/l)	18	18	0.00%
3001467	alkalinenfosfataasi(afos)	— (—)	6	6	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Renal tubulo-interstitial diseases

1323

2952

3.34

318.94

1.3

1.2

65.53

63.68

u/l

0.22

1205

2563

ILD medications: immunosuppressive drugs

1158

2382

4.50

307.65

1.3

1.2

71.21

62.48

u/l

1.23

1046

2068

Nephropathy related operations

445

436

11.06

307.65

1.4

1.2

77.44

71.02

u/l

0.35

417

385

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1447

3012

3.29

307.65

1.2

69.43

62.09

u/l

1.14

1310

2621

All chronic kidney diseases

1020

1870

4.46

307.65

1.3

1.2

63.71

64.69

u/l

0.11

936

1610

Care involving dialysis

360

237

16.87

307.65

1.4

1.2

73.83

73.34

u/l

0.01

337

202

Dialysis, with operation codes

474

415

12.39

307.65

1.4

1.2

75.12

71.84

u/l

0.16

442

365

Renal failure

985

1779

4.86

307.65

1.3

1.2

64.51

66.53

u/l

0.22

903

1528

Autoimmune diseases excluding thyroid diseases, strict definition

1391

2170

3.54

307.65

1.3

1.2

57.81

72.39

u/l

3.96

1252

1892

Transplanted organ and tissue status

342

302

12.22

307.65

1.4

1.1

104.53

69.79

u/l

1.75

318

263

Chronic kidney disease

785

1239

6.35

307.65

1.3

1.2

65.12

66.97

u/l

0.18

721

1061

Autoimmune diseases excluding thyroid diseases

1440

2270

3.49

307.65

1.3

1.2

57.94

71.80

u/l

3.90

1295

1981

Diseases of liver

865

1541

5.85

307.65

1.3

1.2

52.30

66.92

u/l

6.55

786

1335

Anaemias

392

226

11.40

288.85

1.3

1.2

71.16

65.33

u/l

0.36

357

198

Other diseases of liver

481

780

6.47

284.27

1.3

1.2

54.66

64.94

u/l

2.00

435

676

All kidney diseases

1356

2981

3.09

281.76

1.2

67.12

65.08

u/l

0.24

1226

2595

L04AD Calcineurin inhibitors

345

392

9.42

280.11

1.4

1.1

106.68

60.53

u/l

2.90

317

349

Autoimmune diseases related-to ILD

1229

3355

3.11

274.09

1.3

1.2

56.23

67.41

u/l

4.36

1105

2945

ILD medications

1435

2571

3.05

271.32

1.3

1.2

71.16

63.24

u/l

1.11

1291

2242

Extracorporeal dialysis

255

197

14.35

270.95

1.4

1.2

74.24

62.38

u/l

0.91

239

176

First line medication for Crohn's disease

1387

2433

3.10

270.35

1.3

1.2

71.37

63.18

u/l

1.13

1257

2097

Preparatory care for dialysis

225

141

18.27

269.46

1.4

1.2

71.71

54.16

u/l

2.13

210

126

ILD medications: prednisolone, methylprednisolone, prednisone

1383

2554

3.05

264.64

1.3

1.2

71.70

62.99

u/l

1.24

1244

2227

Fibrosis and cirrhosis of liver

290

292

10.80

258.50

1.3

1.1

46.22

66.87

u/l

3.31

269

258

Other bacterial diseases

1305

2949

2.97

253.15

1.3

1.2

73.08

61.81

u/l

1.85

1191

2552

L04AA Selective immunosuppressants

500

967

5.37

244.74

1.3

1.2

82.27

62.73

u/l

1.49

451

835

Bacterial infection, other or unspecified

857

2080

3.55

235.76

1.3

1.2

75.76

59.99

u/l

2.80

809

1785

Abnormal findings on examination of blood, without diagnosis

776

1917

3.75

235.68

1.2

58.56

65.62

u/l

1.24

707

1658

Bacterial infection, other or unspecified, including avohilmo

906

2208

3.42

234.75

1.3

1.2

75.37

60.19

u/l

2.83

852

1901

Inflammatory bowel disease treatment related agents

1427

2873

2.79

234.48

1.3

1.2

66.42

64.96

u/l

0.14

1280

2514

Glomerular disorders in diseases classified elsewhere

320

417

8.12

231.93

1.4

1.2

64.23

63.73

u/l

0.03

302

367

Primary biliary cholangitis, wide definition

159

29.85

231.83

1.4

1.0

45.94

51.51

u/l

0.62

149

Other bacterial diseases, including avohilmo

1316

2943

2.83

229.99

1.3

1.2

73.63

62.66

u/l

1.77

1200

2553

Kidney transplant status

212

163

14.35

225.75

1.4

1.2

86.76

71.82

u/l

0.40

194

145

Glomerular diseases

407

709

5.98

223.38

1.3

1.2

66.81

69.51

u/l

0.18

382

619

Any gastric operation

794

1006

4.00

215.30

1.2

67.68

66.47

u/l

0.09

717

815

GASTRO-related operations

794

1006

4.00

215.30

1.2

67.68

66.47

u/l

0.09

717

815

Heart failure, not strict

1047

2358

3.03

210.92

1.3

1.2

67.36

64.97

u/l

0.20

942

2049

Autoimmune diseases

1273

2296

2.84

210.66

1.3

1.2

60.07

71.91

u/l

2.82

1132

2003

IBD patients in KELA-register

436

853

5.27

210.19

1.3

1.2

56.57

62.84

u/l

0.96

385

746

Primary biliary cholangitis (PBC)

146

27.25

206.03

1.4

1.0

45.78

52.19

u/l

0.66

135

Secondary hypertension

225

211

11.10

205.90

1.3

1.1

69.77

61.50

u/l

0.95

208

180

Septicaemia

664

1669

3.70

199.15

1.3

1.2

71.90

61.53

u/l

0.77

610

1430

Inflammatory bowel disease, strict (require KELA)

436

896

5.01

198.59

1.3

1.2

56.57

62.50

u/l

0.91

385

785

ILD medications: azathioprine

307

455

7.00

197.49

1.3

1.1

84.28

59.33

u/l

1.00

276

392

Second line medication for Crohn's disease

862

2851

3.07

197.35

1.2

67.07

63.45

u/l

0.28

780

2487

Bacterial Sepsis

743

1812

3.46

195.74

1.3

1.2

70.28

63.57

u/l

0.55

683

1573

Other septicaemia, including avohilmo

617

1555

3.80

193.98

1.3

1.2

71.72

61.58

u/l

0.69

567

1327

Other septicaemia

605

1522

3.83

192.24

1.3

1.2

72.20

59.26

u/l

1.02

555

1299

Acute renal failure

416

845

5.08

192.18

1.3

1.2

65.29

66.84

u/l

0.14

379

714

Fever of other and unknown origin

783

2114

3.26

191.18

1.3

1.2

68.31

65.90

u/l

0.25

719

1848

Explicit Sepsis, including avohilmo

690

1836

3.47

187.95

1.3

1.2

71.06

63.69

u/l

0.51

635

1597

Abnormal serum enzyme levels

505

1173

4.26

186.50

1.3

1.2

57.76

68.19

u/l

1.39

459

1016

Explicit Sepsis

677

1800

3.49

186.24

1.3

1.2

71.56

63.45

u/l

0.56

622

1569

Implicit bacterial Sepsis

667

1637

3.57

186.01

1.3

1.2

69.74

63.96

u/l

0.40

609

1419

5-aminosalicylic acid

385

755

5.25

185.07

1.3

1.2

54.77

63.82

u/l

2.05

339

650

Noninfective enteritis and colitis

700

2140

3.33

183.02

1.3

1.2

57.07

66.62

u/l

2.56

627

1862

Azathioprine

307

493

6.46

182.86

1.3

1.2

84.28

63.29

u/l

0.77

276

428

Dialysis

162

113

15.86

182.44

1.4

1.2

80.49

79.04

u/l

0.02

150

103

Used for control exclusion in common control thyroid runs

1130

2062

2.79

180.75

1.3

1.2

61.24

73.39

u/l

2.48

1012

1798

Aplastic and other anaemias

721

2066

3.26

177.74

1.3

1.2

68.74

63.44

u/l

0.42

647

1794

Implicit bacterial Sepsis, including avohilmo

699

1767

3.35

176.16

1.3

1.2

69.17

63.70

u/l

0.40

636

1535

Inflammatory bowel disease

523

1364

3.93

174.82

1.3

1.2

56.33

65.29

u/l

2.07

467

1191

L04AX Other immunosuppressants

810

2800

2.94

171.63

1.2

68.13

63.31

u/l

0.37

733

2446

Oral corticosteroids

1219

2842

2.54

171.47

1.3

1.2

61.72

64.77

u/l

0.49

1093

2487

Polyarthropathies

904

2032

2.90

166.59

1.2

56.24

68.85

u/l

4.19

810

1780

Reimbursement for rheumatic diseases

814

2863

2.87

165.13

1.2

54.18

63.86

u/l

3.90

739

2490

Insulin, fast-acting

542

1533

3.61

160.57

1.3

1.2

59.35

67.74

u/l

2.14

492

1323

Primary Sclerosing Cholangitis, IBD and UDCA required

123

21.80

159.86

1.3

52.29

63.90

u/l

0.67

113

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1154

2962

2.49

158.90

1.3

1.2

67.85

64.39

u/l

0.47

1026

2596

Implicit Sepsis

970

2721

2.66

158.85

1.2

65.74

63.54

u/l

0.19

871

2365

Persons encountering health services for specific procedures and health care

1226

3021

2.42

156.24

1.3

1.2

73.67

62.03

u/l

2.04

1113

2627

Other anaemias

656

1974

3.17

155.75

1.2

68.21

63.84

u/l

0.30

589

1712

Other and unspecified anaemias

650

1960

3.17

154.67

1.2

68.33

63.89

u/l

0.30

583

1701

Budesonide

291

526

5.73

153.47

1.4

1.2

52.73

59.81

u/l

1.51

259

456

Disorders resulting from impaired renal tubular function

150

124

13.40

153.02

1.4

1.3

72.91

70.81

u/l

0.04

133

113

Mucosal proctocolitis

255

409

6.46

152.15

1.4

1.2

51.20

63.37

u/l

1.97

223

361

Insulin, fast-acting or short human

544

1599

3.47

151.89

1.3

1.2

59.35

69.06

u/l

1.93

494

1379

Tramadol

953

2154

2.69

150.98

1.2

60.26

57.04

u/l

0.78

843

1893

Disorders of parathyroid gland

413

999

4.22

150.76

1.3

1.2

75.75

58.43

u/l

4.12

376

862

Dental caries

416

962

4.17

148.93

1.3

1.2

74.61

63.51

u/l

1.09

384

838

Ulcer of lower limb, not elsewhere classified

301

582

5.37

147.55

1.3

1.2

53.11

73.75

u/l

2.77

274

509

Unspecified kidney failure

228

342

6.95

145.32

1.2

67.00

69.36

u/l

0.12

205

295

Nonalcoholic fatty liver disease

252

421

6.28

144.86

1.2

58.46

58.75

u/l

0.02

221

368

Ulcerative colitis

401

992

4.14

144.40

1.3

1.2

57.05

64.77

u/l

1.22

356

864

Disorders of gallbladder, biliary tract and pancreas

1172

3121

2.36

143.88

1.2

56.36

64.24

u/l

2.80

1044

2736

Osteopathies and chondropathies

789

2676

2.74

143.56

1.3

1.2

67.56

61.64

u/l

1.18

706

2339

Insulin, intermediate and long-acting

720

2483

2.84

142.42

1.3

1.2

57.80

66.37

u/l

2.62

652

2174

Implicit Sepsis, including avohilmo

994

2878

2.49

142.30

1.2

65.57

63.81

u/l

0.15

888

2510

Cholangitis (primary sclerosing, PSC)

177

204

9.21

142.07

1.3

1.2

54.97

65.65

u/l

0.93

164

177

Caries of dentine

377

868

4.29

140.72

1.3

1.2

70.15

64.59

u/l

0.42

348

754

Insulin, combination of fast acting with intermediate-acting or long-acting

785

2661

2.71

140.47

1.3

1.2

63.22

65.92

u/l

0.21

710

2330

Other dialysis

131

102

14.35

138.77

1.4

1.2

68.52

80.60

u/l

0.19

123

Diabetic nephropathy, excluding more controls

324

541

5.08

138.46

1.3

1.2

62.58

61.61

u/l

0.08

303

466

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

316

674

4.83

137.85

1.4

1.2

55.19

63.76

u/l

1.50

281

597

Hyperparathyroidism

369

879

4.29

137.74

1.3

1.2

76.37

59.05

u/l

3.72

334

757

Any reimbursement code in KELA

481

584

4.16

137.35

1.2

1.1

68.07

61.34

u/l

0.48

436

501

Metabolic disorders

1095

2771

2.39

137.32

1.2

66.00

63.74

u/l

0.31

970

2433

Type 1 diabetes

376

920

4.17

136.97

1.3

1.2

59.45

69.63

u/l

2.05

342

797

Insulin medication

785

2441

2.70

136.87

1.3

1.2

63.22

66.19

u/l

0.24

710

2141

Ulcerative colitis (strict definition, require KELA)

301

622

4.99

136.43

1.4

1.2

55.39

63.04

u/l

1.19

267

550

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

294

602

5.03

134.72

1.4

1.2

55.58

63.80

u/l

1.27

261

532

Type 1 diabetes, wide definition, subgroup 1

322

709

4.64

134.64

1.3

1.2

59.59

69.41

u/l

1.55

295

616

Crohn disease

246

442

5.75

130.62

1.3

1.2

59.70

64.23

u/l

0.34

218

386

Disorders of other endocrine glands

616

2098

2.94

130.13

1.3

1.2

72.84

64.39

u/l

1.38

555

1829

Condition for Implicit Sepsis (Organ dysfunction codes)

987

2890

2.39

128.13

1.2

65.75

64.09

u/l

0.14

885

2520

Diabetic nephropathy

327

756

4.44

126.94

1.3

1.2

62.31

60.01

u/l

0.24

306

662

Heart failure,strict

649

1565

2.94

125.70

1.2

58.71

65.82

u/l

0.88

578

1341

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

997

2911

2.33

122.08

1.2

66.73

64.28

u/l

0.22

892

2542

Type 1 diabetes, wide definition

323

774

4.26

121.14

1.3

1.2

59.47

68.46

u/l

1.46

296

673

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

275

594

4.79

118.43

1.3

1.2

52.78

65.82

u/l

2.40

255

510

Pneumonias (Asthma/COPD co-morbidities)

1108

3310

2.20

118.05

1.3

1.2

73.17

62.92

u/l

1.32

1002

2898

All pneumoniae

1114

3317

2.20

117.97

1.3

1.2

73.20

62.94

u/l

1.33

1007

2904

Pneumonia, organism unspecified

1022

3135

2.26

116.31

1.3

1.2

73.73

63.13

u/l

1.24

921

2736

Influenza and pneumonia

1127

3242

2.16

112.96

1.3

1.2

71.87

62.85

u/l

1.14

1023

2832

Heart failure and antihypertensive medication

351

556

4.18

111.43

1.2

62.44

66.42

u/l

0.27

315

479

Malignant neoplasm of breast, HER2-negative

605

1379

2.88

110.39

1.2

59.86

56.96

u/l

0.90

550

1198

Nutritional anaemias

658

2438

2.61

110.37

1.3

1.2

64.03

61.28

u/l

0.31

597

2120

Malignant neoplasm of breast

605

1379

2.88

110.34

1.2

59.86

56.96

u/l

0.90

550

1198

Hernia of abdominal wall, postoperative

226

435

5.25

109.69

1.3

1.1

61.90

64.42

u/l

0.13

206

352

Malignant neoplasm of breast, HER2-negative, including Hilmo

609

1388

2.86

109.56

1.2

59.66

56.93

u/l

0.83

555

1206

Malignant neoplasm of breast, including Hilmo

609

1388

2.86

109.53

1.2

59.66

56.93

u/l

0.83

555

1206

Ulcerative colitis, NAS

237

489

4.99

107.70

1.3

1.2

56.26

67.27

u/l

1.32

212

425

Acute tubulo-interstitial nephritis

716

2447

2.50

107.15

1.2

64.37

63.36

u/l

0.08

645

2111

Malignant neoplasm

903

2292

2.33

106.19

1.3

1.2

72.51

58.92

u/l

3.06

813

1984

Cholangitis (primary sclerosing, PSC), with reimbursement 202

17.16

105.94

1.2

49.13

51.94

u/l

0.17

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1066

3349

2.14

105.77

1.3

1.2

73.55

62.94

u/l

1.32

965

2929

Hypertensive diseases (excluding secondary)

560

1107

2.98

105.40

1.2

69.50

65.89

u/l

0.20

501

983

Malignant neoplasm of breast, HER-positive

503

1254

3.05

105.34

1.2

60.70

57.40

u/l

0.94

467

1085

Malignant neoplasm of breast, ER-positive, including Hilmo

503

1255

3.04

104.94

1.2

60.70

57.37

u/l

0.95

467

1086

Malignant neoplasm

901

2298

2.32

104.83

1.3

1.2

72.61

58.93

u/l

3.08

811

1990

Examination and observation for other reasons

653

1363

2.73

104.72

1.2

64.72

68.80

u/l

0.30

592

1178

Other Crohn's disease

149

201

7.74

104.70

1.3

1.2

61.60

65.07

u/l

0.15

127

181

Diseases of oesophagus, stomach and duodenum

1120

3157

2.11

104.64

1.2

59.48

65.66

u/l

1.14

993

2780

Sub-endpoint used in defining T1D endpoints

386

1137

3.40

104.47

1.3

1.2

59.29

70.65

u/l

1.67

351

989

Other disorders of fluid, electrolyte and acid-base balance

444

1355

3.14

104.44

1.3

1.2

63.72

61.76

u/l

0.20

406

1174

Complications of surgical and medical care, not elsewhere classified

1091

3489

2.10

104.04

1.3

1.2

60.67

64.37

u/l

0.81

989

3055

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

974

2577

2.23

103.54

1.3

1.2

65.54

63.45

u/l

0.27

881

2258

974

2577

2.23

103.54

1.3

1.2

65.54

63.45

u/l

0.27

881

2258

General symptoms and signs

1044

2396

2.20

103.10

1.2

63.28

65.69

u/l

0.31

925

2099

Implicit viral Sepsis, including avohilmo

414

1316

3.19

101.66

1.2

59.04

61.99

u/l

0.44

373

1134

Heart failure, strict

697

1957

2.51

100.20

1.2

58.23

65.59

u/l

1.09

617

1697

Certain infectious and parasitic diseases

942

2096

2.27

99.99

1.2

67.69

63.54

u/l

0.44

833

1818

Iron deficiency anaemia

567

2117

2.67

99.94

1.3

1.2

65.13

61.72

u/l

0.34

516

1846

Osteoporosis

432

1302

3.12

99.21

1.3

1.2

63.77

58.94

u/l

0.95

381

1137

Infections, IBD-co-morbidities

219

282

5.56

98.87

1.3

1.2

59.18

75.11

u/l

0.78

194

251

Malaise and fatigue

606

1847

2.61

97.95

1.2

55.62

64.39

u/l

2.11

535

1609

Malignant neoplasm, including Hilmo

889

2310

2.26

97.73

1.2

73.30

59.11

u/l

3.20

802

2000

Ulcerative colitis (strict definition, all Crohn cases excluded)

229

503

4.67

96.49

1.3

1.2

53.84

64.24

u/l

1.55

205

443

Malignant neoplasm, wide definition

888

2319

2.25

96.35

1.2

73.32

59.06

u/l

3.21

800

2010

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1133

2952

2.05

96.06

1.2

62.87

65.36

u/l

0.35

1033

2575

Diseases of arteries, arterioles and capillaries (FINNGEN)

330

604

3.84

96.02

1.3

1.2

66.36

65.82

u/l

0.04

298

530

Other disorders of kidney and ureter

234

531

4.55

94.87

1.3

1.2

67.76

68.00

u/l

0.01

211

470

Solid cancers

860

2260

2.25

93.73

1.2

72.98

58.24

u/l

3.24

768

1959

Insulin, fast-acting (human)

207

430

4.93

93.24

1.4

1.1

61.53

66.98

u/l

0.42

190

374

Erysipelas, including avohilmo

780

2563

2.28

92.52

1.2

59.81

60.65

u/l

0.06

689

2204

Implicit viral Sepsis

303

843

3.67

92.46

1.3

1.2

60.66

64.32

u/l

0.41

275

720

Viral Sepsis

303

843

3.67

92.46

1.3

1.2

60.66

64.32

u/l

0.41

275

720

All-cause Heart Failure

673

1934

2.45

92.36

1.2

58.86

65.82

u/l

0.97

595

1675

Cirrhosis of liver, NAS

139

201

7.32

92.14

1.3

1.2

46.95

62.49

u/l

1.41

132

181

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

785

3108

2.22

90.78

1.2

59.51

62.05

u/l

0.43

704

2711

Oedema, not elsewhere classified

423

1418

2.96

90.75

1.3

1.2

53.03

62.68

u/l

3.54

376

1230

Erysipelas

619

2189

2.46

90.66

1.2

61.63

60.47

u/l

0.06

551

1879

Other and unspecified iron deficiency

458

1646

2.82

90.44

1.3

1.2

67.41

62.04

u/l

0.48

417

1427

Gout, FINNGEN

369

1174

3.18

89.78

1.2

59.40

66.27

u/l

1.04

328

1012

Hypertension

787

1949

2.30

88.99

1.2

68.97

67.52

u/l

0.09

692

1734

Gout

369

998

3.23

88.86

1.2

59.40

68.63

u/l

1.03

328

859

Hypertensive diseases

786

1949

2.29

88.66

1.2

68.97

67.52

u/l

0.09

692

1734

Persons encountering health services in other circumstances, wide

1141

2962

1.99

88.61

1.2

61.69

65.33

u/l

0.58

1022

2585

Other heart diseases

486

1117

2.86

88.53

1.3

1.2

76.11

68.31

u/l

0.36

445

992

Solid cancers, including Hilmo

860

2301

2.20

88.39

1.3

1.2

72.54

58.82

u/l

2.93

770

1995

Hypertension, essential

773

1921

2.29

87.25

1.2

61.65

64.97

u/l

0.41

676

1708

Other disorders of skin and subcutaneous tissue

838

3348

2.13

87.19

1.3

1.2

58.27

63.22

u/l

1.24

747

2943

Other diseases of intestines

1025

2843

2.02

84.57

1.2

63.47

68.17

u/l

0.49

900

2506

L02BG Aromatase inhibitors

460

1705

2.72

83.99

1.2

60.71

59.10

u/l

0.35

428

1478

Crohn's disease NAS

130

193

7.01

83.81

1.3

1.2

60.96

62.69

u/l

0.07

115

177

Any event in cancer register

884

2454

2.12

83.45

1.3

1.2

72.59

59.36

u/l

2.80

789

2137

Cholelithiasis, broad definition with cholecystitis

912

2967

2.06

82.77

1.2

55.31

62.28

u/l

2.11

815

2595

Intestinal infectious diseases

978

3682

1.99

82.48

1.2

67.51

64.01

u/l

0.30

874

3238

Pain in limb

851

2570

2.12

82.16

1.2

62.30

68.26

u/l

0.97

742

2255

Autoimmune hepatitis, wide definition

108

134

8.47

81.64

1.2

1.1

50.39

63.27

u/l

0.79

114

Finngen Rheumatological endpoints

914

2528

2.07

80.32

1.2

60.70

67.35

u/l

1.42

813

2228

Colitis, primary sclerosing

17.60

79.03

1.3

51.35

45.34

u/l

0.39

Oxycodone

475

1576

2.61

78.22

1.3

1.2

97.10

55.98

u/l

4.55

445

1372

Diarrhoea and gastroenteritis of presumed infectious origin

740

3122

2.13

78.16

1.3

1.2

72.11

64.13

u/l

0.63

658

2738

Other inflammatory liver diseases

132

215

6.40

77.88

1.2

1.1

49.91

59.67

u/l

0.94

121

187

Medicines for HER+ breast cancer

509

1928

2.50

77.74

1.2

60.53

58.34

u/l

0.59

472

1681

Exposure to unspecified factor

1029

3680

1.91

76.36

1.2

62.54

65.76

u/l

0.55

880

3279

Cholelithiasis

867

2933

2.03

76.31

1.2

55.18

62.43

u/l

2.14

774

2566

Abnormal results of function studies

160

323

5.12

74.85

1.2

1.1

53.73

64.25

u/l

1.23

141

286

Intestinal infectious diseases, including avohilmo, including avohilmo

1137

3412

1.87

74.79

1.3

1.2

60.55

64.57

u/l

0.66

1017

2997

Gout, strict definition

253

723

3.58

74.35

1.2

59.38

67.76

u/l

0.90

227

617

Other noninfective gastroenteritis and colitis

325

1082

3.05

74.13

1.3

1.2

57.83

69.82

u/l

1.70

292

934

Amputation

172

372

4.76

74.04

1.3

1.2

57.71

64.93

u/l

0.60

166

325

Chronic hepatitis, not elsewhere classified

114

8.88

74.02

1.3

1.2

49.43

51.26

u/l

0.16

104

Diabetes, varying definitions

995

2997

1.94

73.77

1.2

65.31

65.07

u/l

0.02

885

2641

Crohn's disease of large intestine

111

161

7.21

73.24

1.3

1.2

69.06

63.58

u/l

0.21

145

Complications of medical and surgical care

798

3576

2.02

73.13

1.3

1.2

58.10

62.46

u/l

1.20

725

3139

Opioids

886

2267

2.03

72.68

1.2

64.68

58.43

u/l

1.39

780

1998

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

129

221

6.05

72.27

1.2

60.02

59.91

u/l

0.00

111

200

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

946

2895

1.95

72.04

1.2

63.92

64.71

u/l

0.06

841

2548

Diabetes mellitus

993

3002

1.92

71.94

1.2

64.83

65.27

u/l

0.03

882

2646

Complications of procedures, not elsewhere classified

836

3411

1.99

71.78

1.2

60.06

63.63

u/l

0.66

754

2983

Gastrointestinal diseases

465

865

2.71

71.37

1.2

69.87

71.41

u/l

0.08

419

743

Colitis, primary sclerosing, strict definition

20.72

71.08

1.3

45.69

50.52

u/l

0.33

Diseases of arteries, arterioles and capillaries

720

2534

2.10

70.36

1.3

1.2

60.57

61.99

u/l

0.18

651

2207

Crohn disease (strict definition, require KELA)

124

210

6.13

70.33

1.2

60.16

60.09

u/l

0.00

107

191

Other heart diseases, wide

873

2678

1.99

70.19

1.2

70.85

66.82

u/l

0.29

783

2365

Cardiovascular diseases (excluding rheumatic etc)

538

1271

2.44

69.95

1.2

77.95

68.12

u/l

0.53

490

1130

Crohn disease (strict definition, require KELA, min 2 HDR)

123

208

6.14

69.88

1.2

60.03

59.95

u/l

0.00

106

189

Endocrine, nutritional and metabolic diseases

653

1464

2.27

69.72

1.2

67.83

70.63

u/l

0.22

582

1284

Gout, idiopatic and unspecified

312

1053

3.02

69.67

1.2

60.64

66.80

u/l

0.76

278

902

Gout, unspecified

267

833

3.27

68.26

1.2

61.68

67.90

u/l

0.62

238

703

Disorders of mineral metabolism

149

308

4.99

67.83

1.4

1.2

69.14

60.50

u/l

0.57

139

268

Other retinal disorders

707

2604

2.08

67.81

1.3

1.2

59.81

63.95

u/l

0.77

614

2300

Osteomyelitis

118

199

6.15

67.22

1.4

1.2

60.25

71.45

u/l

0.59

112

171

Peripheral artery operations in Hilmo

188

470

4.09

67.02

1.3

1.2

62.61

64.55

u/l

0.10

180

408

Codeine

828

2244

2.01

66.64

1.2

59.71

58.22

u/l

0.26

725

1975

Diabetic maculopathy, excluding more controls

159

355

4.59

65.79

1.3

1.2

63.92

62.15

u/l

0.12

142

311

Biological medication for rheuma

243

733

3.38

65.64

1.2

51.23

62.48

u/l

2.93

219

647

Crohn's disease of small intestine

121

214

5.84

65.56

1.4

1.2

55.59

59.99

u/l

0.39

108

192

Diseases of the digestive system

518

2282

2.28

65.55

1.3

1.2

63.68

64.70

u/l

0.10

470

1991

Other diseases of biliary tract

152

331

4.74

65.01

1.4

1.2

59.39

61.59

u/l

0.17

142

285

Other soft tissue disorders, not elsewhere classified

883

2613

1.93

64.97

1.2

61.98

68.31

u/l

1.08

780

2298

Diabetes, insulin treatment (Kela reimbursement)

997

3228

1.85

64.82

1.2

62.83

64.62

u/l

0.16

889

2840

Nausea and vomiting

333

1177

2.80

64.75

1.3

1.2

75.31

67.26

u/l

0.31

298

1026

Disorders of choroid and retina

852

3130

1.92

64.24

1.3

1.2

58.71

63.27

u/l

1.10

736

2771

Other arthritis (FG)

361

1379

2.65

63.72

1.2

52.62

65.53

u/l

4.99

323

1194

Gastro-oesophageal reflux disease

699

2941

2.02

63.35

1.2

59.35

64.03

u/l

0.53

624

2587

Hyperkalaemia

110

184

6.19

63.18

1.3

71.59

62.32

u/l

0.34

103

160

Bleeding

845

3119

1.91

63.13

1.3

1.2

61.90

63.50

u/l

0.23

763

2723

Ulcerative ileocolitis

123

7.68

62.72

1.2

51.40

54.54

u/l

0.23

109

Asthma, unspecified (mode), excluding more controls

499

1542

2.33

62.64

1.2

55.16

67.13

u/l

2.96

438

1345

Hypothyroidism (congenital or acquired)

185

227

4.60

62.59

1.2

61.08

62.43

u/l

0.10

162

200

Type 2 diabetes, wide definition

810

2639

1.95

62.48

1.2

59.53

64.39

u/l

1.02

724

2316

Liquid cancers, including Hilmo

389

1354

2.56

62.41

1.2

67.64

59.39

u/l

0.73

360

1163

Liquid cancers

332

1158

2.75

62.13

1.2

68.53

60.82

u/l

0.55

308

990

Glomerulonephritis

152

344

4.55

61.95

1.3

1.2

74.48

78.99

u/l

0.15

139

303

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

655

3195

2.03

61.55

1.3

1.2

59.13

63.00

u/l

0.84

595

2793

Hypothyroidism and >3 levothyroxin purchases

183

227

4.56

61.28

1.2

60.26

62.43

u/l

0.17

160

200

Hypothyroidism, levothyroxine purchases

183

227

4.56

61.28

1.2

60.26

62.43

u/l

0.17

160

200

Other diseases of blood and blood-forming organs, wide

294

1043

2.87

60.10

1.2

81.73

64.66

u/l

1.01

275

899

Disorders of lipoprotein metabolism and other lipidaemias

806

2554

1.93

60.09

1.2

61.25

63.32

u/l

0.28

705

2243

Diabetes medication

987

3200

1.81

59.97

1.2

63.59

65.06

u/l

0.13

875

2822

Anaemia in chronic diseases classified elsewhere

10.68

59.92

1.3

1.2

66.92

87.64

u/l

0.23

Acute peritonitis

117

220

5.51

59.46

1.3

1.2

69.05

65.52

u/l

0.17

107

194

Sulfasalazine

318

1181

2.73

59.40

1.2

55.45

62.10

u/l

1.58

289

1025

Peripheral artery disease

479

1665

2.30

59.16

1.3

1.2

58.53

63.81

u/l

0.67

439

1435

Type 2 diabetes

923

2923

1.84

58.67

1.2

59.04

63.74

u/l

1.06

819

2575

Heart failure and coronary heart disease

477

1462

2.31

58.04

1.2

55.73

64.72

u/l

1.68

422

1263

Heart failure and bmi 25plus

396

1055

2.54

58.02

1.2

59.05

59.81

u/l

0.05

354

931

Diabetic retinopathy, strict definition

254

742

3.11

57.92

1.3

1.2

60.71

60.72

u/l

0.00

231

659

Infections of the skin and subcutaneous tissue

585

2821

2.06

57.34

1.3

1.2

70.40

66.18

u/l

0.38

527

2467

Tumor necrosis factor alpha inhibitors

214

650

3.36

57.25

1.2

51.80

62.52

u/l

2.31

193

575

Constipation

893

3343

1.82

57.00

1.2

63.86

62.32

u/l

0.19

783

2954

Other specified/unspecified arthritis

325

1250

2.64

56.69

1.2

52.33

66.90

u/l

5.20

291

1085

Certain disorders involving the immune mechanism

251

844

3.03

56.61

1.2

73.92

68.34

u/l

0.15

229

736

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

115

7.47

55.86

1.4

1.2

65.97

51.75

u/l

1.31

101

Covid-19 confirmed case

413

1785

2.34

55.71

1.3

1.2

67.81

63.28

u/l

0.28

373

1550

Noninfectious colitis NAS

182

508

3.66

55.53

1.2

57.95

68.49

u/l

0.83

167

443

Medical observation and evaluation for suspected diseases and conditions

575

1368

2.16

55.38

1.3

1.2

65.73

68.75

u/l

0.26

519

1183

Disorders of thyroid, IBD co-morbidities

179

312

3.97

54.99

1.2

72.26

71.57

u/l

0.02

158

276

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

128

279

4.73

54.75

1.3

1.2

56.05

62.17

u/l

0.41

118

241

Adjustment and management of implanted device

220

699

3.20

54.64

1.2

58.01

66.68

u/l

0.58

197

599

Diseases of the skin and subcutaneous tissue

852

2310

1.86

54.32

1.2

60.37

66.62

u/l

1.12

748

2028

Other and unspecified polyneuropathies, also in other diseases

245

832

3.00

54.30

1.3

1.2

52.92

67.93

u/l

3.53

217

715

Asthma, unspecified (mode)

510

1708

2.17

54.19

1.2

54.86

66.00

u/l

2.91

446

1484

Other ulcerative colitis

174

5.88

54.07

1.3

1.2

66.60

62.56

u/l

0.13

155

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

948

3463

1.77

54.03

1.3

1.2

66.59

64.45

u/l

0.16

849

3041

Rheumatoid arthritis

376

1390

2.42

53.73

1.2

53.30

65.47

u/l

4.60

342

1212

Systemic connective tissue disorders

413

1820

2.30

53.52

1.3

1.2

57.68

61.10

u/l

0.37

371

1590

Ascites

130

294

4.56

53.15

1.3

1.2

53.56

63.35

u/l

1.02

124

261

Ulcerative rectosigmoiditis

117

243

4.94

52.97

1.4

1.2

55.10

61.52

u/l

0.53

107

215

Hypertensive heart and/or renal disease

283

737

2.84

52.93

1.3

1.2

55.40

71.05

u/l

1.89

255

642

Diabetic retinopathy, excluding more controls

336

710

2.69

52.40

1.3

1.2

59.14

60.68

u/l

0.16

298

617

Hypertensive Renal Disease

103

7.58

51.98

1.3

61.20

75.60

u/l

0.64

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

133

197

4.82

51.74

1.2

65.97

60.56

u/l

0.33

118

174

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

398

1055

2.40

51.43

1.3

1.2

62.39

63.62

u/l

0.10

355

937

Atrial fibrillation and flutter

320

784

2.66

51.38

1.2

62.98

66.98

u/l

0.30

289

693

Certain infectious and parasitic diseases, including avohilmo

601

1468

2.06

51.27

1.2

63.35

65.51

u/l

0.19

534

1264

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

599

3080

1.96

51.15

1.3

1.2

59.06

61.70

u/l

0.53

542

2690

Pain in joint

539

1583

2.11

51.14

1.2

57.65

68.16

u/l

2.59

479

1395

Chronic pancreatitis

166

462

3.67

50.96

1.3

1.2

53.20

65.60

u/l

2.28

145

400

Cardiovascular diseases

457

1066

2.29

50.93

1.3

1.2

81.12

70.92

u/l

0.45

409

945

Neoplasms

572

1446

2.09

50.90

1.2

70.93

64.98

u/l

0.54

504

1262

Polyneuropathies and other disorders of the peripheral nervous system

266

979

2.76

50.79

1.2

52.78

67.03

u/l

3.85

236

839

Cardiac arrhythmias

530

1627

2.10

50.59

1.3

1.2

70.44

68.43

u/l

0.09

469

1433

Other medical care

495

1990

2.11

50.21

1.3

1.2

83.52

62.49

u/l

2.92

461

1721

Continuous positive airway pressure

205

533

3.25

49.99

1.2

1.3

54.74

71.51

u/l

2.38

190

467

Oesophageal varices

150

6.14

49.80

1.2

62.51

55.83

u/l

0.35

130

Explicit bacterial Sepsis, including avohilmo

139

347

4.09

49.76

1.3

1.2

69.89

64.74

u/l

0.22

133

303

Asthma, excluding more controls

619

1589

2.01

49.73

1.2

56.93

66.86

u/l

2.16

545

1387

Hypothyroidism, strict autoimmune

583

1915

2.01

49.71

1.2

56.68

65.47

u/l

2.65

509

1662

Spondyloarthritis

196

615

3.23

49.68

1.2

54.96

64.55

u/l

1.30

183

529

Abnormalities of breathing

778

2433

1.84

49.51

1.2

56.67

68.42

u/l

3.85

688

2144

Hypothyroidism, drug reimbursement

123

177

4.91

49.07

1.3

1.2

55.86

60.72

u/l

0.47

107

154

Seropositive rheumatoid arthritis

290

1131

2.59

48.67

1.2

54.62

64.07

u/l

2.55

264

979

Disorders of calcium metabolism

108

226

4.93

48.58

1.3

1.2

70.43

60.03

u/l

0.54

101

196

Primary hyperparathyroidism

181

551

3.38

48.55

1.2

73.14

56.88

u/l

1.85

166

479

COPD/asthma related infections

902

2577

1.76

48.40

1.3

1.2

62.96

63.45

u/l

0.05

807

2258

COPD/asthma/ILD related infections

902

2577

1.76

48.40

1.3

1.2

62.96

63.45

u/l

0.05

807

2258

6-mercaptopurine

8.22

48.39

1.3

1.1

52.97

62.65

u/l

0.59

Follow-up examination after treatment for conditions other than malignant neoplasms

417

1235

2.27

48.27

1.2

57.61

62.88

u/l

1.03

372

1066

Explicit bacterial Sepsis

136

342

4.06

48.22

1.3

1.2

70.59

64.79

u/l

0.25

130

298

Amputation of foot

8.37

47.75

1.3

53.36

47.80

u/l

0.41

Dermatitis and eczema

1022

3633

1.67

47.48

1.2

58.97

66.56

u/l

2.29

904

3210

Pain, not elsewhere classified

295

1183

2.52

47.23

1.3

1.2

57.84

63.07

u/l

0.66

270

1030

Diseases of peritoneum

149

409

3.73

46.79

1.3

1.2

66.84

64.35

u/l

0.16

132

357

Codeine or tramadol medication

1003

3252

1.68

46.73

1.2

59.61

62.68

u/l

0.63

871

2879

Atherosclerosis, excluding cerebral and coronary sclerosis

429

1565

2.18

46.61

1.2

59.39

64.16

u/l

0.60

393

1352

Streptococcal septicaemia, including avohilmo

119

278

4.38

46.60

1.4

1.1

69.98

62.73

u/l

0.29

113

239

Asthma

653

1760

1.92

46.47

1.2

56.99

65.81

u/l

1.98

576

1530

Low back pain

721

2691

1.82

46.03

1.2

56.95

64.49

u/l

3.11

643

2373

Streptococcal septicaemia

116

269

4.41

45.86

1.4

1.1

70.82

63.05

u/l

0.31

110

232

Dermatitis

622

3301

1.86

45.25

1.3

1.2

60.89

63.39

u/l

0.38

540

2914

Persons encountering health services in other circumstances

393

1801

2.18

44.95

1.2

61.87

65.39

u/l

0.42

346

1555

Pure hypercholesterolaemia

698

2436

1.83

44.88

1.2

59.74

63.76

u/l

0.59

617

2136

Dyspnoea

843

3569

1.71

44.54

1.2

55.72

65.13

u/l

4.13

752

3141

Hypo-osmolality and hyponatraemia

214

748

2.88

44.35

1.2

57.95

61.43

u/l

0.41

197

649

Osteoporosis with pathological fracture (FG)

121

299

4.17

44.16

1.2

60.52

57.53

u/l

0.28

102

257

Disorders of lens

667

2252

1.85

44.06

1.3

1.2

63.60

63.40

u/l

0.02

605

1970

Cutaneous abscess, furuncle and carbuncle

279

1128

2.50

43.99

1.2

72.45

63.38

u/l

0.58

256

988

Other systemic involvement of connective tissue (FG)

283

1130

2.49

43.87

1.2

58.14

62.91

u/l

0.40

250

980

Other diseases of the digestive system

340

1505

2.28

43.67

1.2

62.91

65.77

u/l

0.27

309

1294

Non-ischemic cardiomyopathy

339

1165

2.34

43.66

1.2

64.12

66.40

u/l

0.13

297

1013

GI-bleeding

338

1498

2.28

43.27

1.2

63.37

65.93

u/l

0.23

306

1291

Pain in throat and chest

726

2410

1.79

43.02

1.2

58.08

66.54

u/l

2.44

631

2124

Cholecystectomy

699

3367

1.78

42.93

1.2

55.29

61.64

u/l

1.87

624

2956

Other and unspecified dermatitis

528

2774

1.92

42.74

1.3

1.2

61.33

64.10

u/l

0.36

463

2431

Asthma (only as main-diagnosis), excluding more controls

558

1589

1.95

42.23

1.3

1.2

58.31

66.86

u/l

1.61

503

1387

Other diseases of pancreas

123

319

3.96

41.97

1.3

1.2

57.00

62.83

u/l

0.52

110

283

Congenital malformations of the urinary system, including avohilmo

203

4.82

41.72

1.3

1.2

83.50

76.39

u/l

0.17

183

Atrial fibrillation and flutter with reimbursement

261

626

2.66

41.58

1.2

62.09

65.73

u/l

0.21

231

550

Other diseases of intestine

193

667

2.94

41.57

1.3

1.2

76.00

64.53

u/l

0.25

169

576

Congenital malformations of the urinary system

192

4.94

41.57

1.3

1.2

84.88

71.92

u/l

0.33

174

Asthma (mode)

629

1776

1.87

41.45

1.2

56.89

65.92

u/l

2.08

553

1544

Valvular heart disease excluding rheumatic fever

444

1551

2.06

41.32

1.2

73.06

66.95

u/l

0.24

398

1349

Fracture of femur

304

1174

2.36

41.32

1.3

1.2

70.54

60.03

u/l

1.48

268

1024

Collagenous colitis

131

359

3.74

41.29

1.2

51.21

59.36

u/l

1.11

117

313

Non-rheumatic valve diseases

442

1544

2.06

41.06

1.2

65.01

66.57

u/l

0.08

396

1343

Fall on same level

976

3190

1.64

40.97

1.3

1.2

68.84

64.95

u/l

0.36

841

2841

Vitreous haemorrhage

140

404

3.55

40.83

1.4

1.2

61.33

64.10

u/l

0.18

125

354

Symptoms and signs involving the digestive system and abdomen

830

2435

1.72

40.81

1.2

66.48

67.58

u/l

0.09

723

2131

Other nutritional deficiencies

630

3225

1.80

40.81

1.2

61.07

63.61

u/l

0.35

558

2832

Other diseases of pleura

448

1953

2.01

40.55

1.2

69.10

65.66

u/l

0.15

402

1694

Other disorders of urethra and urinary system

661

2584

1.79

40.40

1.2

62.58

62.74

u/l

0.02

582

2290

Crohn disease (strict definition, all UC cases excluded)

170

5.16

40.38

1.2

52.72

57.34

u/l

0.42

155

Arthropathies in other diseases classified elsewhere

105

6.53

39.97

1.4

1.1

53.74

57.01

u/l

0.20

Other bacterial intestinal infections

209

770

2.75

39.93

1.3

1.2

60.51

64.76

u/l

0.40

187

669

Antihypertensive medication - note that there are other indications

435

1084

2.11

39.88

1.2

75.54

71.32

u/l

0.17

388

953

Benzodiazepine use

899

3718

1.64

39.80

1.2

58.49

64.17

u/l

1.36

794

3281

Other functional intestinal disorders

444

2041

1.99

39.51

1.2

62.88

65.97

u/l

0.34

397

1790

Codes for special purposes

506

2675

1.89

39.11

1.3

1.2

65.93

62.01

u/l

0.30

459

2343

Other specific joint derangements/joint disorders

618

2128

1.82

38.96

1.2

57.81

72.99

u/l

3.60

548

1866

Personal history of malignant neoplasm

135

393

3.52

38.93

1.2

60.14

58.91

u/l

0.11

119

344

Rheumatoid arthritis, including avohilmo

407

2026

2.03

38.73

1.2

53.98

62.31

u/l

3.22

366

1769

Enterocolitis due to Clostridium difficile

139

414

3.42

38.57

1.3

1.2

61.24

63.97

u/l

0.17

130

363

Provisional assignment of new diseases of uncertain etiology

504

2674

1.88

38.54

1.3

1.2

65.76

62.05

u/l

0.28

457

2342

Excluding asthma or asthma-COPD overlap

643

1779

1.82

38.54

1.2

64.06

65.82

u/l

0.17

574

1549

Other CVD (FINNGEN)

132

275

3.72

38.52

1.3

1.2

61.66

64.79

u/l

0.22

115

240

Cystic kidney disease, including avohilmo

130

5.79

38.44

1.3

1.2

69.11

53.79

u/l

0.85

117

Haemorrhage from respiratory passages

346

1426

2.17

38.37

1.2

66.85

64.96

u/l

0.06

311

1242

Other diseases of arteries and capillaries

125

349

3.66

38.35

1.4

1.2

61.19

59.77

u/l

0.09

115

308

Diabetic retinopathy

400

1194

2.11

37.92

1.3

1.2

59.29

59.10

u/l

0.02

353

1056

Alcoholic liver disease

122

338

3.68

37.83

1.2

58.07

71.35

u/l

1.16

111

293

Chronic gastritis

292

1293

2.29

37.61

1.2

58.31

65.44

u/l

1.36

256

1121

Other pulmonary diagnosis

639

1779

1.81

37.56

1.3

1.2

64.36

65.82

u/l

0.13

571

1549

Hyperlipidaemia, other/unspecified

377

1648

2.07

37.45

1.2

59.10

63.52

u/l

0.64

327

1437

Cystic kidney disease

127

5.78

37.22

1.3

1.2

70.00

54.00

u/l

0.87

115

COPD differential diagnosis

636

1776

1.80

37.05

1.2

64.33

65.92

u/l

0.15

568

1544

ILD differential diagnosis

636

1776

1.80

37.04

1.2

64.33

65.92

u/l

0.15

568

1544

Persons encountering health services for specific procedures, not carried out

103

258

4.07

36.83

1.3

1.2

58.80

57.34

u/l

0.10

222

Other diseases of urinary system

850

2915

1.64

36.72

1.2

66.42

64.16

u/l

0.19

739

2588

Unspecified privation

131

388

3.44

36.70

1.2

56.68

66.81

u/l

1.08

112

345

Polycystic kidney disease

6.65

36.65

1.3

1.2

62.42

54.94

u/l

0.43

Asthma (only as main-diagnosis)

575

1760

1.84

36.44

1.2

58.26

65.81

u/l

1.45

517

1530

Fungal Sepsis

144

5.32

36.33

1.4

1.2

64.49

55.12

u/l

0.54

128

Paralytic ileus and intestinal obstruction

270

1173

2.33

36.29

1.3

1.2

57.06

63.05

u/l

1.13

251

1017

Presence of other functional implants

559

2112

1.82

36.26

1.2

56.93

63.78

u/l

1.60

492

1838

Abdominal and pelvic pain

807

2435

1.67

36.18

1.2

65.30

67.58

u/l

0.19

700

2131

Adalimumab

123

353

3.55

36.18

1.1

1.2

53.56

68.77

u/l

1.92

111

311

Immunodeficiencies

156

5.10

36.09

1.3

1.2

114.72

58.41

u/l

0.63

142

Nephrotic syndrome

103

6.29

36.06

1.2

85.76

86.27

u/l

0.01

Bacterial intestinal infections, IBD co-morbidities

211

823

2.60

36.05

1.3

1.2

60.21

66.38

u/l

0.66

189

714

Chronic tubulo-interstitial nephritis

120

5.78

35.99

1.2

65.07

54.31

u/l

0.61

110

Diverticular disease of intestine

651

2333

1.75

35.89

1.2

57.87

63.74

u/l

0.95

568

2048

Chronic nephritic syndrome

124

5.69

35.87

1.3

1.2

85.82

51.19

u/l

1.62

112

Cerebrovascular diseases (FINNGEN)

278

834

2.36

35.79

1.2

60.91

65.10

u/l

0.50

249

740

Benign neoplasm of colon, rectum, anus and anal canal

619

3034

1.74

35.35

1.2

56.79

62.58

u/l

1.21

547

2653

Abnormal findings on diagnostic imaging of lung

471

2399

1.87

35.32

1.2

61.13

62.62

u/l

0.16

425

2084

Other gastritis (incl. Duodenitis)

237

986

2.43

35.28

1.2

58.36

66.97

u/l

0.96

205

847

Viral pneumonia

145

468

3.15

35.28

1.3

1.2

67.04

64.74

u/l

0.13

129

411

Lower back pain or/and sciatica

935

3691

1.58

35.24

1.2

56.02

64.36

u/l

4.16

828

3255

Implicit fungal Sepsis, including avohilmo

250

4.06

35.11

1.4

1.2

71.37

56.88

u/l

1.32

220

Cellulitis

234

970

2.44

35.10

1.3

1.2

62.05

64.56

u/l

0.15

216

845

Complications of internal orthopaedic prosthetic devices, implants and grafts

254

1094

2.35

35.00

1.3

1.2

56.37

64.56

u/l

1.38

227

935

Parasetamol

537

1462

1.87

34.93

1.2

63.96

68.21

u/l

0.39

469

1311

Other necrotizing vasculopathies

103

269

3.93

34.90

1.3

1.2

45.36

56.96

u/l

2.52

240

Other bacterial intestinal infections, including avohilmo

248

1059

2.37

34.81

1.3

1.2

60.22

64.51

u/l

0.48

218

911

All influenza

252

1083

2.35

34.79

1.3

1.2

65.42

62.50

u/l

0.25

234

927

Depression medications

159

242

3.32

34.39

1.2

66.40

65.01

u/l

0.07

138

214

Primary_lymphoid and hematopoietic malignant neoplasms

257

1122

2.32

34.32

1.2

73.98

67.75

u/l

0.31

238

961

Pleural effusion

178

654

2.77

34.31

1.2

57.85

66.48

u/l

0.64

158

567

Other necrotizing vasculopathies (FG)

188

4.53

33.97

1.3

1.1

44.16

62.85

u/l

3.14

160

Other diseases of stomach and duodenum

227

4.16

33.70

1.3

1.2

49.09

66.09

u/l

2.16

196

Injuries to the hip and thigh

469

2286

1.85

33.66

1.3

1.2

66.58

61.13

u/l

0.93

412

2004

Other cataract

439

1723

1.91

33.34

1.3

1.2

64.62

64.22

u/l

0.03

391

1495

L04AC Interleukin inhibitors

229

4.12

33.30

1.1

1.2

48.30

56.01

u/l

0.95

204

Other disorders of glucose regulation and pancreatic internal secretion

103

278

3.78

33.23

1.3

1.2

60.47

78.88

u/l

0.90

247

Coagulation defects, purpura and other haemorrhagic conditions

212

864

2.49

33.06

1.3

1.2

63.78

68.82

u/l

0.27

203

760

Obesity and other hyperalimentation

576

3153

1.73

32.96

1.2

57.84

64.26

u/l

1.70

512

2770

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

149

4.98

32.93

1.2

55.25

52.54

u/l

0.22

129

Other disorders of white blood cells

185

4.51

32.86

1.2

86.25

58.76

u/l

0.43

167

Obesity

573

3140

1.73

32.85

1.2

57.88

64.32

u/l

1.70

510

2757

Iron deficiency anaemia secondary to blood loss (chronic)

179

679

2.67

32.42

1.3

1.2

56.59

64.36

u/l

0.86

164

592

Hypokalaemia

145

492

3.00

32.42

1.2

62.84

60.72

u/l

0.13

130

426

Other systemic involvement of connective tissue

293

1382

2.14

32.37

1.2

58.33

60.57

u/l

0.17

260

1205

Intestinal stricture

321

1567

2.07

32.35

1.3

1.2

57.67

63.23

u/l

1.10

296

1343

Sequelae of external causes of morbidity and mortality

275

1268

2.19

32.20

1.3

1.2

68.18

64.03

u/l

0.32

247

1094

Implicit fungal Sepsis

133

5.21

32.20

1.4

1.2

65.72

55.15

u/l

0.57

119

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

238

477

2.52

32.16

1.2

1.1

62.89

68.28

u/l

0.39

215

412

Psoriatic and enteropathic arthropathies

133

432

3.13

32.08

1.2

60.32

66.52

u/l

0.46

118

368

Syncope and collapse

383

1646

1.95

32.04

1.2

59.84

64.94

u/l

0.49

345

1432

Benign neoplasm: Colon

529

2849

1.76

31.97

1.2

54.77

63.06

u/l

2.38

472

2480

Volume depletion

112

329

3.46

31.82

1.3

1.2

69.62

64.54

u/l

0.27

285

Enlarged lymph nodes

164

603

2.75

31.55

1.2

85.03

68.44

u/l

0.34

151

524

Depression

822

3490

1.58

31.54

1.2

57.36

64.15

u/l

2.87

723

3075

Symptoms and signs involving the circulatory and respiratory systems

786

2438

1.62

31.51

1.2

59.76

68.44

u/l

1.89

698

2149

Vocal cord dysfunction

117

306

3.40

31.46

1.2

54.72

73.96

u/l

2.80

100

266

Gastroduodenal ulcer

253

1135

2.24

31.40

1.2

55.75

65.77

u/l

1.90

226

976

UC patients in KELA-register (code 208), prior to 1994

152

4.83

31.26

1.4

1.2

65.16

59.36

u/l

0.28

138

Hard cardiovascular diseases

741

2704

1.63

31.18

1.2

67.09

65.09

u/l

0.13

668

2378

Asthma-related infections

536

3035

1.73

31.18

1.2

58.56

66.91

u/l

2.10

477

2673

Asthma, hospital admission 2, infections

536

3035

1.73

31.18

1.3

1.2

58.56

66.91

u/l

2.10

477

2673

967

3203

1.54

30.90

1.3

1.2

59.71

64.01

u/l

0.96

861

2819

Cough

388

1910

1.91

30.86

1.2

58.80

68.49

u/l

2.07

351

1675

Other/unspecified seropositive rheumatoid arthritis

288

1376

2.12

30.83

1.2

54.40

60.68

u/l

1.63

262

1205

Artificial opening status

178

4.44

30.76

1.4

1.2

111.83

75.21

u/l

0.35

160

Peripheral arterial reconstruction

178

692

2.61

30.70

1.2

56.06

66.36

u/l

1.34

162

599

Seropositive rheumatoid arthritis, wide

290

1392

2.11

30.67

1.2

54.63

60.46

u/l

1.46

264

1217

Chronic ulcer of skin, not elsewhere classified

239

3.90

30.60

1.2

53.41

69.08

u/l

1.24

212

Spondylopathies

694

2505

1.65

30.59

1.2

59.44

62.69

u/l

0.57

604

2208

Viral and other specified intestinal infections

169

625

2.66

30.42

1.3

1.2

74.50

73.09

u/l

0.03

157

549

Any death

594

2463

1.70

30.36

1.3

1.2

74.24

59.14

u/l

2.74

552

2120

Fracture of lumbar spine and pelvis

239

1064

2.27

30.33

1.3

1.2

66.68

61.45

u/l

0.47

221

916

Symptoms and signs concerning food and fluid intake

118

370

3.23

30.09

1.2

69.38

68.43

u/l

0.03

100

320

Mood disorders, excluding more controls

799

2979

1.58

30.05

1.2

57.23

62.38

u/l

1.77

701

2639

ILD, hospital admission 2, with pulmonary infections

115

357

3.28

29.97

1.2

65.33

64.60

u/l

0.04

104

308

Diaphragmatic hernia

370

1954

1.91

29.79

1.2

64.26

60.44

u/l

0.32

320

1703

Presence of cardiac and vascular implants and grafts

380

1460

1.93

29.79

1.2

58.24

66.36

u/l

0.91

348

1255

Myocardial infarction

443

1696

1.84

29.70

1.2

57.30

62.31

u/l

1.04

390

1477

Chronic apical periodontitis

927

3412

1.53

29.70

1.2

61.36

63.36

u/l

0.34

814

3019

ILD, hospital admissions 3, with pneumonia sepsis

104

305

3.48

29.69

1.2

64.06

67.09

u/l

0.16

266

Cystitis

724

2678

1.62

29.67

1.2

63.85

63.24

u/l

0.04

635

2376

Obesity due to excess calories

426

2355

1.82

29.60

1.2

58.47

63.25

u/l

0.81

378

2079

Other reaction to severe stress, and adjustment disorders

329

1671

1.98

29.59

1.3

1.2

68.38

60.77

u/l

0.86

304

1474

141

496

2.88

29.52

1.3

1.2

73.16

59.88

u/l

0.79

122

430

Ischemic heart diseases

740

2759

1.60

29.51

1.2

69.11

64.19

u/l

0.38

658

2437

Mood disorders

869

3623

1.54

29.47

1.2

57.49

63.92

u/l

2.72

766

3197

Mood [affective] disorders

867

3620

1.54

29.45

1.2

57.53

63.94

u/l

2.70

764

3194

Irritable bowel syndrome

264

1244

2.14

29.25

1.2

55.81

61.86

u/l

1.40

231

1101

Statin medication

545

1771

1.74

29.22

1.2

75.99

63.18

u/l

0.76

481

1598

Anxiety disorders, excluding more controls

704

2808

1.61

28.84

1.2

64.29

63.05

u/l

0.14

623

2484

Diabetic maculopathy

155

546

2.73

28.81

1.3

1.2

63.32

63.44

u/l

0.01

138

481

Other or unspecified ileus, impaction or obstruction

186

761

2.47

28.79

1.4

1.2

56.24

63.75

u/l

1.14

171

652

Abnormal findings on diagnostic imaging of other body structures

168

657

2.60

28.71

1.2

58.61

62.53

u/l

0.33

149

575

Other disorders of skin and subcutaneous tissue, not elsewhere classified

159

605

2.67

28.70

1.2

1.1

51.25

63.72

u/l

2.36

149

525

Sequelae with surgical and medical care as external cause

220

973

2.29

28.62

1.3

1.2

64.52

65.15

u/l

0.04

197

844

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

776

3898

1.56

28.60

1.2

60.71

65.79

u/l

1.03

685

3440

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

279

1356

2.08

28.58

1.2

54.91

60.79

u/l

1.43

255

1186

Hypertensive Heart Disease

215

696

2.36

28.55

1.2

52.53

71.97

u/l

2.53

191

607

Ulcerative proctitis

185

4.20

28.37

1.4

1.2

52.35

64.36

u/l

1.17

167

Viral and other specified intestinal infections, including avohilmo

225

968

2.25

28.18

1.3

1.2

69.69

68.16

u/l

0.05

207

849

Senile cataract

571

2063

1.69

28.15

1.3

1.2

61.45

64.10

u/l

0.29

518

1799

Asthma, hospital admissions 3, pneumonia

355

1881

1.90

27.97

1.2

59.43

64.95

u/l

0.79

318

1642

Asthma-related pneumonia or sepsis

355

1881

1.90

27.97

1.2

59.43

64.95

u/l

0.79

318

1642

Acute pancreatitis

190

796

2.41

27.97

1.2

56.26

68.50

u/l

2.21

174

682

Agranulocytosis

135

479

2.87

27.94

1.3

1.2

85.97

61.34

u/l

1.65

127

420

Percutaneous Coronary Intervention

702

2680

1.60

27.90

1.2

67.25

64.48

u/l

0.18

624

2364

Headache

503

2264

1.72

27.87

1.3

1.2

58.94

64.61

u/l

1.02

436

1983

Asthma-related pneumonia

354

1878

1.89

27.80

1.2

59.46

64.99

u/l

0.79

317

1640

Other respiratory diseases principally affecting the interstitium

188

790

2.41

27.53

1.2

64.38

66.79

u/l

0.18

167

683

Care involving use of rehabilitation procedures

521

2787

1.69

27.47

1.3

1.2

71.16

61.84

u/l

0.60

461

2416

Use of hypnotics and sedatives

883

3339

1.52

27.44

1.3

1.2

65.88

62.91

u/l

0.34

772

2954

General examination and investigation of persons without complaint and reported diagnosis

470

1367

1.79

27.37

1.2

64.73

68.77

u/l

0.38

431

1182

Hepatic failure, not elsewhere classified

125

4.96

27.31

1.3

1.2

54.82

58.89

u/l

0.18

113

Idiopathic gout

105

328

3.26

27.14

1.2

58.10

66.19

u/l

0.53

286

Psoriasis

283

1409

2.03

27.13

1.2

61.41

65.75

u/l

0.45

250

1220

Failure and rejection of transplanted organs and tissues

8.22

27.11

1.3

1.2

74.11

94.99

u/l

0.15

AV-block

169

573

2.55

27.01

1.2

53.73

69.08

u/l

2.63

159

501

Total colectomy operation

142

4.64

26.99

1.6

1.2

56.13

56.95

u/l

0.04

129

Total colectomy

142

4.64

26.99

1.6

1.2

56.13

56.95

u/l

0.04

129

Emergency coronary revascularization (for ACS)

749

2908

1.56

26.84

1.2

67.41

65.92

u/l

0.09

666

2559

Osteonecrosis

230

3.74

26.69

1.3

1.2

77.75

59.06

u/l

0.79

206

Urinary track infection

527

1539

1.73

26.63

1.2

63.58

62.67

u/l

0.05

461

1380

Disorders of the thyroid gland

777

3286

1.54

26.52

1.2

61.08

62.80

u/l

0.25

685

2905

Spondylopathies (FG)

127

449

2.86

26.40

1.2

52.33

64.72

u/l

1.80

118

388

Symptoms and signs involving the urinary system

663

3174

1.58

26.22

1.2

65.11

63.32

u/l

0.18

587

2780

Benign neoplasm of other and ill-defined parts of digestive system

199

878

2.30

26.12

1.2

54.21

61.67

u/l

1.37

180

764

Methotrexate

146

559

2.65

26.07

1.2

58.46

64.45

u/l

0.44

133

478

Type 1 diabetes, definitions combined

237

3.62

26.04

1.3

1.2

63.43

74.56

u/l

0.71

213

Pyogenic arthritis

202

3.88

25.96

1.3

1.1

62.28

67.46

u/l

0.21

175

Injuries to the abdomen, lower back, lumbar spine and pelvis

371

2018

1.82

25.94

1.2

74.48

62.50

u/l

0.59

334

1746

Other antidepressants

826

2770

1.53

25.93

1.2

58.00

64.71

u/l

1.94

724

2450

Other CVD

208

937

2.25

25.91

1.3

1.2

59.78

65.45

u/l

0.69

181

819

Periodontitis

847

3605

1.50

25.78

1.3

1.2

61.78

61.37

u/l

0.05

741

3183

Coronary revascularization (ANGIO or CABG)

692

2681

1.58

25.76

1.2

67.55

64.47

u/l

0.21

615

2365

Gingivitis and periodontal diseases

813

2756

1.53

25.71

1.2

63.28

63.53

u/l

0.03

712

2425

Papulosquamous disorders

370

2049

1.82

25.70

1.2

59.38

63.97

u/l

0.69

329

1786

Type 2 diabetes, strict (exclude DM1)

766

2904

1.54

25.69

1.2

60.07

63.42

u/l

0.58

677

2558

Dorsalgia

790

2734

1.54

25.68

1.2

56.60

64.62

u/l

2.67

690

2415

Mycoses

268

1340

2.02

25.42

1.3

1.2

70.06

63.43

u/l

0.67

244

1158

Type 1 diabetes, strict (exclude DM2)

241

3.56

25.41

1.3

1.2

63.43

94.30

u/l

1.08

217

Viral pneumonia (unknown virus, not influenza)

219

3.73

25.40

1.3

1.2

66.69

62.14

u/l

0.22

197

Chronic periodontitis, including avohilmo

844

3607

1.50

25.35

1.3

1.2

61.82

61.27

u/l

0.08

738

3185

Type 2 diabetes, definitions combined

756

2869

1.54

25.25

1.2

59.56

62.89

u/l

0.58

667

2528

Asthma (diagnoses ohter than nonallergic)

733

3890

1.53

25.13

1.2

56.65

65.15

u/l

3.07

643

3440

Hydronephrosis

110

370

3.01

25.06

1.2

76.59

62.10

u/l

0.67

321

Cardiomyopathy

156

628

2.51

25.06

1.2

72.23

68.33

u/l

0.08

137

536

Major coronary heart disease event

730

2837

1.55

25.01

1.2

67.38

64.66

u/l

0.19

651

2492

Arthropathies

679

2173

1.58

25.00

1.2

61.53

72.86

u/l

2.08

612

1909

Elevated blood glucose level

269

3.40

25.00

1.1

1.2

62.22

62.30

u/l

0.00

239

Disorder of lipoprotein metabolism, unspecified

135

508

2.70

24.98

1.3

1.2

51.98

63.69

u/l

1.68

120

435

Postmenopausal osteoporosis with pathological fracture

295

3.30

24.93

1.2

61.23

60.97

u/l

0.02

257

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

221

1004

2.15

24.80

1.5

1.2

131.63

57.91

u/l

3.74

212

859

Diabetic neuropathy

143

554

2.62

24.78

1.3

1.2

58.63

61.56

u/l

0.24

131

490

Hypothyroidism, other/unspecified

725

3113

1.54

24.67

1.2

59.17

61.40

u/l

0.44

635

2746

Vitamin B12 deficiency anaemia

111

379

2.97

24.66

1.3

1.2

54.80

64.06

u/l

1.21

332

Bronchitis

901

3680

1.47

24.65

1.3

1.2

59.96

63.19

u/l

0.65

810

3233

Neurotic, stress-related and somatoform disorders

740

3354

1.53

24.55

1.2

64.77

64.41

u/l

0.04

657

2954

Other diseases of anus and rectum

278

1420

1.97

24.51

1.2

59.61

63.63

u/l

0.34

240

1243

Myocardial infarction, strict

397

1590

1.78

24.13

1.2

58.76

62.86

u/l

0.63

347

1387

Open wound of ankle and foot

109

373

2.97

24.13

1.3

1.2

58.98

65.21

u/l

0.33

100

328

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

808

3427

1.50

24.04

1.2

63.39

61.68

u/l

0.13

712

3019

Hypothyreosis and Thyroxine purchase for inclusion criteria

759

3298

1.51

24.03

1.2

59.32

62.00

u/l

0.59

665

2911

Anxiety disorders

745

3384

1.52

24.00

1.2

64.58

64.47

u/l

0.01

662

2979

STROKE

465

1853

1.70

23.84

1.2

60.37

63.98

u/l

0.58

413

1624

Diseases of the eye and adnexa

574

1773

1.63

23.59

1.2

68.98

68.91

u/l

0.00

504

1576

Postprocedural disorders of digestive system, not elsewhere classified

121

4.70

23.49

1.5

1.3

57.51

50.73

u/l

0.53

109

Seronegative rheumatoid arthritis

123

456

2.74

23.48

1.2

53.70

64.76

u/l

1.44

113

388

Myocardial infarction, without ST-elevation

355

1792

1.80

23.47

1.2

57.32

64.23

u/l

1.19

318

1551

Vascular disorders of the intestines

231

3.53

23.47

1.4

1.2

54.84

60.96

u/l

0.46

199

Hypoglycaemia, other or unspecified

222

3.58

23.40

1.3

1.2

57.82

81.42

u/l

1.00

198

Depression or dysthymia

548

1841

1.63

23.21

1.2

61.46

64.47

u/l

0.32

480

1635

Hypercalcemia

178

3.94

23.15

1.4

1.2

58.13

52.84

u/l

0.47

158

Major coronary heart disease event excluding revascularizations

521

2112

1.64

23.13

1.2

55.49

62.54

u/l

2.07

463

1840

Pain (limb, back, neck, head abdominally)

531

1618

1.65

23.04

1.2

71.18

68.50

u/l

0.16

461

1428

Sleep apnoea

800

3409

1.48

22.99

1.2

58.97

64.16

u/l

1.21

696

3010

Gastric ulcer

171

747

2.31

22.99

1.2

55.10

67.67

u/l

1.87

157

640

Obesity, other/unspecified

300

1617

1.87

22.80

1.2

56.92

61.15

u/l

0.69

275

1417

Type 2 diabetes, definitions combined, including avohilmo

748

2879

1.51

22.77

1.2

59.91

63.61

u/l

0.65

661

2535

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

198

3.70

22.74

1.1

1.2

58.08

52.14

u/l

0.43

173

Other acute lower respiratory infections

445

2554

1.67

22.67

1.2

65.56

66.25

u/l

0.05

399

2244

Malignant neoplasm of breast, HER-negative

204

925

2.14

22.52

1.2

56.49

57.25

u/l

0.11

177

794

Soft tissue disorders

770

2633

1.50

22.52

1.2

64.68

68.35

u/l

0.46

676

2315

Other (not insulin) diabetes medications

782

3093

1.49

22.51

1.2

59.01

63.19

u/l

0.87

691

2726

Hypoparathyroidism

134

4.39

22.43

1.3

1.2

69.73

54.88

u/l

0.72

121

Acute bronchitis

359

2014

1.76

22.31

1.3

1.2

66.27

66.78

u/l

0.03

325

1757

Recurrent or chronic depression

339

1301

1.82

22.15

1.2

57.03

63.81

u/l

1.40

296

1159

Invasive ventilation

260

3.29

22.14

1.2

67.73

63.70

u/l

0.15

228

379

2191

1.73

22.08

1.3

1.2

58.73

69.15

u/l

1.99

342

1919

Other special examinations and investigations of persons without complaint or reported diagnosis

456

1368

1.70

21.92

1.2

63.25

68.75

u/l

0.50

403

1183

Calcific aortic valvular stenosis, including rheumatic fever

264

1331

1.92

21.73

1.2

52.10

63.46

u/l

2.83

235

1153

Acute pancreatitis (for exclusion)

190

888

2.16

21.70

1.2

56.26

66.63

u/l

1.83

174

767

Benign neoplasms

734

2670

1.50

21.66

1.2

60.82

67.60

u/l

1.22

644

2362

Diseases of the respiratory system

500

1526

1.65

21.63

1.2

64.21

67.71

u/l

0.33

448

1326

Operations 2 for CAVS

263

1328

1.92

21.63

1.2

52.26

63.49

u/l

2.77

234

1151

Calcific aortic valvular stenosis, diagnosis (helper)

263

1328

1.92

21.63

1.2

52.26

63.49

u/l

2.77

234

1151

Conduction disorders

249

1016

1.98

21.58

1.2

64.44

70.91

u/l

0.45

232

878

Calcific aortic valvular stenosis

263

1330

1.92

21.54

1.2

52.26

63.73

u/l

2.85

234

1153

Calcific aortic valvular stenosis, operated

263

1330

1.92

21.54

1.2

52.26

63.73

u/l

2.85

234

1153

Gingival hyperplasia

130

4.36

21.49

1.4

1.2

124.07

60.05

u/l

0.66

121

Dipeptidyl peptidase 4 (DPP-4) inhibitors

495

2419

1.61

21.47

1.2

56.99

62.91

u/l

1.35

436

2123

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

145

588

2.42

21.42

1.3

1.2

101.03

75.76

u/l

0.45

127

520

Diagnoses used for exclusion with ILD

236

1202

1.98

21.35

1.2

52.86

64.20

u/l

2.60

216

1037

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

153

640

2.35

21.17

1.3

1.2

98.34

73.82

u/l

0.47

134

567

Mycoses, including avohilmo

751

3907

1.47

21.16

1.2

67.22

63.23

u/l

0.47

664

3450

Other metabolic disorders

134

546

2.48

21.13

1.2

76.52

55.58

u/l

2.10

124

477

Symptoms and signs involving the skin and subcutaneous tissue

610

3801

1.52

21.12

1.2

60.85

64.26

u/l

0.53

553

3337

Falls/tendency to fall

811

2776

1.47

21.11

1.3

1.2

64.96

65.68

u/l

0.08

701

2477

Cardiodefibrillation

309

1722

1.80

20.93

1.2

54.78

65.93

u/l

2.07

265

1493

Malignant neoplasm of breast, ER-negative, including Hilmo

212

977

2.05

20.84

1.2

56.08

57.19

u/l

0.18

185

841

Weight loss

110

411

2.72

20.76

1.2

64.97

67.44

u/l

0.08

362

All influenza (not pneumonia)

124

491

2.55

20.74

1.4

1.1

71.04

64.49

u/l

0.35

116

433

Chronic periodontitis, complicated

498

3081

1.58

20.69

1.3

1.2

69.28

61.04

u/l

0.51

439

2704

Hypotension

169

769

2.22

20.67

1.3

1.2

61.67

64.82

u/l

0.27

147

677

Coronary atherosclerosis

549

2211

1.57

20.66

1.2

58.44

63.19

u/l

0.97

482

1937

Intestinal malabsorption

175

3.75

20.48

1.4

1.2

50.96

58.62

u/l

0.62

161

Symptoms and signs involving cognition, perception, emotional state and behaviour

786

3631

1.45

20.42

1.2

62.66

63.94

u/l

0.15

687

3211

Paroxysmal tachycardia

170

638

2.23

20.35

1.4

1.2

63.08

64.89

u/l

0.08

157

565

Candidiasis, including avohilmo

275

1501

1.85

20.17

1.3

1.2

61.18

61.93

u/l

0.07

241

1314

Sarcoidosis

134

559

2.43

20.12

1.2

55.62

59.22

u/l

0.35

122

490

Zoster [herpes zoster], including avohilmo

469

2852

1.60

20.11

1.2

58.66

62.03

u/l

0.62

403

2498

Unspecified haematuria

350

1655

1.73

20.06

1.2

63.68

65.96

u/l

0.17

309

1439

Ischaemic heart disease, wide definition

660

2716

1.50

20.06

1.2

59.53

63.27

u/l

0.69

577

2389

Sleep disorders (combined)

876

3211

1.43

20.04

1.2

60.76

64.84

u/l

0.84

758

2847

Disorders of synovium and tendon

440

2307

1.63

20.00

1.2

61.17

63.19

u/l

0.32

395

2020

Bacterial pneumoniae

328

1650

1.76

19.96

1.3

1.2

62.98

61.61

u/l

0.11

303

1436

Anxiety (asthma-related co-morbidities)

475

2270

1.60

19.76

1.2

63.16

67.42

u/l

0.47

416

2005

Chronic lymphocytic leukaemia

5.27

19.67

1.1

1.2

100.00

47.67

u/l

1.04

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

5.27

19.67

1.1

1.2

100.00

47.67

u/l

1.04

Chronic lymphocytic leukaemia, helper endpoint

5.27

19.67

1.1

1.2

100.00

47.67

u/l

1.04

Malignant neoplasm of digestive organs, including Hilmo

338

1430

1.75

19.65

1.2

69.07

56.46

u/l

1.35

308

1226

Other joint disorders

630

2172

1.52

19.48

1.2

58.77

72.74

u/l

3.10

566

1908

Other arrhythmias

498

2373

1.57

19.39

1.2

63.51

64.32

u/l

0.03

438

2089

Exclusions for E4_PCOS_BROAD

156

705

2.23

19.39

1.3

1.2

65.60

75.61

u/l

0.58

141

621

Abnormal weight loss

100

369

2.75

19.37

1.2

65.73

65.66

u/l

0.00

325

Acute upper respiratory infections

845

3572

1.42

19.34

1.3

1.2

57.33

64.55

u/l

2.28

760

3140

Sleep apnoea, including avohilmo

814

3450

1.43

19.33

1.2

60.04

64.41

u/l

0.87

709

3046

Other specified/unspecified systemic involvement of connective tissue

221

3.33

19.32

1.2

44.06

60.02

u/l

1.78

200

Other pleural conditions

105

398

2.68

19.29

1.2

61.79

68.21

u/l

0.29

349

Any mental disorder

856

3013

1.43

19.28

1.2

65.42

63.91

u/l

0.14

743

2670

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

146

3.91

19.16

1.1

1.2

55.67

51.41

u/l

0.27

126

Diseases of the musculoskeletal system and connective tissue

347

993

1.76

19.05

1.2

72.71

74.60

u/l

0.09

304

867

ILD, hospital admissions

148

661

2.27

19.02

1.2

67.00

65.85

u/l

0.07

132

577

Chronic lower respiratory diseases

937

3545

1.40

18.83

1.2

57.26

67.77

u/l

3.99

826

3131

Intracranial trauma

438

1838

1.62

18.76

1.2

61.72

71.54

u/l

1.38

378

1634

Sicca syndrome [Sjögren]

100

376

2.71

18.72

1.2

53.36

57.08

u/l

0.39

333

Persons encountering health services for examination and investigation

444

1368

1.63

18.66

1.2

67.84

68.75

u/l

0.06

394

1183

ILD, hospital admissions 1, main diag only

133

574

2.35

18.54

1.2

69.18

65.29

u/l

0.25

119

500

Degeneration of macula and posterior pole

421

2021

1.62

18.45

1.3

1.2

57.46

63.40

u/l

1.00

358

1779

Genitourinary diseases

358

1045

1.72

18.39

1.2

76.09

71.46

u/l

0.19

318

910

Other interstitial pulmonary diseases

149

677

2.23

18.38

1.2

66.77

65.74

u/l

0.06

133

588

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

307

1783

1.73

18.30

1.2

66.55

62.44

u/l

0.48

274

1560

Retention of urine

271

1214

1.82

18.29

1.2

65.34

67.94

u/l

0.14

244

1060

Cardiomyopathy, other and unspecified

249

3.10

18.28

1.2

63.23

63.92

u/l

0.01

217

Interstitial lung disease endpoints

149

679

2.22

18.26

1.2

66.77

65.59

u/l

0.07

133

591

Interstitial lung disease

149

679

2.22

18.26

1.2

66.77

65.59

u/l

0.07

133

591

Bacterial pneumonia, not elsewhere classified

307

1558

1.74

18.19

1.3

1.2

61.91

61.38

u/l

0.04

283

1350

Exposure to other specified factors

642

3783

1.46

18.12

1.3

1.2

60.44

66.30

u/l

1.08

565

3336

Nerve, nerve root and plexus disorders

845

3624

1.40

18.09

1.2

59.10

63.03

u/l

0.89

758

3191

Type 1 diabetes, strict definition, subgroup 1

147

3.78

18.05

1.3

1.2

64.73

85.84

u/l

1.08

130

Thyrotoxicosis, other and/or unspecified

190

961

2.00

17.66

1.2

76.81

60.79

u/l

1.82

166

841

Open wound of lower leg

140

631

2.24

17.62

1.3

1.2

94.20

68.01

u/l

0.45

121

554

Other (seronegative) rheumatoid arthritis, wide

188

949

2.00

17.60

1.2

57.88

61.42

u/l

0.25

173

817

Congenital malformations, deformations and chromosomal abnormalities

444

2701

1.56

17.59

1.3

1.2

61.93

65.68

u/l

0.56

395

2379

All anxiety disorders

480

2416

1.55

17.58

1.2

63.14

65.47

u/l

0.23

420

2128

Postprocedural endocrine and metabolic disorders, not elsewhere classified

121

514

2.38

17.51

1.2

71.79

55.30

u/l

1.51

112

451

Tubulo-interstitial nephritis, not specified as acute or chronic

199

3.31

17.49

1.3

1.2

58.42

62.51

u/l

0.20

179

Other and unspecified local infections of skin and subcutaneous tissue

366

2.66

17.48

1.3

1.2

66.00

73.55

u/l

0.31

326

Acute upper respiratory infections of multiple and unspecified sites

608

3023

1.47

17.38

1.3

1.2

58.23

65.15

u/l

1.78

552

2652

Diseases of pulp and periapical tissues, including avohilmo

792

2901

1.42

17.28

1.2

63.51

65.04

u/l

0.17

690

2564

Viral hepatitis, IBD co-morbidity

4.56

17.28

1.2

65.31

50.09

u/l

1.30

Disorders of sclera, cornea, iris and ciliary body

450

2918

1.55

17.22

1.2

55.00

65.04

u/l

3.93

415

2541

Disorders of continuity of bone

100

392

2.59

17.22

1.3

1.2

66.99

58.14

u/l

0.86

350

Other local infections of skin and subcutaneous tissue

101

398

2.57

17.20

1.3

1.2

65.22

72.52

u/l

0.33

354

L02BA Anti-estrogens

178

890

2.02

17.15

1.2

59.50

59.53

u/l

0.00

166

774

Isolated proteinuria with specified morphological lesion

7.52

17.13

1.1

1.3

91.12

41.59

u/l

0.83

Other external causes of accidental injury

593

1993

1.50

17.07

1.2

64.23

67.78

u/l

0.37

516

1789

Accidents

593

1993

1.50

17.07

1.2

64.17

67.78

u/l

0.38

516

1789

Disorders of vitreous body and globe

469

2904

1.54

17.04

1.3

1.2

58.70

61.70

u/l

0.52

415

2542

Viral infections characterized by skin and mucous membrane lesions

350

2144

1.64

17.01

1.2

64.53

65.84

u/l

0.12

320

1870

Lymphoid leukaemia

188

3.36

17.00

1.1

1.2

88.42

77.49

u/l

0.18

167

Candidiasis

137

622

2.23

16.97

1.3

1.2

62.31

63.96

u/l

0.10

122

548

Injuries to the thorax

375

2339

1.61

16.93

1.2

67.37

61.01

u/l

0.87

328

2048

Other diseases of blood and blood-forming organs

245

3.03

16.89

1.2

57.81

59.21

u/l

0.07

216

Fracture of rib(s), sternum and thoracic spine

264

1509

1.76

16.71

1.2

66.50

62.21

u/l

0.38

226

1310

Malignant neoplasm of prostate

186

542

2.04

16.68

1.5

1.2

103.76

54.33

u/l

2.85

159

464

Malignant neoplasm of liver and intrahepatic bile ducts

4.85

16.66

1.0

1.2

45.22

46.46

u/l

0.08

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

147

3.67

16.63

1.1

1.2

54.19

51.88

u/l

0.11

127

Early onset COPD, excluding more controls

161

784

2.07

16.58

1.2

57.86

62.73

u/l

0.37

141

673

malignant neoplasm of male genital organs

190

570

2.02

16.58

1.5

1.2

102.93

54.39

u/l

2.88

163

489

Thyrotoxicosis

236

1310

1.82

16.53

1.2

72.22

60.30

u/l

1.59

206

1146

Disorders of vitreous body

458

2860

1.53

16.48

1.3

1.2

59.01

61.84

u/l

0.47

406

2508

Injuries to the head

867

3748

1.38

16.47

1.2

62.74

65.39

u/l

0.37

736

3338

Factors influencing health status and contact with health services

188

461

2.06

16.44

1.2

1.1

66.77

71.57

u/l

0.17

165

393

Seropositive rheumatoid arthritis, strict definition

150

717

2.12

16.35

1.2

55.34

62.54

u/l

1.06

137

624

Pacemaker

301

1663

1.69

16.33

1.2

56.64

65.93

u/l

1.11

275

1432

Other diseases of pericardium

140

3.72

16.27

1.3

1.2

46.18

60.51

u/l

1.17

126

Bacterial pneumonia (organism specified)

359

2021

1.62

16.25

1.3

1.2

63.32

63.56

u/l

0.02

331

1761

Urticaria and erythema

303

1815

1.68

16.15

1.2

69.48

64.47

u/l

0.16

274

1584

Cardiomyopathy (excluding other)

101

411

2.48

16.08

1.2

82.09

67.35

u/l

0.22

348

Other anxiety disorders

348

1832

1.62

15.91

1.2

64.09

64.21

u/l

0.01

302

1623

Malignant neoplasm of skin, including Hilmo

397

1686

1.58

15.74

1.3

1.2

56.59

56.35

u/l

0.03

343

1451

Intestinal adhesions without obstruction

311

2.71

15.69

1.2

52.87

60.21

u/l

0.80

273

Alcohol use disorder, Swedish definition

408

2397

1.55

15.64

1.2

60.74

64.90

u/l

0.38

349

2117

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

484

2957

1.50

15.60

1.3

1.2

60.69

65.22

u/l

0.81

429

2594

Persons with potential health hazards related to communicable diseases

268

1554

1.72

15.57

1.3

1.2

74.37

66.53

u/l

0.32

231

1377

Type 1 diabetes, strict definition

173

3.32

15.49

1.3

1.2

63.86

81.11

u/l

0.92

154

Hypothyroidism, strict autoimmune, 3 medication purchases required

658

3122

1.42

15.44

1.2

56.55

62.06

u/l

1.82

574

2749

Other/unspecified dorsalgia

311

1875

1.65

15.40

1.2

57.95

61.89

u/l

0.62

273

1636

Hernia

736

3522

1.39

15.38

1.2

64.87

62.73

u/l

0.24

650

3111

Zoster [herpes zoster]

178

925

1.94

15.38

1.2

62.79

64.67

u/l

0.13

158

803

Disorders of eyelid, lacrimal system and orbit

700

3674

1.40

15.36

1.2

66.05

63.15

u/l

0.21

617

3244

Other dorsopathies, not elsewhere classified

738

2742

1.40

15.31

1.2

58.05

64.72

u/l

1.89

647

2422

Non-selective monoamine reuptake inhibitors

322

1904

1.63

15.31

1.1

1.2

52.76

62.67

u/l

3.74

284

1659

Other disorders of lacrimal gland

336

2099

1.61

15.23

1.2

57.23

61.32

u/l

0.77

294

1832

Secondary uncertain malignant neoplasm

110

478

2.32

15.17

1.3

1.2

75.09

57.36

u/l

1.05

100

409

Cardiomyopathies, Primary/intrinsic

401

2.44

14.97

1.2

83.39

66.32

u/l

0.25

344

Personality disorders, excluding more controls

185

983

1.89

14.80

1.2

55.52

60.64

u/l

0.71

155

874

Secondary and unspecified malignant neoplasm of lymph nodes

292

2.71

14.79

1.2

1.1

56.47

54.67

u/l

0.12

252

KRA_PSY_EATING, excluding more controls

167

3.29

14.75

1.3

1.2

63.92

67.70

u/l

0.12

157

Lichen simplex chronicus and prurigo

238

2.90

14.66

1.2

50.71

63.77

u/l

1.42

210

malignant neoplasm of male genital organs, including Hilmo

186

579

1.94

14.60

1.5

1.2

104.26

54.42

u/l

2.86

158

497

Functional dyspepsia

223

1265

1.78

14.57

1.2

56.08

64.50

u/l

1.53

194

1112

Benign neoplasm: Colon, unspecified

224

1274

1.77

14.53

1.2

51.54

64.25

u/l

3.74

198

1089

Other and unspecified psoriasis

256

2.82

14.50

1.2

61.13

60.37

u/l

0.03

226

Neurological diseases, wide definition

155

371

2.11

14.49

1.2

61.93

90.09

u/l

1.21

145

327

Thyroiditis, ILD-related definition

100

426

2.37

14.46

1.2

53.13

63.57

u/l

1.53

371

Cholecystitis

120

552

2.19

14.45

1.3

1.2

55.80

65.36

u/l

1.34

109

476

Drug-induced osteoporosis with pathological fracture

5.21

14.45

1.2

57.32

57.71

u/l

0.01

Other disorders of adrenal gland

147

3.47

14.44

1.2

74.44

74.10

u/l

0.01

136

Psoriasis vulgaris

162

834

1.96

14.42

1.2

56.36

65.85

u/l

1.41

145

726

Colectomy operation

153

773

2.00

14.39

1.4

1.2

62.39

61.29

u/l

0.06

135

672

Malignant neoplasm of prostate, including Hilmo

182

555

1.95

14.35

1.5

1.2

105.50

54.50

u/l

2.85

154

476

Coxarthrosis [arthrosis of hip](FG)

421

1905

1.53

14.33

1.2

60.66

64.79

u/l

0.53

372

1665

Other renal tubulo-interstitial diseases

4.83

14.31

1.2

76.00

50.90

u/l

1.99

Malignant neoplasm of skin

373

1617

1.57

14.25

1.3

1.2

56.74

56.51

u/l

0.03

323

1388

Pneumonia due to other infectious organisms, not elsewhere classified

4.17

14.25

1.2

69.76

55.41

u/l

0.72

Other general symptoms and signs

142

3.47

14.19

1.1

1.2

68.69

67.98

u/l

0.02

127

Selective serotonin reuptake inhibitors

737

2778

1.38

14.18

1.2

61.14

65.27

u/l

0.62

640

2458

423

2515

1.51

14.16

1.2

61.63

64.79

u/l

0.28

363

2228

Substance abuse, excluding more controls

403

2215

1.53

14.15

1.2

63.80

64.75

u/l

0.07

346

1962

COPD (mode)

232

1035

1.76

14.11

1.2

50.69

66.32

u/l

2.85

201

888

Valvular operations

109

487

2.26

14.10

1.3

1.2

81.31

71.80

u/l

0.11

422

Malignant neoplasm of digestive organs

287

1332

1.66

14.01

1.2

71.70

56.23

u/l

1.47

262

1141

Arthropathy in ulcerative colitis

5.78

13.97

1.2

56.10

54.87

u/l

0.03

Infection due to other mycobacteria

6.20

13.95

1.5

1.2

51.42

43.73

u/l

0.52

Psoriatic arthropathies

409

2.38

13.91

1.2

63.03

63.46

u/l

0.02

347

443

2598

1.49

13.90

1.2

61.88

64.80

u/l

0.26

379

2299

Gonarthrosis [arthrosis of knee](FG)

547

2181

1.45

13.90

1.2

57.96

65.55

u/l

1.47

481

1918

Acute sinusitis

395

2370

1.52

13.84

1.3

1.2

60.56

65.47

u/l

0.84

361

2074

Disorders of skin appendages

379

2477

1.53

13.76

1.2

67.35

64.62

u/l

0.24

339

2171

Oesophagitis

167

3.22

13.71

1.2

52.57

73.99

u/l

1.69

146

Pruritus

110

501

2.22

13.63

1.2

57.35

67.52

u/l

1.08

439

Nonorganic sleeping disorders, excluding more controls

156

809

1.94

13.59

1.2

67.83

61.27

u/l

0.57

134

720

Trigger finger

141

707

2.01

13.58

1.3

1.2

56.89

61.92

u/l

0.56

127

616

Concussion

362

1817

1.55

13.53

1.2

59.86

69.71

u/l

1.62

315

1615

Arthropathic psoriasis

105

472

2.25

13.45

1.2

68.43

62.18

u/l

0.31

411

Spondylosis

443

2344

1.48

13.43

1.2

59.16

62.88

u/l

0.71

374

2060

Family history of malignant neoplasm

100

441

2.29

13.39

1.3

1.2

63.43

54.23

u/l

2.01

394

Other abnormal findings of blood chemistry

151

3.30

13.17

1.2

56.20

57.04

u/l

0.05

137

Pulmonary heart disease, diseases of pulmonary circulation

266

1630

1.64

13.11

1.2

61.85

63.21

u/l

0.11

240

1401

Arterial embolism and thrombosis

182

3.06

13.10

1.2

67.33

58.25

u/l

0.32

162

Injuries to the elbow and forearm

565

3458

1.40

13.04

1.2

65.10

63.79

u/l

0.17

486

3058

Etanercept

226

2.83

13.02

1.1

1.2

54.27

65.44

u/l

0.77

203

Obesity related asthma

285

1780

1.61

13.02

1.2

59.16

62.58

u/l

0.40

245

1554

Disorders of conjunctiva

644

3633

1.38

13.01

1.2

59.69

65.82

u/l

1.32

588

3182

Infection due to other mycobacteria, including avohilmo

5.75

12.97

1.5

1.2

51.42

45.86

u/l

0.34

Unspecified fall

405

2683

1.49

12.93

1.2

70.88

64.06

u/l

0.32

362

2355

Missing teeth due to accident, extraction or parodontitis

509

3204

1.42

12.77

1.2

61.88

61.24

u/l

0.07

442

2816

Carbimazole or st.post thyroidectomy, condition for graves disease

185

1035

1.80

12.77

1.1

1.2

75.42

57.82

u/l

2.73

166

908

Episodal and paroxysmal disorders

806

3058

1.34

12.73

1.2

58.96

68.10

u/l

2.13

699

2711

Other follicular disorders

240

2.74

12.72

1.2

64.39

59.32

u/l

0.29

221

Persistent mood disorders

159

850

1.88

12.69

1.2

54.62

62.75

u/l

1.33

137

735

Misadventures to patients during surgical and medical care

128

636

2.03

12.68

1.3

1.2

51.58

64.02

u/l

2.05

117

558

Asthma, including avohilmo

886

3715

1.32

12.56

1.2

57.49

67.27

u/l

3.58

783

3282

Thyrotoxicosis with diffuse goitre

127

634

2.02

12.43

1.2

80.00

57.07

u/l

2.52

112

556

Dorsopathies

733

2751

1.35

12.32

1.2

61.42

66.24

u/l

0.81

646

2429

Exclusions for E4_PCOS_CONSORTIUM

558

2487

1.40

12.28

1.2

59.68

63.07

u/l

0.61

495

2199

Open wound of head

415

2668

1.47

12.28

1.2

59.49

66.41

u/l

1.17

356

2367

Biguanides

735

3310

1.34

12.25

1.2

59.35

62.93

u/l

0.70

649

2920

Duodenal ulcer

395

2.30

12.23

1.2

56.51

70.95

u/l

1.36

342

Bronchiectasis

322

2.46

12.20

1.3

1.2

53.86

66.17

u/l

1.39

278

Malignant melanoma, including Hilmo

135

694

1.96

12.15

1.3

1.2

60.20

55.98

u/l

0.27

123

594

Acute posthaemorrhagic anaemia

100

3.77

12.14

1.8

1.2

69.13

53.42

u/l

1.07

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

124

619

2.02

12.14

1.2

58.32

56.65

u/l

0.13

113

529

Venous thromboembolism

430

2868

1.45

12.03

1.3

1.2

60.28

60.65

u/l

0.04

388

2508

Neurological diseases

597

2159

1.39

11.98

1.2

67.07

70.92

u/l

0.34

521

1918

External causes of morbidity and mortality

446

1528

1.47

11.91

1.2

66.48

68.03

u/l

0.11

388

1364

Injuries to the ankle and foot

535

3287

1.39

11.86

1.3

1.2

58.13

67.23

u/l

2.21

468

2902

Sciatica+with lumbago

398

2406

1.47

11.86

1.2

53.09

63.62

u/l

4.93

348

2121

Myalgia

193

1118

1.74

11.83

1.2

56.72

62.18

u/l

0.82

175

973

Other diseases of the respiratory system

167

928

1.81

11.82

1.3

1.2

82.64

67.72

u/l

0.28

147

806

Other respiratory disorders and diseases

167

928

1.81

11.82

1.3

1.2

82.64

67.72

u/l

0.28

147

806

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

383

2.30

11.77

1.2

67.09

70.16

u/l

0.11

341

Other coagulation defects

268

2.57

11.73

1.3

1.2

48.34

70.75

u/l

1.89

245

Psoriatic arthropathies, ICD10

441

2.20

11.73

1.2

63.03

59.66

u/l

0.23

388

Hernia of abdominal wall

345

2306

1.50

11.68

1.2

59.09

63.70

u/l

0.47

317

2008

Renal tubulo-interstitial disorders in diseases classified elsewhere

9.74

11.67

1.6

1.2

61.43

50.85

u/l

0.35

Fracture of lower leg, including ankle

439

3017

1.43

11.64

1.2

62.28

64.68

u/l

0.31

392

2646

Other embolism and thrombosis

112

548

2.06

11.62

1.2

66.86

58.43

u/l

0.68

482

Injuries to unspecified part of trunk, limb or body region

373

2.30

11.58

1.3

1.2

58.31

68.82

u/l

0.56

333

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

345

1538

1.52

11.58

1.3

1.2

56.04

56.47

u/l

0.06

297

1313

Other viral diseases

204

1203

1.70

11.55

1.2

69.69

70.60

u/l

0.05

187

1052

Amiodarone users

393

2.27

11.53

1.2

48.46

73.22

u/l

2.28

344

Other/unspecified rheumatoid arthritis

112

551

2.05

11.47

1.1

1.2

62.61

61.67

u/l

0.04

104

480

Chronic rhinitis, nasopharyngitis and pharyngitis

262

1657

1.59

11.41

1.3

1.2

54.11

67.85

u/l

3.39

225

1443

Dysphagia

196

1153

1.71

11.38

1.3

1.2

76.31

65.17

u/l

0.25

175

1001

Coxarthrosis

385

1684

1.48

11.34

1.2

60.81

67.02

u/l

0.78

339

1473

Fracture of forearm

454

2882

1.42

11.30

1.2

65.18

62.53

u/l

0.39

392

2546

Myeloproliferative diseases

328

2.38

11.27

1.2

52.03

64.77

u/l

1.27

289

Faecal incontinence

423

2.20

11.24

1.2

53.66

58.89

u/l

0.52

367

Abnormalities of heart beat

270

1673

1.57

11.20

1.2

73.91

64.76

u/l

0.29

241

1465

Other psoriatic arthropathies

425

2.19

11.11

1.2

63.04

60.14

u/l

0.18

374

Cerebrovascular diseases

571

2898

1.37

11.10

1.2

58.98

62.35

u/l

0.60

504

2538

Overexertion and strenuous or repetitive movements

368

2.28

11.07

1.3

1.2

51.79

59.81

u/l

0.65

326

Other malignant neoplasms of skin (=non-melanoma skin cancer)

331

1487

1.52

11.06

1.3

1.2

54.06

56.72

u/l

0.53

285

1267

Malignant melanoma

121

620

1.97

11.05

1.3

1.2

60.78

56.45

u/l

0.25

111

529

Fluid overload

24.16

10.99

1.5

1.4

97.27

28.43

u/l

—

Fracture of shoulder and upper arm

294

1924

1.53

10.96

1.2

60.98

65.57

u/l

0.74

259

1677

Disorders of lacrimal system

375

2539

1.46

10.95

1.2

58.27

61.46

u/l

0.49

330

2218

Retinal detachments and breaks

280

1819

1.55

10.89

1.2

55.10

62.33

u/l

1.71

240

1595

Other other unspecified disorders of the circulatory system

128

3.27

10.87

1.2

1.3

51.63

50.71

u/l

0.07

117

Asthma, hospital admissions , main diagnosis only

612

3972

1.34

10.85

1.2

57.83

65.47

u/l

2.25

548

3498

Caries of dentine, including avohilmo

571

2126

1.38

10.82

1.2

67.10

66.77

u/l

0.02

506

1881

Fissure and fistula of anal and rectal regions

176

1020

1.74

10.82

1.1

1.2

52.04

65.50

u/l

3.58

158

886

Discitis, unspecified

4.54

10.81

1.3

1.2

46.46

48.64

u/l

0.10

Keratitis

277

1798

1.55

10.81

1.2

58.14

63.70

u/l

1.10

256

1563

Other specified and unspecified personality disorders

285

2.45

10.80

1.2

61.60

60.54

u/l

0.06

259

Type1 diabetes, definitions combined, early onset

159

2.97

10.75

1.4

1.2

67.79

104.78

u/l

0.81

143

Injuries to the knee and lower leg

882

3708

1.29

10.74

1.2

63.86

65.19

u/l

0.10

777

3271

Gonarthrosis

464

1853

1.42

10.71

1.2

58.88

67.27

u/l

1.38

409

1623

Basal cell carcinoma, including Hilmo

332

1501

1.50

10.66

1.2

57.31

56.58

u/l

0.09

288

1279

Reactive arthropathies

306

2.38

10.60

1.3

1.1

57.08

60.15

u/l

0.16

264

Psychiatric diseases

709

2683

1.33

10.56

1.2

67.13

64.44

u/l

0.23

619

2372

Myeloproliferative diseases (CML excluded)

290

2.41

10.44

1.2

50.40

58.51

u/l

0.93

258

Urticaria

229

1435

1.60

10.43

1.2

75.10

64.35

u/l

0.29

205

1259

Familial hypercholesterolemia, with ischemic heart disease

346

2.28

10.42

1.2

56.49

68.55

u/l

0.95

300

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

340

2.29

10.39

1.2

1.1

72.07

54.55

u/l

0.87

288

Undetermined asthma, excluding more controls

101

496

2.05

10.38

1.3

1.1

54.53

61.66

u/l

0.90

428

Mental and behavioural disorders due to psychoactive substance use

420

2727

1.41

10.34

1.2

64.64

63.15

u/l

0.12

362

2409

Other infective otitis externa

214

2.65

10.34

1.3

1.2

49.78

59.80

u/l

0.95

192

Spinal stenosis

405

2091

1.43

10.34

1.2

60.02

61.25

u/l

0.13

351

1840

Dental caries, including avohilmo

526

1951

1.38

10.33

1.2

67.86

64.36

u/l

0.34

464

1731

Arthrosis

493

1947

1.39

10.14

1.2

60.50

66.98

u/l

0.89

436

1703

Obsessive-compulsive disorder

160

2.90

10.10

1.2

47.08

65.34

u/l

1.90

147

Malignant neoplasm of kidney, except renal pelvis

307

2.34

10.08

1.2

1.1

75.18

55.62

u/l

0.90

263

Conjunctivitis

566

3397

1.34

10.04

1.2

61.83

66.07

u/l

0.67

515

2980

Diseases of external ear

275

1813

1.52

10.03

1.2

63.77

65.80

u/l

0.15

248

1570

Reactive arthropathies, FINNGEN

206

2.65

10.00

1.4

1.1

57.03

65.85

u/l

0.39

176

Caries of enamel

712

3575

1.31

9.97

1.2

62.86

63.39

u/l

0.06

625

3151

Other diseases of hard tissues of teeth

393

1411

1.45

9.95

1.2

64.62

60.66

u/l

0.47

352

1242

Superficial injury of hip and thigh

118

623

1.91

9.90

1.3

1.1

60.36

60.95

u/l

0.04

106

549

Other specified/unspecified bacterial intestinal infections

237

2.52

9.86

1.2

49.85

64.01

u/l

1.29

211

Degenerative macular diseases

102

515

2.00

9.79

1.2

59.64

66.81

u/l

0.44

453

Polymyalgia rheumatica

113

591

1.93

9.79

1.2

69.10

62.63

u/l

0.21

511

Stroke, excluding SAH

455

2372

1.39

9.74

1.2

59.68

62.65

u/l

0.41

405

2075

Ventral hernia

195

1197

1.64

9.72

1.2

55.18

66.20

u/l

2.14

179

1033

Personality disorders

185

1120

1.66

9.72

1.2

55.52

59.78

u/l

0.57

155

993

Other viral diseases, including avohilmo

256

1657

1.54

9.70

1.2

67.09

69.12

u/l

0.14

231

1458

Substance abuse

403

2669

1.41

9.67

1.2

63.80

63.16

u/l

0.05

346

2362

Protozoal diseases

107

3.34

9.63

1.2

55.21

54.22

u/l

0.04

Cyst of kidney

258

2.43

9.62

1.3

1.2

57.21

64.47

u/l

0.43

229

Exposure to other and unspecified inanimate mechanical forces

264

2.41

9.61

1.2

53.76

63.95

u/l

0.92

236

Other eating disorders

107

3.30

9.57

1.1

1.2

59.91

93.01

u/l

0.69

Unspecified urinary incontinence

399

2.13

9.53

1.2

53.92

61.18

u/l

1.03

349

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

183

1097

1.65

9.49

1.2

54.28

62.29

u/l

1.23

154

975

Benign neoplasm: Stomach

440

2.07

9.47

1.3

1.2

52.78

60.99

u/l

0.99

391

Ischaemic Stroke, excluding all haemorrhages

426

2256

1.39

9.39

1.2

58.36

62.97

u/l

0.70

376

1968

Cerebral palsy and other paralytic syndromes

421

2.08

9.39

1.5

1.2

62.53

69.24

u/l

0.29

373

Coeliac disease

482

2.01

9.37

1.3

1.1

73.46

78.90

u/l

0.15

423

Protozoal diseases, including avohilmo

109

3.28

9.36

1.2

55.21

54.48

u/l

0.03

100

Other and unspecified urticaria

147

847

1.75

9.31

1.3

1.2

84.33

66.16

u/l

0.33

134

747

Basal cell carcinoma

314

1456

1.48

9.30

1.3

1.2

55.31

56.85

u/l

0.23

273

1242

Other arthrosis

385

1822

1.42

9.30

1.2

57.02

67.51

u/l

2.48

349

1596

Lung cancer and mesothelioma

137

651

1.80

9.29

1.2

70.01

70.52

u/l

0.02

128

554

Hypopituitarism

226

2.50

9.27

1.3

1.2

64.68

75.09

u/l

0.33

201

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

438

2.05

9.27

1.2

1.1

58.94

57.80

u/l

0.07

374

Phobic anxiety disorders

402

2.10

9.25

1.2

56.59

64.68

u/l

0.76

365

Eating disorder

220

2.51

9.22

1.3

1.2

63.92

80.59

u/l

0.52

206

Pulmonary embolism

231

1495

1.55

9.22

1.2

62.87

63.14

u/l

0.02

212

1284

Calculus of kidney and ureter

217

1385

1.58

9.22

1.2

68.42

62.27

u/l

0.44

192

1201

Other and unspecified disorders of skin and subcutaneous tissue

227

2.50

9.21

1.2

45.65

54.93

u/l

1.38

202

Abnormal findings in nipple discharge synovial fluid wound secretions

4.39

9.20

1.5

1.2

120.75

52.14

u/l

0.82

Injury of unspecified body region

276

2.34

9.18

1.3

1.2

59.52

58.27

u/l

0.04

251

Malignant neoplasm of urinary organs

333

2.21

9.17

1.2

1.1

74.22

54.80

u/l

0.94

283

Need for other prophylactic measures

204

2.58

9.16

1.2

60.35

66.41

u/l

0.23

187

Graves disease, strict definition

433

2.05

9.11

1.2

90.70

56.73

u/l

2.85

389

Panic disorder

494

1.98

9.09

1.2

62.95

58.17

u/l

0.28

440

Benign neoplasm: Sigmoid colon

158

936

1.70

9.08

1.3

1.2

54.99

64.33

u/l

0.80

136

813

Autoimmune hyperthyroidism

199

2.59

9.07

1.2

1.1

88.47

58.86

u/l

1.14

173

Malignant neoplasm of urinary organs, including Hilmo

400

2.09

9.07

1.2

74.08

56.49

u/l

0.94

340

Other skin changes

164

983

1.68

9.02

1.2

64.16

63.14

u/l

0.07

143

848

Shoulder lesions

530

2372

1.34

8.93

1.2

60.71

64.47

u/l

0.53

468

2080

Other disorders of veins

338

2338

1.43

8.93

1.2

53.22

61.57

u/l

2.29

291

2048

Other diseases of upper respiratory tract

808

3317

1.27

8.92

1.3

1.2

58.36

67.10

u/l

2.16

710

2915

Nonorganic sleeping disorders

156

925

1.70

8.92

1.2

67.83

64.58

u/l

0.21

134

822

Pulmonary heart disease

231

1507

1.54

8.91

1.2

62.87

63.02

u/l

0.01

212

1294

Undetermined asthma

101

525

1.94

8.91

1.3

1.1

54.53

60.35

u/l

0.67

453

Benign neoplasm: Transverse colon

485

1.98

8.89

1.3

1.2

52.34

63.91

u/l

1.45

421

Conjunctivitis (acute, non atopic), including avohilmo

735

3470

1.28

8.87

1.2

63.31

65.80

u/l

0.21

639

3058

Substance use, excluding alcohol

139

800

1.75

8.86

1.2

61.54

66.12

u/l

0.36

124

705

Other diseases of oesophagus

325

2.20

8.85

1.3

1.2

115.16

67.19

u/l

0.45

283

Abnormalities of gait and mobility

101

529

1.93

8.77

1.2

94.95

72.76

u/l

0.23

471

Disorders of adult personality and behaviour

190

1190

1.60

8.76

1.2

58.59

61.33

u/l

0.30

159

1056

Scar conditions and fibrosis of skin

135

2.93

8.73

1.2

58.32

53.40

u/l

0.37

122

Generalized anxiety disorder

105

557

1.89

8.70

1.2

59.17

60.81

u/l

0.12

499

Other intervertebral disc disorders

576

2610

1.32

8.62

1.2

59.29

62.71

u/l

0.58

506

2304

Nonischemic cardiomyopathy

368

2.11

8.61

1.1

1.2

115.00

66.66

u/l

0.63

318

Dizziness and giddiness

563

3339

1.31

8.59

1.2

63.22

60.93

u/l

0.24

493

2955

Trochanteric bursitis

129

735

1.77

8.56

1.2

52.48

59.08

u/l

0.63

113

649

Diseases of oral cavity, salivary glands and jaws

387

1421

1.41

8.50

1.2

69.17

60.58

u/l

0.55

339

1252

Familial hypercholesterolemia

107

577

1.87

8.49

1.2

63.63

64.90

u/l

0.07

494

Procreative management

246

1346

1.51

8.49

1.3

1.2

76.09

65.50

u/l

0.89

220

1193

Macular pucker

133

767

1.75

8.47

1.3

1.2

52.56

66.18

u/l

2.51

114

662

Secondary right heart disease

143

2.84

8.46

1.2

55.15

64.52

u/l

0.33

128

Diffuse large B-cell lymphoma, including Hilmo

160

2.73

8.44

1.2

65.81

52.13

u/l

0.50

138

Diffuse large B-cell lymphoma, helper endpoint

160

2.73

8.44

1.2

1.1

65.81

52.13

u/l

0.50

138

Diffuse large B-cell lymphoma

160

2.73

8.44

1.2

1.1

65.81

52.13

u/l

0.50

138

Coronary artery bypass grafting

172

778

1.65

8.43

1.3

1.2

60.34

68.83

u/l

0.72

151

690

Convulsions, not elsewhere classified

142

824

1.71

8.40

1.2

63.84

71.31

u/l

0.42

129

706

Haemorrhoids and perianal venous thrombosis

242

1605

1.50

8.37

1.2

60.73

62.59

u/l

0.15

217

1401

Special screening examination for other diseases and disorders

426

2.01

8.35

1.3

1.2

105.28

64.08

u/l

0.49

361

Urolithiasis

227

1498

1.52

8.34

1.2

68.46

62.19

u/l

0.48

200

1305

Chronic laryngitis and laryngotracheitis

119

668

1.80

8.32

1.2

51.73

61.56

u/l

1.88

111

579

Alcohol-induced chronic pancreatitis

221

2.43

8.25

1.2

48.63

57.58

u/l

0.89

197

Soft tissue disorders related to use, overuse and pressure

215

1407

1.54

8.23

1.2

56.98

63.85

u/l

0.90

189

1222

Polyuria

163

1000

1.64

8.23

1.3

1.2

56.58

65.72

u/l

0.99

137

868

Stomatitis and related lesions

151

909

1.67

8.21

1.3

1.2

72.53

64.95

u/l

0.35

135

800

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

158

785

1.66

8.21

1.2

69.33

56.60

u/l

1.27

148

670

Vitamin D deficiency

3.99

8.20

1.6

1.2

65.00

56.70

u/l

0.35

Asthma/COPD (KELA code 203)

676

3541

1.28

8.18

1.2

57.99

66.55

u/l

2.64

604

3128

Poisoning by medicine

148

887

1.68

8.18

1.2

53.06

61.60

u/l

1.68

124

787

In situ neoplasms

312

2203

1.42

8.12

1.2

58.60

60.71

u/l

0.24

282

1923

Intracranial injury

415

2857

1.36

8.10

1.2

62.72

64.15

u/l

0.15

357

2529

Delirium, not induced by alcohol and other psychoactive substances

528

1.89

8.10

1.2

66.13

64.11

u/l

0.10

462

Suppurative and necrotic conditions of lower respiratory tract

187

2.54

8.08

1.5

1.2

80.48

66.75

u/l

0.25

163

Rheumatism, unspecified

119

675

1.78

8.05

1.2

53.17

59.07

u/l

0.90

113

594

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

345

2.11

8.05

1.2

53.11

74.46

u/l

1.43

302

Disease of hard tissues of teeth, NOS

371

1389

1.40

8.05

1.2

63.26

61.11

u/l

0.17

321

1223

Non-allergic asthma (mode), excluding more controls

124

705

1.75

8.01

1.2

51.68

65.23

u/l

2.65

110

614

Acute and subacute iridocyclitis

144

863

1.68

7.98

1.2

50.56

64.46

u/l

2.94

130

747

Specific personality disorders

153

931

1.65

7.98

1.2

58.64

58.92

u/l

0.02

123

824

Stroke, including SAH

472

2545

1.33

7.96

1.2

59.07

62.46

u/l

0.52

421

2231

Iridocyclitis

170

1064

1.61

7.93

1.2

52.14

66.87

u/l

2.94

155

916

Visual disturbances and blindness

393

2896

1.36

7.86

1.2

64.89

64.56

u/l

0.01

345

2541

Myocardial infarction, with ST-elevation

121

696

1.75

7.80

1.1

1.2

82.59

67.52

u/l

0.20

102

596

Benign neoplasm: Adrenal gland

330

2.12

7.78

1.3

1.2

52.49

60.07

u/l

0.80

292

Viral warts, including avohilmo

155

954

1.63

7.75

1.2

63.24

64.69

u/l

0.07

140

840

Other secondary coxarthrosis

128

2.86

7.73

1.1

1.3

52.54

53.88

u/l

0.06

118

DVT of lower extremities and pulmonary embolism

313

2222

1.41

7.72

1.2

61.41

60.94

u/l

0.04

292

1930

Other pulmonary heart/vessel disease

162

2.63

7.71

1.2

53.91

63.57

u/l

0.38

146

Other complications of surgical and medical care, not elsewhere classified

371

2.04

7.71

1.2

1.1

54.27

73.45

u/l

1.37

324

Dilated cardiomyopathy

454

1.93

7.69

1.1

1.2

89.09

66.23

u/l

0.31

401

Dental operations

418

1580

1.36

7.69

1.2

67.64

63.24

u/l

0.25

366

1393

Respiratory insufficiency

259

2.25

7.67

1.2

1.1

126.58

66.27

u/l

0.44

221

Seborrhoeic dermatitis

372

2.03

7.66

1.4

1.2

60.98

65.38

u/l

0.23

325

Diseases of the ear and mastoid process

815

3283

1.25

7.63

1.2

61.46

65.13

u/l

0.59

729

2877

Symptoms and signs involving the nervous and musculoskeletal systems

427

3204

1.34

7.63

1.2

68.87

63.20

u/l

0.27

379

2803

Problems related to lifestyle

287

2.17

7.57

1.2

1.1

67.90

63.98

u/l

0.16

254

Benign neoplasm: Skin of trunk

158

2.63

7.56

1.4

1.2

56.97

54.76

u/l

0.13

144

Mental and behavioural disorders due to alcohol

336

2316

1.39

7.53

1.2

65.50

63.70

u/l

0.12

285

2045

Diseases of pulp and periapical tissues and dental caries

449

1719

1.34

7.48

1.2

65.61

65.14

u/l

0.04

400

1524

Personal history of other diseases and conditions

300

2.14

7.47

1.2

1.1

66.85

73.63

u/l

0.36

266

Rash and other nonspecific skin eruption

397

1.98

7.43

1.3

1.2

71.68

67.49

u/l

0.13

349

Malignant neoplasm of endocrine gland

277

2.19

7.41

1.2

78.20

57.08

u/l

0.89

239

Other arterial embolism and thrombosis

3.31

7.41

1.2

82.57

46.04

u/l

0.91

Aspergillosis

7.11

7.39

1.4

1.1

84.94

42.35

u/l

1.21

Aspergillosis, including avohilmo

7.10

7.39

1.4

1.1

84.94

42.35

u/l

1.21

Other disorders of bone

131

783

1.68

7.37

1.3

1.2

76.44

63.84

u/l

0.62

123

687

Symptoms and signs involving speech and voice

260

1811

1.44

7.36

1.2

57.30

62.67

u/l

0.76

230

1579

Otitis externa

167

1062

1.58

7.32

1.3

1.2

65.09

63.95

u/l

0.06

149

929

Mental and behavioural disorders due to tobacco

338

2.06

7.32

1.2

61.67

57.92

u/l

0.19

298

Pure hyperglyceridaemia

3.44

7.29

1.2

1.3

68.66

50.37

u/l

0.57

Malignant neoplasm of endocrine gland, including Hilmo

312

2.10

7.28

1.2

77.22

56.82

u/l

0.96

272

Fibroblastic disorders

171

1096

1.57

7.25

1.3

1.2

58.52

64.61

u/l

0.65

146

953

Viral warts

360

2.02

7.22

1.3

1.2

63.48

64.89

u/l

0.05

322

Smoking dependency

340

2.05

7.21

1.2

61.67

57.89

u/l

0.19

299

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

231

1580

1.47

7.21

1.2

51.97

61.31

u/l

2.70

206

1380

Glucagon-like peptide-1 (GLP-1) analogues

231

1580

1.47

7.21

1.2

51.97

61.31

u/l

2.70

206

1380

Other viral diseases, not elsewhere classified

121

710

1.71

7.20

1.3

1.2

74.65

76.93

u/l

0.08

113

628

Deforming dorsopathies

212

1426

1.49

7.17

1.3

1.2

59.20

64.30

u/l

0.74

187

1244

Anterior Iridocyclitis

150

935

1.61

7.17

1.2

50.84

63.63

u/l

2.82

136

814

Benign neoplasm of other and unspecified endocrine glands

105

596

1.78

7.14

1.3

1.2

48.81

61.14

u/l

2.43

527

Other symptoms and signs involving the digestive system and abdomen

129

775

1.67

7.14

1.2

72.05

62.61

u/l

0.69

118

687

Other symptoms and signs involving cognitive functions and awareness

356

2325

1.36

7.12

1.2

62.54

60.35

u/l

0.26

308

2046

Chronic sinusitis

310

2238

1.39

7.10

1.3

1.2

51.64

64.86

u/l

7.11

276

1952

Fall involving bed

112

2.90

7.08

1.1

1.3

74.26

60.77

u/l

0.54

Other and unspecified drugs and medicaments

329

2.06

7.07

1.1

1.2

53.50

68.43

u/l

0.89

294

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

109

627

1.75

7.07

1.2

54.91

60.57

u/l

0.72

558

Polyarthrosis

170

983

1.57

7.06

1.2

51.55

66.26

u/l

3.48

148

855

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

396

2847

1.34

7.06

1.2

63.69

61.90

u/l

0.19

362

2502

Benign neoplasm: Small intestine

152

2.61

7.06

1.1

1.2

53.72

49.91

u/l

0.33

136

Squamous cell neoplasms and carcinomas of the skin

336

2.04

7.03

1.2

52.43

58.01

u/l

0.43

287

Eating disorders

289

2.12

7.02

1.2

59.97

73.98

u/l

0.53

266

Bipolar affective disorders

121

719

1.69

6.98

1.2

52.14

58.03

u/l

0.89

107

633

Malignant neoplasm of respiratory system and intrathoracic organs

139

705

1.64

6.97

1.1

1.2

71.78

56.93

u/l

1.34

129

601

Status post-ami

175

855

1.56

6.97

1.2

57.66

68.36

u/l

1.19

162

752

Unstable angina pectoris

253

1384

1.44

6.94

1.2

55.38

64.95

u/l

1.79

224

1192

Mental and behavioural disorders due to alcohol, excluding acute intoxication

289

2056

1.40

6.90

1.2

64.77

64.00

u/l

0.04

243

1804

L01XX Other antineoplastic agents

221

2.29

6.89

1.3

1.2

45.64

57.65

u/l

1.45

198

Poisoning by drugs, medicaments and biological substances

158

1008

1.57

6.86

1.2

52.30

61.47

u/l

2.09

133

891

Retinal detachment with retinal break

552

1.79

6.86

1.2

50.69

65.79

u/l

2.57

485

Social phobias

221

2.28

6.85

1.2

48.51

61.63

u/l

1.65

203

Atypical mycobacterium lung infection

5.81

6.83

1.6

1.3

51.67

51.63

u/l

0.00

Pneumonia derived septicemia

109

2.89

6.81

1.3

1.2

111.45

57.75

u/l

0.84

100

Other disorders of cornea

410

1.92

6.80

1.1

1.2

56.51

64.96

u/l

0.79

363

Bacterial, viral and other infectious agents

274

2.13

6.79

1.3

1.2

61.87

69.53

u/l

0.26

248

Diseases of the myoneural junction and muscle

503

1.82

6.78

1.2

60.20

67.76

u/l

0.35

443

Infections with a predominantly sexual mode of transmission

193

1287

1.50

6.77

1.2

61.20

58.97

u/l

0.21

171

1142

228

1349

1.46

6.75

1.2

61.57

61.79

u/l

0.02

192

1175

Other disorders of optic [2nd] nerve and visual pathways

217

2.28

6.72

1.2

63.12

60.57

u/l

0.09

198

Phlebitis and thrombophlebitis (not including DVT)

168

1094

1.54

6.69

1.2

58.97

62.37

u/l

0.32

152

954

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

168

1081

1.54

6.66

1.2

87.61

63.61

u/l

0.80

146

956

Unspecific neurodegenerative disorder

163

1700

0.65

6.63

1.1

1.2

61.50

60.65

u/l

0.06

134

1490

Follow-up examination after treatment for malignant neoplasms

421

1.89

6.62

1.2

1.1

60.37

60.94

u/l

0.03

358

Idiopathic thrombocytopenic purpura

100

2.95

6.61

1.4

1.2

52.66

81.30

u/l

0.57

Neuromuscular dysfunction of bladder

338

2.00

6.59

1.4

1.1

57.90

63.69

u/l

0.33

297

Non-allergic asthma (mode)

124

747

1.65

6.57

1.2

51.68

64.47

u/l

2.45

110

646

Allergic conjunctivitis

410

3009

1.31

6.57

1.2

63.43

61.55

u/l

0.21

372

2653

Impacted cerumen

487

1.82

6.55

1.2

53.98

66.15

u/l

1.64

428

COPD-related respiratory insufficiency

487

1.82

6.55

1.1

1.2

58.27

64.78

u/l

0.38

427

Allergic asthma (mode), excluding more controls

133

803

1.62

6.55

1.2

64.73

65.30

u/l

0.04

116

696

Unspecified acute lower respiratory infection

101

582

1.75

6.55

1.2

66.80

66.70

u/l

0.00

507

Other disorders of the musculoskeletal system and connective tissue

114

681

1.69

6.50

1.3

1.2

60.49

62.05

u/l

0.11

102

601

Transport accidents

299

1809

1.38

6.48

1.2

60.43

64.88

u/l

0.52

256

1620

N06DA Anticholinesterases

123

1525

0.62

6.48

1.1

1.2

66.08

60.72

u/l

0.36

103

1334

Use of anticholinesterases

123

1525

0.62

6.48

1.1

1.2

66.08

60.72

u/l

0.36

103

1334

Barrett oesophagus

165

2.45

6.45

1.1

1.2

39.72

64.29

u/l

2.38

146

Sulfonylureas

241

1342

1.43

6.44

1.2

56.72

65.57

u/l

1.35

220

1168

Other keratitis

447

1.85

6.41

1.2

55.95

64.48

u/l

0.96

391

Erosion of teeth , including avohilmo

177

1177

1.51

6.40

1.2

71.71

63.19

u/l

0.63

148

1036

Fracture of skull and facial bones

144

915

1.58

6.40

1.3

1.2

79.29

64.60

u/l

0.64

125

803

Dislocation, sprain and strain of joint and ligaments of hip

136

2.61

6.39

1.3

1.2

49.83

50.23

u/l

0.02

123

Atopic dermatitis

391

2361

1.32

6.39

1.3

1.2

60.35

68.31

u/l

1.38

350

2080

Chorioretinal inflammation

2.93

6.34

1.2

52.86

51.16

u/l

0.07

Viral hepatitis, including avohilmo

249

2.15

6.32

1.3

1.2

60.56

60.58

u/l

0.00

225

Other blood glucose lowering drugs, excl. Insulins

121

741

1.64

6.29

1.1

1.2

54.10

63.38

u/l

1.48

109

639

Benign thyroid growths and nodules

255

1695

1.40

6.23

1.2

65.38

58.68

u/l

0.66

226

1485

Somatoform disorder

117

712

1.65

6.23

1.2

56.09

57.33

u/l

0.10

630

Non-small cell lung cancer, including Hilmo

100

546

1.73

6.22

1.1

1.2

63.54

55.33

u/l

0.69

466

Early onset COPD

161

1058

1.53

6.19

1.2

57.86

65.63

u/l

0.69

141

914

Melanocytic naevi

222

1555

1.43

6.18

1.3

1.2

63.26

61.54

u/l

0.10

193

1359

Bacterial, viral and other infectious agents, including avohilmo

305

2.02

6.18

1.3

1.2

61.32

72.76

u/l

0.45

275

Atopic dermatitis, strict definition with reimbursement

184

1194

1.49

6.14

1.2

64.87

68.68

u/l

0.23

162

1056

Other diseases of lip and oral mucosa

316

2352

1.35

6.11

1.2

57.73

63.87

u/l

1.13

270

2064

Malignant neoplasm of pancreas, including Hilmo

293

2.03

6.09

1.1

56.85

57.32

u/l

0.03

255

Malignant melanoma of skin, including Hilmo

565

1.73

6.09

1.3

1.2

60.40

55.13

u/l

0.27

480

Congenital malformations and deformations of the musculoskeletal system

278

2.05

6.08

1.2

131.41

86.56

u/l

0.31

252

Personal history of medical treatment

5.32

6.07

1.3

1.2

47.76

62.00

u/l

0.73

L02BB Anti-androgens

321

1.98

6.06

2.2

1.1

173.74

66.62

u/l

2.51

279

Behavioural syndromes associated with physiological disturbances and physical factors

670

3686

1.23

6.06

1.2

64.20

64.76

u/l

0.06

583

3258

Monoamine oxidase A inhibitors

515

1.76

6.03

1.2

58.46

63.49

u/l

0.31

447

Thyrotoxicosis with toxic multinodular goitre

261

2.09

6.02

1.3

1.2

75.09

55.90

u/l

1.16

232

Benign neoplasm: Rectum, anus and anal canal

151

985

1.54

6.02

1.2

57.92

64.58

u/l

0.40

130

849

Acute pharyngitis

473

1.79

6.02

1.3

1.2

103.60

68.58

u/l

0.38

413

Voice disturbances

206

1432

1.45

6.00

1.2

59.46

61.73

u/l

0.20

179

1252

Malignant neoplasm of thyroid gland

248

2.12

5.99

1.2

79.83

54.95

u/l

0.92

214

Non-small cell lung cancer

360

1.91

5.97

1.2

55.67

54.62

u/l

0.05

307

Internal derangement of knee

242

1714

1.40

5.97

1.2

54.60

67.21

u/l

3.53

223

1494

severe traumatic brain injury, does not include concussion

149

971

1.54

5.96

1.3

1.2

66.99

66.49

u/l

0.03

130

842

therapeutic use

112

2.72

5.95

1.4

1.2

53.90

54.82

u/l

0.04

100

Diseases of salivary glands

238

1701

1.40

5.93

1.2

60.03

62.20

u/l

0.24

217

1490

Corneal scars and opacities

101

2.82

5.92

1.2

56.07

50.37

u/l

0.33

COPD

318

1925

1.35

5.92

1.2

55.93

64.20

u/l

1.33

278

1674

Colonic or urogenital fistula

190

1305

1.46

5.90

1.1

1.2

51.64

63.41

u/l

3.33

172

1133

Other neurological diseases

521

3214

1.26

5.88

1.2

60.47

62.34

u/l

0.26

471

2807

Dermatophytosis

586

1.70

5.88

1.2

70.52

63.50

u/l

0.33

513

Malignant neoplasm of colon, including Hilmo

120

743

1.62

5.87

1.1

1.2

69.88

56.86

u/l

0.84

110

639

Myocardial infarction, unclassifiable

144

832

1.55

5.87

1.2

83.02

65.91

u/l

0.30

126

728

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

183

1249

1.47

5.86

1.2

54.28

61.19

u/l

1.03

154

1111

Mental disorders, not otherwise specified

257

2.08

5.85

1.3

1.2

48.41

61.72

u/l

1.36

229

Disturbances of skin sensation

193

1333

1.45

5.82

1.3

1.2

52.76

60.44

u/l

1.41

175

1159

Malignant neoplasm of bronchus and lung, including Hilmo

135

717

1.58

5.82

1.2

70.50

56.91

u/l

1.14

126

608

Malignant neoplasm of bladder, including Hilmo

370

1.88

5.80

1.2

51.72

54.94

u/l

0.25

317

Other/unspecified synovitis and tenosynovitis

485

1.76

5.76

1.2

62.99

61.77

u/l

0.07

428

Injuries to the wrist and hand

713

3889

1.22

5.76

1.2

63.35

65.19

u/l

0.23

621

3437

Other viral hepatitis, including avohilmo

206

2.20

5.75

1.3

1.2

61.50

62.96

u/l

0.07

186

Other problems related to primary support group, including family circumstances

345

1.90

5.74

1.2

123.82

69.46

u/l

0.75

309

Fracture of foot, except ankle

169

1142

1.49

5.71

1.4

1.2

58.04

64.16

u/l

0.81

146

1007

Colorectal cancer, including Hilmo

169

1062

1.49

5.71

1.2

74.44

56.64

u/l

1.04

156

910

Artificial joint re-operation

287

2.01

5.71

1.2

53.34

56.45

u/l

0.24

256

Fall on same level involving ice and snow

419

3272

1.28

5.71

1.2

62.19

62.59

u/l

0.05

361

2872

Other viral hepatitis

194

2.24

5.70

1.3

1.2

61.03

58.68

u/l

0.13

175

Angina pectoris

392

2000

1.30

5.69

1.2

60.54

61.39

u/l

0.08

348

1753

Abscess of anal and rectal regions

267

2.04

5.67

1.1

1.2

67.34

61.34

u/l

0.29

237

Carpal tunnel syndrome

449

3062

1.27

5.66

1.3

1.2

58.72

60.30

u/l

0.30

400

2685

Emotionally unstable personality disorder

393

1.84

5.65

1.2

60.21

61.86

u/l

0.08

359

Viral hepatitis

234

2.11

5.64

1.3

1.2

61.10

61.21

u/l

0.01

212

Umbilical hernia

174

1186

1.47

5.64

1.2

61.18

64.96

u/l

0.17

158

1029

Benign neoplasm: Rectum

135

873

1.56

5.63

1.2

57.57

64.29

u/l

0.36

116

759

Hyperaldosteronism

104

2.74

5.63

1.1

1.2

51.16

49.41

u/l

0.11

Visual disturbances

349

2669

1.31

5.62

1.2

65.30

64.29

u/l

0.03

303

2338

Injury, poisoning and certain other consequences of external causes

340

1279

1.34

5.59

1.2

72.91

69.64

u/l

0.18

298

1148

Other chronic obstructive pulmonary disease

304

1861

1.34

5.57

1.2

56.08

64.15

u/l

1.21

265

1615

Other specified disorders of kidney and ureter

122

2.58

5.57

1.1

1.2

89.97

51.78

u/l

1.26

110

Dermatophytosis, including avohilmo

449

3478

1.27

5.54

1.2

65.62

64.27

u/l

0.09

401

3050

Other congenital malformations

276

2.01

5.54

1.2

60.54

83.01

u/l

0.99

248

Thiazolidinediones

469

1.76

5.54

1.1

1.2

55.12

65.99

u/l

1.21

414

Alcohol use disorder, ICD-based

261

1918

1.37

5.52

1.2

66.74

64.31

u/l

0.13

219

1681

Lung diseases due to external agents

544

1.70

5.51

1.2

50.24

64.72

u/l

2.16

475

Carcinoma in situ of skin of other and unspecified parts of face

340

1.90

5.49

1.2

65.61

64.93

u/l

0.03

298

Delivery, wide proxy

126

1034

0.64

5.47

1.3

1.2

64.46

59.65

u/l

0.55

111

907

Hemiplegia

172

2.29

5.47

1.3

1.2

54.66

62.00

u/l

0.33

154

Allergic asthma (mode)

133

841

1.55

5.47

1.2

1.1

64.73

63.82

u/l

0.06

116

727

Carcinoma in situ of skin

362

1.87

5.47

1.1

1.2

56.04

64.28

u/l

0.52

319

Focal brain injury

224

2.11

5.45

1.1

1.2

77.74

65.57

u/l

0.34

190

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

122

777

1.58

5.45

1.2

67.96

56.78

u/l

0.94

114

658

Delivery

169

1298

0.68

5.44

1.2

59.87

59.59

u/l

0.03

149

1144

Melanoma in situ

173

2.28

5.41

1.2

46.58

52.94

u/l

0.40

155

Malignant melanoma of skin

458

1.76

5.39

1.3

1.2

60.89

55.10

u/l

0.25

390

Other/unspecified reactive arthropathies

232

2.09

5.38

1.4

1.2

59.29

60.60

u/l

0.04

209

Single spontaneous delivery

169

1298

0.68

5.38

1.2

60.41

59.59

u/l

0.09

150

1144

Retinal vascular occlusion

490

1.73

5.31

1.2

58.06

66.71

u/l

0.84

435

Other chronic obstructive pulmonary disease, including avohilmo

381

2435

1.29

5.26

1.2

54.98

63.00

u/l

1.63

328

2132

Acute suppurative otitis media

138

847

1.52

5.25

1.3

1.2

77.72

69.15

u/l

0.45

130

753

Use of pramipexole

166

1139

1.46

5.25

1.2

59.87

63.17

u/l

0.37

139

992

Enthesopathies of lower limb, excluding foot

164

1123

1.47

5.23

1.3

1.2

56.96

62.18

u/l

0.53

142

983

Later onset COPD, excluding more controls

133

659

1.54

5.22

1.2

53.21

70.15

u/l

1.60

115

565

Fall on and from stairs and steps

186

1305

1.43

5.21

1.2

54.88

66.56

u/l

2.20

164

1130

Sacroiliitis, not elsewhere classified

132

2.45

5.21

1.3

1.2

44.04

65.72

u/l

1.37

119

Superficial injury of lower leg

181

1264

1.44

5.20

1.2

56.16

66.32

u/l

1.61

158

1110

Corneal ulcer

126

818

1.55

5.20

1.4

1.2

60.64

64.07

u/l

0.31

117

715

Retinal vascular disorders

501

1.71

5.18

1.2

57.73

66.42

u/l

0.86

443

Sequelae of cerebrovascular disease

252

1586

1.36

5.17

1.2

59.23

63.09

u/l

0.43

221

1377

Malignant neoplasm of bronchus and lung

118

628

1.58

5.16

1.1

1.2

73.40

56.36

u/l

1.33

109

536

Ganglion

147

988

1.49

5.15

1.2

61.67

61.32

u/l

0.03

133

864

Acanthosis nigricans

14.09

5.15

1.1

1.0

51.25

38.67

u/l

—

Suicide or other Intentional self-harm

156

1062

1.47

5.13

1.2

55.96

61.47

u/l

0.65

135

937

Superficial injury of head

165

1135

1.46

5.11

1.2

60.57

65.88

u/l

0.49

140

996

Disorders of breast

368

2523

1.29

5.11

1.2

56.31

59.20

u/l

0.81

335

2228

Asthma and allergy, excluding more controls

372

1.81

5.11

1.3

1.1

75.04

67.43

u/l

0.39

324

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

292

1.93

5.10

1.3

1.2

47.69

60.20

u/l

1.62

265

COPD related to multimorbidity

272

1718

1.34

5.08

1.2

52.93

64.74

u/l

2.49

238

1488

Melanocytic naevi of trunk

474

1.72

5.08

1.2

71.81

60.60

u/l

0.31

424

Traumatic subdural haemorrhage

534

1.65

5.07

1.2

62.90

66.96

u/l

0.21

457

Postprocedural musculoskeletal disorders, not elsewhere classified

300

1.92

5.07

1.2

63.64

63.52

u/l

0.00

266

Superficial injury of abdomen, lower back and pelvis

611

1.63

5.07

1.3

1.2

92.22

64.76

u/l

0.33

531

Malignant neoplasm of thyroid gland, including Hilmo

286

1.94

5.06

1.2

79.12

54.96

u/l

0.96

249

Biomechanical lesions, not elsewhere classified

198

2.14

5.05

1.3

1.2

59.97

54.29

u/l

0.54

178

Aortic aneurysm

142

934

1.50

5.02

1.2

48.39

64.37

u/l

3.75

130

808

Fracture at wrist and hand level

225

1639

1.37

4.98

1.2

62.30

64.92

u/l

0.24

189

1439

Inflammatory diseases of the central nervous system

302

1.90

4.97

1.2

55.74

62.44

u/l

0.48

268

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

526

1.63

4.95

1.3

1.2

110.85

71.94

u/l

0.74

470

304

2091

1.31

4.90

1.2

57.22

60.92

u/l

0.49

264

1819

Other inflammation of eyelid

109

695

1.58

4.90

1.3

1.2

99.98

63.53

u/l

0.53

610

Injuries to the shoulder and upper arm

606

3864

1.21

4.86

1.2

58.72

65.00

u/l

1.69

535

3410

Other congenital malformations, including avohilmo

465

1.71

4.85

1.2

56.35

73.04

u/l

1.17

420

Disorders of optic nerve and visual pathways

355

1.82

4.84

1.2

60.07

66.13

u/l

0.30

323

Excessive attrition of teeth

407

3206

1.26

4.83

1.2

62.63

63.70

u/l

0.14

356

2818

Special screening examination for infectious and parasitic diseases

115

538

1.56

4.78

1.2

70.72

71.42

u/l

0.02

101

467

Allergic urticaria

292

1.90

4.78

1.1

1.2

52.68

75.21

u/l

1.25

264

Other viral diseases, not elsewhere classified, including avohilmo

165

1146

1.44

4.75

1.3

1.2

67.62

69.52

u/l

0.09

149

1005

Drug-induced adrenocortical insufficiency

3.00

4.75

1.3

1.2

71.60

91.72

u/l

0.21

Other and unspecified disorders of vitreous body

328

2494

1.29

4.73

1.3

1.2

58.12

62.02

u/l

0.57

286

2178

Alzheimer disease

120

1289

0.66

4.73

1.1

1.2

60.98

61.51

u/l

0.03

1128

Lumbar disc prolapse

426

2520

1.25

4.73

1.2

56.65

62.96

u/l

1.75

370

2221

Mental and behavioural disorders due to opioids

102

2.57

4.72

1.3

60.62

52.24

u/l

0.45

Asthma and allergy

382

1.76

4.70

1.3

1.2

75.04

69.10

u/l

0.28

332

Infections with a predominantly sexual mode of transmission, including avohilmo

236

1602

1.35

4.70

1.2

59.09

61.35

u/l

0.25

204

1427

COPD, hospital admissions 3, with asthma pneumonia sepsis

181

1102

1.41

4.67

1.2

58.46

64.77

u/l

0.53

159

950

Hyperfunction of pituitary gland

152

2.26

4.67

1.3

1.2

70.10

63.95

u/l

0.16

140

Paracetamol or NSAID medication

259

1.70

4.66

1.2

62.76

97.63

u/l

1.24

232

157

1018

1.45

4.65

1.2

59.84

61.16

u/l

0.09

129

884

Injury of intra-abdominal organs

2.79

4.63

1.2

44.14

56.20

u/l

0.93

Alzheimer disease, including avohilmo

148

1473

0.69

4.62

1.1

1.2

60.46

60.45

u/l

0.00

125

1286

Restless leg syndrome

105

674

1.57

4.61

1.1

1.2

56.85

61.60

u/l

0.49

595

Colorectal cancer

147

972

1.46

4.56

1.1

1.2

79.42

57.07

u/l

1.19

135

833

Pain in thoracic spine

110

716

1.54

4.54

1.1

1.2

90.85

63.36

u/l

0.40

626

Spontaneous rupture of synovium and tendon

348

1.79

4.54

1.1

1.2

59.89

57.72

u/l

0.13

310

Encephalopathy

4.95

4.54

1.2

1.1

55.54

45.77

u/l

0.31

Epilepsy

199

1446

1.38

4.52

1.2

63.37

70.90

u/l

0.58

172

1275

Infective dermatitis

445

1.70

4.52

1.1

1.2

73.54

63.51

u/l

0.30

395

Granulomatous disorders of skin and subcutaneous tissue

2.68

4.51

1.4

1.1

56.00

51.30

u/l

0.32

Rotator cuff syndrome

412

2269

1.25

4.50

1.2

57.59

64.47

u/l

1.39

364

1989

Non-Hodgkin lymphoma, all

123

2.38

4.49

1.3

1.2

64.79

51.90

u/l

0.82

107

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

384

1.74

4.47

1.2

119.18

84.74

u/l

0.27

348

Other chondrocalcinosis

4.47

1.1

1.2

53.86

50.48

u/l

0.11

Primary gonarthrosis, bilateral

397

2659

1.25

4.46

1.2

55.46

62.85

u/l

2.25

339

2325

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

307

1.84

4.43

1.3

1.2

47.69

61.20

u/l

1.89

281

Ingrowing nail

189

2.08

4.41

1.3

1.2

75.97

57.98

u/l

0.31

172

244

1.94

4.38

1.1

1.2

52.06

60.91

u/l

0.80

224

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

199

2.04

4.38

1.2

99.22

90.07

u/l

0.16

180

Other peripheral vascular diseases

301

1.84

4.38

1.2

58.13

59.05

u/l

0.06

271

Recurrent aphthous stomatitis , including avohilmo

635

1.57

4.38

1.3

1.2

81.30

67.43

u/l

0.47

556

Conjunctivitis (acute, non atopic)

184

1327

1.39

4.36

1.3

1.2

58.07

65.30

u/l

0.96

168

1152

Orthopaedic devices associated with adverse incidents

2.93

4.36

1.4

1.2

50.11

50.98

u/l

0.03

Use of memantine

1181

0.64

4.36

1.0

1.2

53.90

62.54

u/l

1.40

1028

Use of other anti-dementia drugs

1181

0.64

4.36

1.0

1.2

53.90

62.54

u/l

1.40

1028

Spirochaetal infections, other/unspecified

375

1.75

4.35

1.2

52.73

61.89

u/l

1.26

336

Other and unspecified follicular disorders

144

2.24

4.35

1.2

64.58

52.17

u/l

0.74

132

Adhesive capsulitis of shoulder

121

813

1.50

4.33

1.2

50.83

64.10

u/l

3.17

109

705

Malignant neoplasm of eye and adnexa, including Hilmo

4.02

4.32

1.2

77.53

121.97

u/l

0.24

COPD, hospital admissions

303

1987

1.29

4.29

1.2

56.06

63.98

u/l

1.21

265

1720

Nonsuppurative otitis media, including avohilmo

183

1147

1.38

4.24

1.3

1.2

59.65

67.48

u/l

0.99

165

1009

COPD, early/later onset

305

1999

1.28

4.22

1.2

56.06

63.78

u/l

1.17

266

1733

Sleep disorders

626

3622

1.19

4.21

1.2

64.23

63.67

u/l

0.06

544

3203

Cerebral cysts

179

2.08

4.21

1.2

71.68

64.52

u/l

0.24

162

Plantar fascial fibromatosis

448

1.66

4.17

1.2

57.38

57.42

u/l

0.00

400

Other misadventures during surgical and medical care

2.63

4.16

1.1

1.2

62.06

51.11

u/l

0.40

Clear cell adenocarcinoma of kidney

147

2.20

4.16

1.3

1.2

60.44

51.07

u/l

0.63

126

Follicular cysts of skin and subcutaneous tissue

122

830

1.48

4.13

1.2

70.98

62.42

u/l

0.44

107

722

Actinic keratosis

276

1945

1.29

4.12

1.2

55.32

61.29

u/l

1.24

238

1689

Acute nephritic syndrome

2.75

4.11

1.2

49.91

57.17

u/l

0.30

Alcohol dependence

156

1112

1.41

4.10

1.1

1.2

73.45

65.47

u/l

0.30

130

967

Other disorders of eye and adnexa

630

1.55

4.09

1.4

1.2

57.83

69.32

u/l

1.11

562

Colorectal adenocarcinoma

121

812

1.48

4.09

1.1

1.2

81.27

57.18

u/l

1.06

110

693

Other headache syndromes

283

2198

1.29

4.09

1.2

59.10

62.55

u/l

0.38

248

1946

Other congenital malformations of skin

142

2.21

4.06

1.1

1.2

56.04

61.27

u/l

0.22

132

Other and unspecified injuries of lower leg

280

1.83

4.05

1.3

1.2

57.86

59.27

u/l

0.07

250

Malignant neoplasm of colon

616

1.55

4.04

1.1

1.2

75.49

55.54

u/l

1.15

526

Thoracic aortic aneurysm

569

1.57

4.03

1.2

49.03

63.93

u/l

1.99

491

Pneumococcal septicemia

117

2.33

4.03

1.3

102.22

54.76

u/l

0.67

108

Hallux rigidus

101

665

1.53

4.02

1.2

52.37

65.85

u/l

2.36

569

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

3.94

4.01

1.1

1.2

71.50

49.33

u/l

0.85

Other enthesopathies

203

1516

1.34

4.00

1.3

1.2

60.83

62.53

u/l

0.16

183

1329

COPD, hospital admission 2, with asthma infections

214

1383

1.34

4.00

1.2

58.15

64.11

u/l

0.61

189

1191

Viral pneumonia (known virus, not influenza)

2.50

3.98

1.5

1.3

85.67

91.55

u/l

0.05

Moderate visual impairment, binocular

2.50

3.98

1.3

1.2

72.00

59.83

u/l

0.49

Disorders of tooth development and eruption

519

1.54

3.97

1.3

1.2

57.20

64.04

u/l

0.65

458

Colon adenocarcinoma

470

1.63

3.96

1.1

1.2

73.87

56.62

u/l

0.83

399

Macular hole

254

1.87

3.95

1.2

46.69

61.10

u/l

1.94

226

Uterine polyps

222

973

1.34

3.94

1.2

63.17

57.71

u/l

0.95

191

854

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

231

1739

1.31

3.93

1.2

53.46

67.52

u/l

3.12

201

1536

Palmar fascial fibromatosis [Dupuytren]

621

1.54

3.91

1.3

1.2

55.96

69.05

u/l

1.16

531

Other diseases of peritoneum

158

2.11

3.89

1.1

1.2

55.93

56.31

u/l

0.02

143

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

213

1.94

3.87

1.2

1.1

59.78

52.58

u/l

0.54

181

Other and unspecified visual disturbances

427

1.65

3.86

1.1

1.2

60.80

59.30

u/l

0.07

376

Inflammatory diseases of female pelvic organs

447

2514

1.22

3.86

1.2

59.08

58.71

u/l

0.06

383

2240

Skin changes due to chronic exposure to nonionizing radiation

281

1996

1.28

3.83

1.2

57.78

61.37

u/l

0.43

243

1735

Benign neoplasm: Ascending colon

100

665

1.51

3.82

1.2

52.74

65.69

u/l

2.11

581

Dementia in Alzheimer disease

737

0.58

3.81

1.0

1.2

58.26

60.05

u/l

0.10

649

Car occupant injured in other and unspecified transport accidents

110

746

1.48

3.81

1.2

58.96

63.25

u/l

0.36

666

Spasmodic torticollis

108

2.34

3.77

1.0

1.2

62.45

54.10

u/l

0.45

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

659

1.51

3.75

1.2

58.96

68.01

u/l

0.71

580

Artrosis, including avohilmo

548

2515

1.19

3.71

1.2

61.25

63.97

u/l

0.30

480

2221

Speech and linguistic disorders, excluding more controls

189

1.94

3.70

1.3

1.2

75.51

79.40

u/l

0.12

176

Other and unspecified injuries of head

274

1.80

3.70

1.1

1.2

68.66

58.36

u/l

0.41

246

Localized swelling, mass and lump of skin and subcutaneous tissue

216

1650

1.31

3.69

1.2

61.80

64.66

u/l

0.20

197

1429

Polyp of the female genital tract

229

987

1.32

3.68

1.2

59.35

57.73

u/l

0.24

203

866

Other and unspecified myopathies

334

1.72

3.67

1.2

64.79

73.08

u/l

0.24

294

Degenerative diseases of the nervous system

148

1464

0.72

3.66

1.1

1.2

64.36

61.61

u/l

0.19

123

1276

Benign neoplasm of eye and adnexa

465

1.60

3.65

1.2

66.45

68.71

u/l

0.10

410

Open wound of forearm

327

1.72

3.65

1.2

74.21

67.72

u/l

0.20

285

Dermatographic urticaria

232

1.87

3.64

1.3

1.2

61.59

61.66

u/l

0.00

212

Somnolence, stupor and coma

149

2.10

3.63

1.2

44.99

57.36

u/l

1.01

133

Other enthesopathy of foot (+metatarsalgia)

458

1.60

3.62

1.3

1.2

63.64

58.94

u/l

0.24

408

Memory loss

381

1.66

3.62

1.2

65.82

63.08

u/l

0.09

335

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

340

2651

1.24

3.62

1.2

59.06

64.95

u/l

1.14

301

2313

Injury of eye and orbit

513

1.57

3.61

1.2

59.52

65.12

u/l

0.37

458

Suppurative and unspecified otitis media

194

1293

1.33

3.61

1.3

1.2

74.76

67.69

u/l

0.51

182

1133

Disorders of psychological development

317

1.70

3.61

1.3

1.2

119.30

83.47

u/l

0.36

290

Subjective visual disturbances

173

1285

1.35

3.60

1.2

52.47

63.27

u/l

2.49

153

1128

Psoriasis (vulgaris), strict definition

117

2.24

3.59

1.2

50.69

54.53

u/l

0.29

105

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

181

1354

1.34

3.58

1.2

65.55

63.69

u/l

0.14

162

1199

Synovial cyst of popliteal space [Baker]

292

1.76

3.57

1.5

1.2

59.43

56.17

u/l

0.24

256

Amenorrhoea

205

1.91

3.57

1.3

1.2

76.22

58.39

u/l

0.80

182

Striking against or struck by other objects

194

1465

1.33

3.56

1.3

1.2

72.50

68.16

u/l

0.09

174

1286

Osteogenesis imperfecta

10.62

3.55

1.0

93.17

198.50

u/l

—

Pregnancy, childbirth and the puerperium

117

873

0.70

3.54

1.3

1.2

63.27

61.19

u/l

0.14

104

761

Other disorders of breast

100

677

1.48

3.53

1.2

55.50

60.00

u/l

0.66

596

Other or unspecified common variable immunodeficiency

10.42

3.53

1.7

1.5

45.83

54.83

u/l

—

Rheumatic fever with heart involvement

10.28

3.52

1.5

1.7

43.00

51.33

u/l

—

Atopic dermatitis, strict definition

168

1218

1.35

3.52

1.2

66.39

68.71

u/l

0.12

149

1087

Hypotension due to drugs

3.67

3.51

1.1

1.2

46.31

49.77

u/l

0.14

Speech therapy

180

1351

1.34

3.50

1.2

61.99

62.91

u/l

0.04

156

1175

Fenamates

100

456

1.50

3.50

1.1

1.2

48.34

63.52

u/l

3.07

407

Nonsuppurative otitis media

117

707

1.44

3.49

1.3

1.2

92.41

72.90

u/l

0.28

108

626

Pilonidal cyst

250

1.81

3.49

1.0

1.2

59.92

59.28

u/l

0.03

223

Other and unspecified glaucoma

287

1.75

3.48

1.3

1.2

87.09

61.62

u/l

0.59

249

Cervicalgia

141

1020

1.39

3.47

1.2

55.15

61.83

u/l

0.93

122

889

Erectile dysfunction

280

1.76

3.47

1.3

1.2

93.89

66.04

u/l

0.73

248

Congenital malformations of the circulatory system

511

1.55

3.46

1.3

1.2

123.95

80.20

u/l

0.44

453

Ovarian cyst

239

1057

1.30

3.45

1.2

57.24

58.67

u/l

0.16

208

929

Pigmented purpuric dermatosis

3.83

3.41

1.2

61.33

44.94

u/l

0.74

Gonarthrosis,primary

635

3281

1.17

3.41

1.2

58.30

62.11

u/l

0.77

562

2891

Atrophic disorders of skin

114

798

1.44

3.40

1.1

1.2

56.75

59.69

u/l

0.30

696

Pain associated with micturition

530

1.54

3.38

1.2

57.23

72.39

u/l

1.18

464

Acne

296

1.72

3.35

1.4

1.2

74.39

71.78

u/l

0.10

263

Other bursopathies

589

1.50

3.31

1.4

1.2

57.45

66.17

u/l

0.84

505

Other disorders of conjunctiva

663

1.47

3.30

1.3

1.2

51.07

64.61

u/l

1.88

578

Disorders of muscles

399

1.61

3.29

1.3

1.2

72.64

64.59

u/l

0.29

352

Vulvovaginal ulceration/inflammation in other diseases

233

1.81

3.29

1.1

1.2

54.09

65.49

u/l

1.05

214

Dental pulpitis, including avohilmo

595

3262

1.17

3.28

1.2

63.23

63.70

u/l

0.04

512

2883

Unspecified mental disorder

245

1935

1.27

3.27

1.2

57.19

62.96

u/l

0.97

210

1708

Adverse effects, not elsewhere classified

121

863

1.41

3.26

1.2

60.79

66.17

u/l

0.33

100

766

Use of donepezil

988

0.64

3.24

1.1

1.2

68.23

62.49

u/l

0.23

864

Alzheimer’s disease (Late onset)

1003

0.67

3.24

1.1

1.2

54.75

61.66

u/l

0.80

876

Other hearing loss

198

1476

1.30

3.24

1.2

57.48

62.75

u/l

0.76

171

1272

Other congenital malformations of skin, including avohilmo

309

1.69

3.23

1.1

1.2

52.24

72.51

u/l

1.23

279

Metatarsalgia

425

1.58

3.22

1.3

1.2

64.52

59.36

u/l

0.24

377

Supplementary factors related to causes of morbidity and mortality classified elsewhere

199

1535

1.30

3.22

1.2

71.32

64.47

u/l

0.77

172

1336

Sequelae of injuries, of poisoning and of other consequences of external causes

146

1079

1.36

3.19

1.2

61.98

62.91

u/l

0.07

125

943

Anorexia (incl.atypical)

157

1.98

3.18

1.2

63.84

66.77

u/l

0.07

146

Insomnia

604

3618

1.16

3.15

1.2

64.17

63.42

u/l

0.08

522

3195

Other hammer toe(s) (acquired)

122

800

1.39

3.07

1.2

54.52

61.90

u/l

0.88

101

696

Heartburn

454

1.55

3.07

1.2

58.37

65.70

u/l

0.61

394

Ocular pain

329

1.65

3.07

1.2

54.81

61.81

u/l

0.66

299

Malignant neoplasm of oral cavity, including Hilmo

132

2.06

3.07

1.3

1.2

50.73

50.39

u/l

0.01

114

Leisure time condition

112

798

1.41

3.07

1.2

70.99

64.83

u/l

0.40

699

Wet age-related macular degeneration

117

809

1.40

3.07

1.2

66.40

62.51

u/l

0.24

104

700

Nummular dermatitis

314

1.67

3.06

1.4

1.2

68.76

68.61

u/l

0.00

277

Alzheimer’s disease, strict definition

1086

0.70

3.06

1.1

1.2

55.72

62.30

u/l

0.84

950

Cysts of oral region, not elsewhere classified

196

1.85

3.02

1.3

1.2

94.63

60.07

u/l

0.39

178

Herpesviral [herpes simplex] infections

480

1.53

3.02

1.2

56.91

64.03

u/l

0.53

422

Unspecified lump in breast

116

836

1.39

2.99

1.3

1.2

58.12

60.01

u/l

0.20

106

732

Acute and transient psychotic disorders

450

1.54

2.97

1.1

1.2

70.52

60.23

u/l

0.48

397

Chondropathies

612

1.46

2.97

1.2

68.76

56.91

u/l

0.86

541

Pleural plaque

325

1.64

2.95

1.2

49.88

69.57

u/l

2.02

279

Alcohol-induced acute pancreatitis

114

2.12

2.95

1.1

1.2

53.95

60.68

u/l

0.22

101

Other symptoms and signs involving the nervous and musculoskeletal systems

270

2186

1.24

2.95

1.2

63.99

u/l

0.00

247

1910

Assault

435

1.55

2.94

1.3

1.2

64.47

65.35

u/l

0.04

386

Alcohol abuse, main dg, excluding more controls

516

1.50

2.92

1.1

1.2

60.08

64.57

u/l

0.35

458

Other noninflammatory disorders of vulva and perineum

468

1.53

2.92

1.2

50.67

56.15

u/l

0.64

409

Spondylolisthesis/Spondylolysis

127

933

1.37

2.92

1.3

1.2

54.48

62.56

u/l

1.29

110

812

D07AA Corticosteroids, weak (group I)

581

1.47

2.90

1.2

82.91

72.05

u/l

0.24

515

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

116

841

1.38

2.89

1.2

53.73

60.19

u/l

0.95

748

Other sleep disorders

470

1.52

2.87

1.2

64.89

65.30

u/l

0.02

415

Haemorrhagic disorder due to circulating anticoagulants

3.21

2.86

1.3

1.1

44.33

42.50

u/l

0.08

Other disorders of bladder

454

1.53

2.86

1.2

55.19

68.80

u/l

0.98

393

Other/unspecified enthesopathies of lower limb, excluding foot

290

1.66

2.84

1.2

64.28

64.67

u/l

0.01

255

Malignant neoplasm of head and neck

267

1.69

2.84

1.3

1.1

69.08

53.62

u/l

0.51

229

Open wound of wrist and hand

262

2051

1.24

2.84

1.2

66.68

65.97

u/l

0.04

230

1805

Other extrapyramidal and movement disorders in other diseases

169

1301

1.30

2.83

1.2

62.04

62.88

u/l

0.04

147

1133

Fracture of neck

223

1.76

2.82

1.2

57.09

67.48

u/l

0.55

194

Respiratory conditions due to other external agents

2.43

2.81

1.4

1.2

42.88

51.25

u/l

0.89

Dementia

202

1747

0.79

2.80

1.1

1.2

65.48

63.38

u/l

0.16

174

1518

Raynaud syndrome

338

1.61

2.79

1.2

62.72

60.26

u/l

0.12

306

Complications of the puerperium, not elsewhere classified

110

2.11

2.79

1.4

1.1

49.83

72.68

u/l

1.25

101

Acute laryngitis and tracheitis

348

1.59

2.78

1.2

60.54

72.98

u/l

0.94

306

Otitis media, unspecified

318

1.60

2.77

1.3

1.2

132.10

71.06

u/l

0.43

282

Other disorders of ear

628

3541

1.15

2.75

1.3

1.2

57.49

64.80

u/l

1.99

565

3105

Disorders of ocular muscles, binocular movement, accommodation and refraction

297

2427

1.21

2.74

1.2

77.92

64.25

u/l

0.72

256

2131

Other and unspecified haemorrhagic conditions

2.74

2.73

1.6

1.3

65.85

45.66

u/l

0.99

Carcinoma in situ of breast, intraductal

468

1.51

2.73

1.2

61.30

59.31

u/l

0.13

411

Hyperplasia of prostate

191

837

1.29

2.72

1.2

68.56

68.23

u/l

0.01

162

737

Radiculopathy

105

758

1.39

2.71

1.2

64.71

65.04

u/l

0.01

654

Idiopathic pulmonary fibrosis

287

1.65

2.69

1.1

1.2

81.50

68.42

u/l

0.46

256

Antenatal screening

600

0.68

2.69

1.2

70.27

59.39

u/l

0.31

541

Superficial injury of wrist and hand

120

887

1.36

2.68

1.2

58.76

67.17

u/l

0.63

107

786

Appendectomy

410

3319

1.18

2.67

1.2

57.05

63.49

u/l

1.52

361

2925

Superficial injury of thorax

626

1.43

2.67

1.2

64.63

61.03

u/l

0.23

548

Other superficial mycoses

2.35

2.66

1.5

1.2

76.41

53.94

u/l

0.82

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

106

769

1.38

2.66

1.2

58.06

69.20

u/l

1.06

674

False labour

837

0.72

2.65

1.1

1.2

53.97

58.31

u/l

0.75

756

Mixed conductive and sensorineural hearing loss

570

1.45

2.63

1.2

52.82

66.20

u/l

2.00

493

Otitis externa, unspecified

431

1.51

2.63

1.2

73.60

66.62

u/l

0.19

387

Benign paroxysmal vertigo

206

1643

1.26

2.63

1.2

62.69

61.17

u/l

0.10

182

1439

Toxic effects of substances chiefly nonmedicinal as to source

400

1.53

2.60

1.1

1.2

60.63

63.93

u/l

0.17

356

Fitting and adjustment of other devices

220

1556

1.25

2.60

1.2

56.34

60.35

u/l

0.50

212

1337

Chronic thyroiditis

7.34

2.57

1.2

1.3

46.00

48.51

u/l

—

Malignant neoplasm of anus and anal canal

5.59

2.56

2.2

1.4

58.83

36.33

u/l

—

Portal vein thrombosis

2.45

2.55

1.3

50.67

43.48

u/l

0.43

Trichomoniasis, including avohilmo

3.29

2.54

1.1

1.2

49.40

53.35

u/l

—

Diseases of middle ear and mastoid

334

2289

1.19

2.52

1.3

1.2

66.31

66.44

u/l

0.01

311

1998

Thyroiditis

293

1.61

2.51

1.1

1.2

53.00

58.30

u/l

0.65

263

Toxic effect of ethanol

122

1.98

2.51

1.1

1.2

73.73

54.44

u/l

0.50

113

Polycystic ovarian syndrome, consortium definition

494

2449

1.16

2.48

1.2

59.36

59.11

u/l

0.04

443

2163

Pathological resorption of teeth

137

1.91

2.46

1.3

1.2

55.32

55.00

u/l

0.01

123

Necrosis of pulp, including avohilmo

365

3064

1.18

2.46

1.2

61.02

63.43

u/l

0.21

325

2691

Use of rivastigmine

742

0.64

2.46

1.1

1.2

61.13

64.29

u/l

0.19

644

Sequelae of injuries of lower limb

366

1.54

2.45

1.2

54.71

59.06

u/l

0.33

328

Burns and corrosions of external body surface, specified by site

366

1.54

2.45

1.2

66.45

64.18

u/l

0.09

326

Transient ischemic attack

345

2320

1.19

2.45

1.2

58.22

63.15

u/l

0.74

306

2034

Cardiac murmurs and other cardiac sounds

338

1.56

2.45

1.3

1.1

73.23

98.21

u/l

0.53

297

Congenital malformations of heart and great arteries

441

1.48

2.44

1.3

1.2

143.75

79.84

u/l

0.55

394

Cervicocranial syndrome

488

1.46

2.44

1.4

1.2

56.98

63.81

u/l

0.63

425

Diplopia

546

1.43

2.44

1.3

1.2

52.64

63.94

u/l

1.29

480

Anogenital herpesviral [herpes simplex] infection

181

1.78

2.43

1.2

61.51

59.68

u/l

0.05

166

Disorders of porphyrin and bilirubin metabolism

2.94

2.43

1.4

1.3

70.30

48.65

u/l

0.74

Other specified and unspecified disorders of eye and adnexa

138

1.90

2.42

1.6

1.2

65.81

53.58

u/l

0.59

125

Coxarthrosis, primary

419

2989

1.17

2.41

1.2

60.71

61.76

u/l

0.12

372

2612

Car occupant injured in noncollision transport accident

117

1.98

2.41

1.3

1.2

65.56

51.21

u/l

0.68

107

Other inflammation of eyelid, including avohilmo

282

2350

1.20

2.39

1.2

71.38

64.55

u/l

0.22

254

2071

Gonarthrosis, primary, with knee surgery

413

2760

1.17

2.39

1.2

54.94

62.49

u/l

2.36

362

2417

Chronic myeloid leukaemia, including Hilmo

3.70

2.38

1.1

1.3

65.13

39.50

u/l

—

Superficial injury of ankle and foot

458

1.47

2.37

1.3

1.2

63.72

75.03

u/l

0.64

410

Diseases of inner ear

369

3013

1.17

2.36

1.2

57.51

60.93

u/l

0.47

329

2631

Type of accident

180

1434

1.26

2.36

1.2

70.81

64.83

u/l

0.60

156

1245

Strabismus

155

1210

1.28

2.35

1.2

115.87

65.03

u/l

1.01

136

1060

Sequelae of infectious and parasitic diseases, including avohilmo

260

1.62

2.32

1.3

1.2

63.04

61.17

u/l

0.07

228

Optic atrophy, wide definition

2.40

2.30

1.3

1.2

50.57

56.11

u/l

0.22

Injuries to the neck

129

990

1.31

2.29

1.2

56.04

62.80

u/l

1.16

110

871

Kela-code for severe mental illness

210

1709

1.23

2.29

1.1

1.2

58.65

63.43

u/l

0.64

179

1509

Glaucoma

390

2845

1.17

2.29

1.2

58.87

61.17

u/l

0.28

336

2492

Pollen allergy

679

1.37

2.27

1.2

61.68

72.47

u/l

0.37

606

Maternal care for other conditions predominantly related to pregnancy

117

864

1.32

2.27

1.2

53.40

59.91

u/l

1.08

108

772

Sequelae of injuries of head

186

1.73

2.24

1.3

1.2

64.00

55.58

u/l

0.29

169

Postmenopausal bleeding

214

907

1.24

2.23

1.1

1.2

56.08

57.73

u/l

0.24

192

795

Leiomyoma of uterus

446

2166

1.16

2.23

1.2

58.47

58.22

u/l

0.04

395

1918

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

380

2533

1.17

2.23

1.2

65.29

60.61

u/l

0.51

332

2238

Psychotic depression

209

1.68

2.23

1.1

1.2

54.07

63.81

u/l

0.61

189

Effects of foreign body entering through natural orifice

130

1004

1.30

2.21

1.2

60.40

70.42

u/l

0.89

111

873

Family history of certain disabilities and chronic diseases leading to disablement

121

1.91

2.21

1.1

97.16

62.36

u/l

0.84

110

Schizophrenia or delusion, excluding more controls

162

1270

1.26

2.20

1.1

1.2

64.06

62.62

u/l

0.10

135

1129

Congenital malformations of uterus and cervix

2.43

2.20

1.2

1.1

334.68

60.62

u/l

0.53

Aggressive periodontitis

2.04

2.17

1.3

74.68

53.85

u/l

0.63

Other predominantly sexually transmitted diseases, not elsewhere classified

644

1.37

2.17

1.2

67.92

59.67

u/l

0.55

574

Trichomoniasis

3.06

2.16

1.1

1.2

50.67

53.00

u/l

—

Other epidermal thickening

151

1.80

2.16

1.5

1.2

58.41

52.79

u/l

0.26

138

Other strabismus

122

934

1.30

2.16

1.2

132.57

65.30

u/l

1.08

107

825

Other and unspecified rosacea

394

1.48

2.16

1.3

1.2

52.43

56.27

u/l

0.37

348

Allergic contact dermatitis due to drugs in contact with skin

2.18

2.15

1.4

1.2

64.25

50.71

u/l

0.35

Dementia, including avohilmo

224

1849

0.82

2.15

1.1

1.2

63.26

62.79

u/l

0.03

192

1605

Hypertrophy of breast in women and men

130

1009

1.29

2.15

1.2

54.46

59.88

u/l

0.92

120

892

Other and unspecified effects of external causes

155

1230

1.26

2.14

1.2

64.80

66.71

u/l

0.11

129

1082

Other specified/unspecified hearing loss

395

1.48

2.13

1.2

67.10

65.71

u/l

0.07

347

Disorders of vestibular function (Vertigo)

320

2657

1.17

2.13

1.2

57.95

61.43

u/l

0.41

285

2323

Seborrhoeic keratosis

166

1332

1.25

2.09

1.3

1.2

66.75

63.87

u/l

0.16

138

1152

Post-traumatic stress disorder

213

1.65

2.09

1.2

60.33

55.26

u/l

0.46

196

Burns and corrosions

513

1.41

2.09

1.2

64.40

68.42

u/l

0.20

449

Neuroendocrine tumor and carcinoma of pancreas

3.57

2.07

1.1

1.4

85.29

32.51

u/l

—

Progressive vascular leukoencephalopathy

146

1.79

2.07

1.2

71.71

61.75

u/l

0.27

127

Abdominal aortic aneurysm (AAA)

330

1.51

2.06

1.2

42.95

62.88

u/l

2.51

288

Benign neoplasm of breast

591

1.38

2.06

1.2

52.46

59.31

u/l

0.92

514

Optic atrophy

2.35

2.06

1.3

52.69

54.34

u/l

0.06

Maternal care related to the fetus and amniotic cavity and possible delivery problems

205

1462

0.82

2.05

1.1

1.2

63.28

58.94

u/l

0.31

182

1312

Malignant neoplasm of rectum, including Hilmo

448

1.43

2.05

1.2

82.03

56.01

u/l

0.59

381

Presbycusis

651

1.35

2.05

1.1

1.2

47.64

64.68

u/l

3.75

554

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

100

754

1.33

2.05

1.2

66.81

61.03

u/l

0.39

672

Other and unspecified tonsillitis

149

981

1.26

2.04

1.2

73.96

70.22

u/l

0.07

127

864

Herpesviral [herpes simplex] infections, including avohilmo

153

1221

1.26

2.03

1.2

56.22

61.05

u/l

0.68

137

1074

Other demyelinating diseases of the central nervous system

125

1.85

2.03

1.1

1.2

43.39

54.47

u/l

0.82

116

Bronchitis, not specified as acute or chronic

318

1.52

2.03

1.4

1.2

59.86

66.54

u/l

0.39

277

Oter anti-inflammatory and antirheumatic agents, non-steroids

134

572

1.29

2.02

1.2

61.55

62.93

u/l

0.08

117

509

Malignant neoplasm of heart, mediastinum and pleura

3.11

2.02

1.1

1.2

68.38

51.12

u/l

—

Scabies, including avohilmo

517

1.40

2.01

1.2

67.34

67.05

u/l

0.01

463

Aphakia

2.65

2.01

1.3

63.00

49.64

u/l

—

Paralytic strabismus

255

1.58

2.01

1.2

56.69

63.62

u/l

0.44

224

Meniscus derangement

325

1844

1.17

2.00

1.2

58.32

67.68

u/l

1.73

288

1616

Speech and linguistic disorders

244

1.58

2.00

1.3

1.2

167.90

95.40

u/l

0.35

222

Benign neoplasm of middle ear and respiratory system

279

1.55

2.00

1.2

55.37

63.44

u/l

0.48

245

Hypertrophy of breast

117

907

1.29

1.98

1.2

52.25

59.14

u/l

1.62

107

801

Flat foot [pes planus] (acquired)

435

1.43

1.98

1.1

1.2

55.55

61.41

u/l

0.43

374

Complications following infusion, transfusion and therapeutic injection

2.38

1.96

1.3

1.2

58.50

61.06

u/l

0.08

Oligomenorrhoea

105

1.92

1.96

1.4

1.2

51.90

59.18

u/l

0.79

Haemorrhage in early pregnancy

108

1355

0.77

1.95

1.2

56.93

57.99

u/l

0.09

101

1207

Urethral stricture

179

1.68

1.95

1.1

1.2

102.08

70.81

u/l

0.82

157

Other obstetric conditions, not elsewhere classified

135

671

1.27

1.89

1.2

61.42

58.63

u/l

0.12

119

613

Any dementia

187

1568

0.82

1.88

1.1

1.2

61.89

61.24

u/l

0.05

161

1371

Malignant neoplasm of head and neck, including Hilmo

332

1.48

1.88

1.3

1.2

64.95

55.85

u/l

0.29

287

Oxicams

137

614

1.27

1.87

1.1

1.2

68.89

63.82

u/l

0.27

122

550

Impotence

197

1.63

1.86

1.1

1.2

63.46

67.43

u/l

0.13

173

Fistulae involving female genital tract

2.23

1.85

1.1

1.2

51.69

62.17

u/l

0.90

Other and unspecified nonorganic psychotic disorders

741

1.31

1.85

1.1

1.2

65.75

60.55

u/l

0.31

662

Other abnormal uterine and vaginal bleeding

161

936

1.24

1.84

1.2

58.28

57.46

u/l

0.08

144

819

Redundant prepuce, phimosis and paraphimosis

747

1.31

1.83

1.4

1.3

56.79

75.33

u/l

2.22

660

Anogenital herpesviral [herpes simplex] infection, including avohilmo

369

1.44

1.79

1.2

53.90

60.17

u/l

0.40

335

Other contact dermatitis

279

1.51

1.79

1.4

1.2

63.43

61.33

u/l

0.09

248

Unspecified chronic bronchitis

116

1.82

1.78

1.4

1.2

52.00

71.82

u/l

0.84

102

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

361

1.45

1.78

1.1

1.2

87.87

55.29

u/l

0.60

308

Other fall from one level to another

116

912

1.27

1.78

1.3

1.2

61.25

71.69

u/l

1.07

103

797

LSIL lesion of the cervix uteri, vagina or vulva

590

1.34

1.77

1.2

73.11

55.06

u/l

0.65

523

Postpartum haemorrhage

922

0.76

1.77

1.2

54.32

61.14

u/l

0.92

821

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

129

643

1.26

1.76

1.2

62.48

58.91

u/l

0.15

113

587

Migraine without aura

109

853

1.28

1.75

1.2

59.05

65.34

u/l

0.48

759

Granuloma annulare

2.25

1.75

1.1

63.42

54.18

u/l

0.40

Vitiligo

2.53

1.74

1.2

1.1

65.00

54.79

u/l

—

Alcohol abuse, main dg

575

1.34

1.73

1.1

1.2

60.08

66.00

u/l

0.50

502

Colon adenocarcinoma, helper endpoint

567

1.34

1.73

1.1

1.2

73.87

63.30

u/l

0.41

493

Bacterial sepsis of newborn

3.91

1.72

1.2

1.1

64.40

349.46

u/l

—

Intracerebral haemorrhage

516

1.36

1.71

1.3

1.2

62.92

65.17

u/l

0.12

454

Superficial injury of forearm

348

1.44

1.70

1.2

71.23

59.86

u/l

0.31

303

Nonspecific lymphadenitis

226

1.56

1.70

1.3

1.2

58.97

54.07

u/l

0.20

200

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

283

1.49

1.69

1.2

55.79

56.30

u/l

0.03

253

Hyperosmolality and hypernatraemia

2.53

1.67

1.6

1.1

50.90

44.38

u/l

—

Hallux valgus (acquired)

208

1249

1.19

1.67

1.2

53.94

65.38

u/l

2.88

188

1090

Malignant neoplasm of corpus uteri, including Hilmo

409

1.40

1.66

1.2

60.14

58.21

u/l

0.16

350

Acne, including avohilmo

537

1.31

1.66

1.3

1.2

65.64

76.35

u/l

0.57

483

Combinations of oral blood glucose lowering drugs

166

1372

1.21

1.66

1.2

61.10

67.52

u/l

0.45

145

1187

Acute alcohol intoxication, ICD10

101

790

1.28

1.65

1.1

1.2

71.92

66.04

u/l

0.28

696

Other and unspecified paralytic syndromes

2.27

1.64

1.6

1.3

46.09

50.86

u/l

0.25

Focal epilepsy

118

941

1.26

1.64

1.2

65.67

70.02

u/l

0.20

108

825

Anisometropia and aniseikonia

105

1.82

1.63

1.2

306.86

59.78

u/l

0.52

Lichen planus

634

1.31

1.63

1.3

1.2

57.81

61.13

u/l

0.26

550

Secondary thrombocytopenia

2.41

1.62

1.5

1.3

79.50

44.70

u/l

—

Scleritis

2.41

1.62

1.3

1.2

59.50

53.10

u/l

—

Coxarthrosis, primary, with hip surgery

315

2549

1.15

1.62

1.2

58.96

60.75

u/l

0.22

278

2225

Presence of other devices

137

1096

1.23

1.61

1.3

1.2

60.13

63.63

u/l

0.25

128

945

Covid-19 suspected case

114

909

1.26

1.60

1.3

1.2

56.90

61.49

u/l

0.32

104

798

Vasomotor and allergic rhinitis

216

1793

1.18

1.59

1.2

57.65

68.57

u/l

1.05

197

1563

LSIL lesion of the cervix uteri

413

1.38

1.58

1.1

1.2

82.71

56.12

u/l

0.70

373

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

388

1.40

1.57

1.4

1.2

50.09

57.36

u/l

0.73

342

Other factor of the environment

2.30

1.56

1.0

1.2

77.10

42.63

u/l

—

Alzheimer’s disease (Late onset), excluding more controls

469

0.72

1.56

1.1

1.2

54.85

66.20

u/l

1.07

401

Extrapyramidal and movement disorders

247

2128

1.16

1.55

1.2

62.78

61.29

u/l

0.12

214

1858

Primary coxarthrosis, bilateral

186

1566

1.19

1.55

1.2

60.50

61.90

u/l

0.10

162

1349

Other symptoms and signs involving the urinary system

407

1.38

1.53

1.3

1.2

60.45

68.91

u/l

0.70

361

Premature rupture of membranes

617

0.75

1.52

1.2

52.25

58.58

u/l

0.83

568

Alopecia areata

1.84

1.52

1.1

1.2

46.29

81.61

u/l

0.71

Postmenopausal atrophic vaginitis

199

914

1.19

1.51

1.2

59.28

57.79

u/l

0.18

177

803

Abrasion of teeth

235

2023

1.16

1.50

1.2

62.08

59.49

u/l

0.27

203

1775

Muscle strain

101

1.79

1.49

1.3

1.2

70.50

59.46

u/l

0.29

Lifestyle-related condition

2.46

1.48

1.0

1.3

78.56

43.46

u/l

—

Donors of organs and tissues

2.24

1.47

1.1

1.3

61.60

53.97

u/l

—

Haemangioma and lymphangioma, any site

377

1.38

1.46

1.3

1.2

56.08

65.39

u/l

0.71

338

COPD, hospital admissions 1, only main diagnosis

204

1495

1.17

1.45

1.2

58.43

64.23

u/l

0.57

177

1286

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

239

0.54

1.42

1.4

1.2

57.46

58.63

u/l

0.06

211

Salpingitis and oophoritis

121

988

1.23

1.41

1.3

1.2

64.92

57.53

u/l

0.80

101

875

Migraine with aura and triptan purchases

649

1.28

1.40

1.3

1.2

48.38

61.12

u/l

3.12

580

Acute epiglottitis

2.19

1.40

1.1

1.3

46.20

47.09

u/l

—

Other specified congenital malformation syndromes affecting multiple systems

2.27

1.40

1.3

1.2

96.22

178.84

u/l

—

Acute nasopharyngitis (common cold)

403

1.36

1.38

1.2

58.19

72.60

u/l

0.96

351

Malignant neoplasm of corpus uteri

364

1.38

1.3

1.2

58.89

58.21

u/l

0.05

314

Demyelinating diseases of the central nervous system

305

1.41

1.38

1.2

45.38

58.20

u/l

1.43

274

Other and unspecified disease of Bartholin gland

104

1.74

1.37

1.1

1.2

61.08

59.63

u/l

0.05

Hydrocephalus in other diseases

2.98

1.36

1.0

1.2

69.80

66.42

u/l

—

Artificial joint operation, meniscal resection

604

3531

1.09

1.36

1.2

56.03

63.21

u/l

2.63

536

3111

Coxibs

156

682

1.20

1.36

1.1

1.2

62.21

68.38

u/l

0.42

136

616

Visual field defects

323

1.40

1.35

1.2

56.48

66.06

u/l

0.70

283

Ptosis of eyelid

530

1.31

1.35

1.2

49.12

62.78

u/l

2.02

460

Superficial injury of shoulder and upper arm

495

1.32

1.35

1.3

1.2

65.02

64.65

u/l

0.01

438

Benign neoplasm: Skin, unspecified

151

1.60

1.35

1.4

1.2

63.58

52.35

u/l

0.45

138

Other mental disorders due to brain damage and dysfunction and to physical disease

531

1.30

1.33

1.3

1.2

59.16

64.81

u/l

0.33

471

Anankastic personality disorder

128

1.65

1.33

1.0

1.2

51.94

51.70

u/l

0.01

119

Ill-defined and unknown causes of mortality

384

1.36

1.33

1.2

60.98

68.13

u/l

0.24

337

Maternal care for other known or suspected fetal problems

560

0.77

1.32

1.2

51.40

58.74

u/l

0.95

513

Menorrhagia

215

1032

1.16

1.31

1.2

58.06

58.14

u/l

0.01

197

907

Abnormal spermatozoa

463

1.32

1.31

1.1

1.2

85.75

70.39

u/l

0.44

394

Mesothelioma, including Hilmo

2.52

1.30

1.2

79.50

36.18

u/l

—

Contact with and exposure to communicable diseases

140

1167

1.20

1.28

1.2

85.61

62.68

u/l

0.57

115

1042

Benign neoplasm of mouth and pharynx

447

1.32

1.28

1.2

51.87

62.45

u/l

1.03

392

Single delivery by caesarean section

527

0.78

1.28

1.2

1.3

50.60

62.04

u/l

1.75

476

Childhood allergy (age < 16)

275

1.38

1.28

1.3

87.79

107.63

u/l

0.41

254

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.76

1.28

1.3

1.2

80.50

116.07

u/l

0.48

Pediculosis, acariasis and other infestations

194

1.50

1.26

1.1

1.2

67.37

60.45

u/l

0.20

174

Glaucoma-related operations

227

1.46

1.26

1.1

1.2

49.58

60.83

u/l

0.77

198

Pre-eclampsia or eclampsia

128

1066

1.20

1.26

1.3

1.2

55.70

57.45

u/l

0.19

119

942

Hydrocele

431

1.33

1.26

1.1

1.2

75.88

69.09

u/l

0.16

376

Other ill-defined and unspecified causes of mortality

346

1.36

1.24

1.2

62.34

67.82

u/l

0.16

302

Pediculosis, acariasis and other infestations, including avohilmo

644

1.26

1.23

1.2

68.41

64.30

u/l

0.21

575

Benign neoplasm: Brain, supratentorial

2.06

1.22

1.0

1.3

97.50

59.02

u/l

—

Varicose veins

404

2757

1.11

1.22

1.2

65.21

60.99

u/l

0.18

351

2430

Family history of other specific disorders

2.18

1.22

1.1

1.2

43.37

53.63

u/l

—

Other diseases of spinal cord

116

1.65

1.22

1.3

1.2

55.15

49.51

u/l

0.29

107

Triptan medication for migraine, single purchase ok

468

2886

1.10

1.20

1.2

56.59

63.55

u/l

2.55

420

2547

Migraine, single triptan purchase ok & required. ICD-code if available is included

468

2886

1.10

1.20

1.2

56.59

63.55

u/l

2.55

420

2547

Other and unspecified acute skin changes due to ultraviolet radiation

1.76

1.19

1.3

1.2

48.27

47.34

u/l

0.06

Unspecified event, undetermined intent

1.76

1.19

1.1

1.3

44.51

48.89

u/l

0.27

Malignant neoplasm of other and unspecified parts of biliary tract

2.12

1.18

1.3

106.88

45.54

u/l

—

Focal epilepsy, strict definition

106

873

1.22

1.18

1.2

66.76

70.83

u/l

0.16

761

Retinal breaks without detachment

802

1.22

1.17

1.3

1.2

55.37

64.78

u/l

0.94

698

Vasomotor rhinitis (mode)

290

1.38

1.17

1.2

51.51

63.66

u/l

1.05

259

Postpartum hemorraghe, all women as controls

1021

0.81

1.15

1.2

54.32

58.68

u/l

0.53

914

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

207

1.45

1.15

1.1

1.2

59.92

56.76

u/l

0.11

186

Haemangioma, any site

343

1.35

1.14

1.3

1.2

56.64

57.98

u/l

0.07

309

Nontoxic goitre/thyroid nodule

192

1671

1.15

1.14

1.2

64.60

58.58

u/l

0.45

172

1464

Foreign body in alimentary tract

191

1.47

1.14

1.2

55.00

75.23

u/l

0.73

175

Dystonia

216

1.44

1.13

1.1

1.2

65.46

57.44

u/l

0.56

195

Bitten or struck by other mammals

439

1.30

1.13

1.1

1.2

56.35

69.44

u/l

0.77

396

Excessive earwax

403

3320

1.10

1.12

1.2

56.90

65.50

u/l

2.02

350

2916

Tonsillectomy and adenotomy

234

1844

0.88

1.12

1.3

1.2

67.89

68.48

u/l

0.03

209

1640

Acute alcohol intoxication

127

1071

1.19

1.12

1.1

1.2

66.71

66.35

u/l

0.02

106

939

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

225

1.43

1.12

1.3

1.2

58.70

64.03

u/l

0.25

204

Alcohol withdrawal state with delirium

242

1.41

1.11

1.1

1.2

52.72

60.32

u/l

0.46

216

Abnormal involuntary movements

600

1.25

1.11

1.3

1.2

54.48

63.33

u/l

0.88

531

Migraine

294

2047

1.12

1.10

1.3

1.2

54.08

67.07

u/l

3.43

259

1809

Pre-eclampsia

115

964

1.20

1.09

1.2

55.11

56.80

u/l

0.19

107

849

Complications of labour and delivery

334

2055

0.90

1.07

1.2

57.75

58.97

u/l

0.21

295

1811

Diseases of male genital organs

238

1057

1.13

1.07

1.2

73.19

73.89

u/l

0.03

207

938

Acetic acid derivatives and related substances

152

671

1.17

1.06

1.1

1.2

64.21

67.78

u/l

0.17

142

605

Mouth breathing

223

1969

1.13

1.06

1.2

56.30

69.64

u/l

3.13

192

1723

Acute alcohol intoxication ICD-9

121

1.58

1.05

1.1

1.3

53.93

57.61

u/l

0.12

109

Temporomandibular joint disorders, including avohilmo

260

2248

1.12

1.05

1.2

61.18

60.49

u/l

0.05

224

1990

Noise effects on inner ear

122

0.49

1.05

1.0

1.2

39.55

56.89

u/l

—

106

Other condition

597

1.24

1.04

1.2

68.45

62.22

u/l

0.45

523

Mesothelioma

2.29

1.03

1.2

82.60

36.18

u/l

—

Any dementia, excluding more controls

174

1370

0.87

1.03

1.2

62.39

61.64

u/l

0.05

150

1196

Medical abortion

412

2034

1.10

1.03

1.2

55.01

59.69

u/l

1.40

367

1784

Mantle cell lymphoma, including Hilmo

2.07

1.03

1.4

1.2

90.57

37.30

u/l

—

Achilles tendinitis

482

1.27

1.02

1.2

52.32

63.24

u/l

1.18

418

Foreign body entering into or through eye or natural orifice

272

1.36

1.02

1.6

1.2

63.31

61.87

u/l

0.07

243

Injury of muscle and tendon at hip and thigh level

394

1.30

1.02

1.1

1.2

56.66

61.26

u/l

0.37

350

Other abnormal products of conception

132

1013

0.85

1.02

1.2

60.07

60.58

u/l

0.04

120

904

Lichen planus, including avohilmo

119

1009

1.18

1.02

1.3

1.2

62.57

61.24

u/l

0.09

102

881

Other diseases of appendix

1.89

1.01

1.1

1.3

63.42

44.64

u/l

—

Labour and delivery complicated by fetal stress [distress]

543

0.80

1.01

1.3

1.2

57.15

61.34

u/l

0.37

488

Malignant neoplasm of tongue

1.85

0.99

1.4

1.2

69.33

44.13

u/l

—

Keratoconus

1.68

0.98

1.1

1.2

59.19

50.21

u/l

0.17

Focal epilepsy, mode (most common among epilepsy diagnosis)

811

1.20

0.97

1.2

69.37

70.78

u/l

0.05

706

Disorders of refraction and accommodation

155

1342

1.15

0.97

1.2

85.88

63.53

u/l

0.43

132

1177

Abnormal findings on diagnostic imaging of breast

1.81

0.97

1.0

1.2

109.11

54.81

u/l

—

Benign lipomatous neoplasm

136

1573

0.86

0.96

1.2

62.25

62.70

u/l

0.04

118

1364

Schizophrenia, schizotypal and delusional disorders

163

1427

1.14

0.94

1.1

1.2

65.24

62.48

u/l

0.21

136

1257

Other and unspecified epidermal thickening

1.64

0.91

1.6

1.1

52.14

52.01

u/l

0.01

Postpartum hemorraghe, parous women as controls

851

0.83

0.91

1.2

54.32

57.95

u/l

0.41

760

Rosacea

599

1.22

0.91

1.3

1.2

55.73

56.65

u/l

0.07

531

Obstructed labour due to maternal pelvic abnormality

863

0.82

0.90

1.3

1.2

55.84

59.34

u/l

0.30

761

Other shoulder lesions

393

1.28

0.90

1.2

61.04

57.54

u/l

0.16

348

Routine general health check-up of defined subpopulation

1.75

0.90

1.2

1.1

58.27

58.87

u/l

0.02

Schizophrenia or delusion

162

1423

1.14

0.90

1.1

1.2

64.06

62.69

u/l

0.10

135

1251

Migraine with aura

131

1133

1.16

0.90

1.3

1.2

51.63

62.70

u/l

2.12

115

1002

Otosclerosis

332

1.30

0.89

1.2

57.21

59.01

u/l

0.10

299

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.92

0.89

1.3

133.50

48.72

u/l

—

Excessive, frequent and irregular menstruation

226

1078

1.12

0.88

1.2

58.52

60.00

u/l

0.18

202

947

Allergic rhinitis

158

1370

1.14

0.88

1.2

60.37

68.97

u/l

0.51

144

1211

Perforation of tympanic membrane

386

1.27

0.87

1.2

60.97

68.01

u/l

0.43

342

Irregular menses

292

1993

1.10

0.87

1.2

57.19

59.59

u/l

0.40

265

1761

Use of antiglaucoma preparations and miotics

316

1.30

0.86

1.2

55.63

61.69

u/l

0.22

274

Suggestive for eosinophilic asthma

369

1.28

0.86

1.2

57.05

66.22

u/l

0.71

321

Supervision of normal pregnancy

578

0.84

0.85

1.1

1.2

68.73

59.13

u/l

0.31

521

Spontaneous abortion

233

1730

0.90

0.84

1.2

54.87

59.87

u/l

1.08

223

1525

Tic and related disorders

1.94

0.84

1.5

1.2

176.83

108.67

u/l

—

Other benign neoplasms of skin

226

2036

1.11

0.84

1.3

1.2

59.30

62.24

u/l

0.38

205

1775

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

121

1.49

0.83

1.3

1.2

58.85

55.63

u/l

0.12

110

Injury of urinary and pelvic organs

1.70

0.82

1.2

53.09

46.59

u/l

0.45

Pre-eclampsia or poor fetal growth

159

1401

1.13

0.81

1.3

1.2

55.58

58.65

u/l

0.44

147

1249

Benign neoplasm of meninges

490

1.23

0.81

1.4

1.2

61.39

58.88

u/l

0.19

436

Lichen ruber planus, wide definition including periferal and oral lichen planus

140

1230

1.14

0.80

1.2

59.94

61.65

u/l

0.13

120

1072

Nontoxic single thyroid nodule

329

1.28

0.80

1.1

1.2

61.43

54.15

u/l

0.40

291

All dysplastic lesions of the cervix uteri, vagina or vulva

152

1313

1.13

0.77

1.2

64.87

58.01

u/l

0.39

136

1165

Pregnancy hypertension

235

1905

1.10

0.77

1.2

58.13

58.81

u/l

0.08

214

1691

Bell's palsy

494

1.22

0.76

1.2

41.83

63.76

u/l

5.12

431

Other meningitis

1.64

0.73

1.1

1.2

86.44

53.01

u/l

—

Foreign body on external eye

506

1.21

0.72

1.2

68.29

62.59

u/l

0.22

442

Distal bite

107

0.55

0.72

1.3

1.2

54.38

123.32

u/l

—

Other obstructed labour

344

1.25

0.71

1.1

1.2

53.86

61.19

u/l

0.73

305

Other obstetric trauma

168

1.37

0.71

1.2

53.91

63.86

u/l

0.57

157

Scabies

160

1.38

0.70

1.1

1.2

70.94

57.68

u/l

0.32

143

Nontoxic multinodular goitre

116

1020

1.14

0.69

1.2

72.01

58.33

u/l

0.74

104

892

Other maternal disorders predominantly related to pregnancy

304

2056

0.92

0.68

1.2

56.47

58.95

u/l

0.50

272

1822

Excessive vomiting in pregnancy

284

1.27

0.68

1.1

1.2

51.94

59.34

u/l

0.61

256

Antepartum haemorrhage, not elsewhere classified

295

0.74

0.67

1.1

1.3

51.24

55.07

u/l

0.20

271

Other disorders of penis

347

1.24

0.67

1.2

67.21

72.71

u/l

0.10

300

Crystalline deposits in vitreous body

1.80

0.66

1.2

1.1

54.20

50.74

u/l

—

Whooping cough, including avohilmo

1.60

0.65

1.7

1.1

35.66

71.13

u/l

—

Sequelae of tuberculosis

1.60

0.65

1.0

1.2

58.57

74.60

u/l

—

Sequelae of tuberculosis, including avohilmo

1.60

0.65

1.0

1.2

58.57

74.60

u/l

—

Melanocytic naevi of other and unspecified parts of face

224

1.30

0.64

1.4

1.2

70.00

54.16

u/l

0.52

203

Serous carcinoma of ovary, including Hilmo

128

0.62

0.64

1.4

1.2

60.13

58.50

u/l

—

109

Abnormal findings in secretions and smears from cervix uteri vagina vulva

294

2004

1.08

0.63

1.2

60.37

58.35

u/l

0.18

258

1786

malignant neoplasm of female genital organs, including Hilmo

791

1.15

0.63

1.2

56.88

57.40

u/l

0.05

679

Nontraumatic intracranial haemmorrhage

107

944

1.13

0.62

1.2

57.24

64.43

u/l

0.75

824

MS-disease / Multiple Sclerosis

252

1.27

0.62

1.2

46.41

59.32

u/l

1.20

227

Rubella [German measles]

101

0.59

0.62

1.2

57.33

48.80

u/l

—

Rubella [German measles], including avohilmo

101

0.59

0.62

1.2

57.33

48.80

u/l

—

HSIL lesion of the vagina

1.58

0.60

1.1

1.2

71.63

53.37

u/l

—

Benign neoplasm of major salivary glands

389

1.21

0.60

1.3

1.2

64.63

65.99

u/l

0.05

343

Other disorders of the genitourinary system

685

1.16

0.60

1.3

1.2

54.31

59.88

u/l

0.60

594

Other female pelvic inflammatory diseases

807

1.14

0.59

1.3

1.2

66.06

58.17

u/l

0.65

710

Obstructive hydrocephalus

1.55

0.59

1.1

1.2

133.25

68.17

u/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

583

1.17

0.59

1.1

1.2

53.93

59.97

u/l

0.83

524

Lesion of ulnar nerve

611

1.16

0.59

1.2

57.78

61.78

u/l

0.31

533

Impacted maxillary canine

0.00

0.59

0.0

1.0

—

129.55

—

Persistent delusional disorders

290

1.24

0.59

1.2

59.87

59.37

u/l

0.01

257

Carcinoma in situ of breast, other/unspecified

1.52

0.58

1.4

1.2

59.12

54.25

u/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

336

1.22

0.58

1.3

1.2

67.34

64.33

u/l

0.12

297

Other disorders of eyelid

284

2494

1.07

0.58

1.2

60.24

61.40

u/l

0.13

249

2172

Acute appendicitis, no complications

308

2860

1.07

0.57

1.2

59.30

63.93

u/l

0.66

267

2513

Malignant neoplasm of testis

1.67

0.57

1.3

1.2

56.50

47.38

u/l

—

Adenocarcinoma of pancreas

1.51

0.56

1.2

64.55

46.80

u/l

1.24

Xerosis cutis

1.46

0.56

1.4

1.3

80.88

41.18

u/l

—

Persons encountering health services in circumstances related to reproduction

335

2102

1.07

0.56

1.2

77.22

66.25

u/l

0.63

295

1865

Early syphilis, including avohilmo

1.59

0.54

1.5

1.2

35.17

51.05

u/l

—

Other bullous disorders

1.42

0.54

1.2

62.14

52.14

u/l

0.29

Diseases of appendix

430

3636

1.06

0.54

1.2

57.00

63.43

u/l

1.56

381

3209

Spermatocele

267

1.24

0.53

1.2

105.22

74.08

u/l

0.43

228

Disorder of external ear, unspecified

125

1.36

0.53

1.2

1.3

55.32

53.72

u/l

0.05

113

Anti-inflammatory and antirheumatic products, non-steroids

154

703

1.10

0.53

1.2

71.81

72.29

u/l

0.02

134

636

Peritonsillar abscess

834

1.13

0.53

1.2

74.55

60.75

u/l

0.68

720

Hypertrichosis

1.46

0.53

1.1

1.2

51.67

58.20

u/l

—

Secondary parkinsonism

0.62

0.52

1.3

83.33

50.26

u/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

110

824

1.12

0.52

1.1

1.2

84.29

59.75

u/l

0.35

102

725

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.51

0.51

1.2

1.3

50.33

51.63

u/l

—

Mature T/NK-cell lymphomas, hilmo

1.51

0.51

1.0

1.3

65.83

49.09

u/l

—

Intussusception

1.39

0.50

1.2

54.56

57.76

u/l

—

Malignant neoplasm of other and unspecified parts of tongue

1.47

0.50

1.7

1.2

84.17

43.22

u/l

—

Bicipital tendinitis

179

0.72

0.50

1.1

1.2

66.77

57.41

u/l

0.28

161

Diabetes mellitus in pregnancy

146

845

1.10

0.50

1.3

1.2

51.12

58.37

u/l

1.42

130

763

Inguinal hernia

259

1840

0.93

0.49

1.2

74.61

64.84

u/l

0.59

221

1598

Endometriosis of ovary

835

1.12

0.49

1.2

59.08

57.65

u/l

0.11

729

Other peripheral vertigo

418

1.17

0.48

1.2

54.10

58.88

u/l

0.46

370

Periapical abscess

269

2522

1.07

0.48

1.2

73.95

62.69

u/l

0.70

230

2211

Other abnormal findings in urine

1.53

0.48

1.1

1.2

72.90

48.18

u/l

—

Other noninflammatory disorders of uterus, except cervix

146

890

1.10

0.48

1.2

55.26

57.92

u/l

0.41

129

781

Benign neoplasm: Parotid gland

308

1.20

0.48

1.3

1.2

69.25

64.08

u/l

0.20

272

Migraine without aura and triptan purchases

700

1.13

0.47

1.2

54.04

60.20

u/l

0.89

624

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

634

0.87

0.47

1.1

1.2

59.22

61.12

u/l

0.13

560

Ectopic pregnancy

940

0.89

0.46

1.1

1.2

57.29

59.86

u/l

0.29

825

Motorcycle rider injured in other and unspecified transport accidents

183

1.26

0.45

1.2

63.89

63.99

u/l

0.00

165

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

1.38

0.44

1.3

1.2

77.29

61.15

u/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

129

1406

0.92

0.43

1.3

1.2

52.59

64.98

u/l

2.77

110

1216

Endometriosis of pelvic peritoneum

745

0.89

0.43

1.2

56.40

57.28

u/l

0.06

661

Secondary parkinsonism, excluding more controls

0.64

0.42

1.3

1.2

83.33

48.40

u/l

—

Benign neoplasm: Other/unspecified site

1.38

0.41

1.4

1.2

50.16

49.72

u/l

—

Early syphilis

1.52

0.41

1.4

1.3

32.40

44.32

u/l

—

323

1.18

0.41

1.1

1.2

58.36

66.34

u/l

0.33

279

Inflammatory disease of uterus

595

1.13

0.41

1.3

1.2

61.75

59.44

u/l

0.16

533

Hypersensitivity pneumonitis due to organic dust

1.36

0.41

1.1

1.3

67.63

45.76

u/l

—

Organic, including symptomatic, mental disorders

312

2079

1.06

0.41

1.2

62.61

62.15

u/l

0.04

271

1810

Maternal care for known or suspected abnormality of pelvic organs

102

757

0.91

0.41

1.3

1.2

52.32

58.84

u/l

1.09

689

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

262

2143

1.06

0.41

1.2

60.20

58.69

u/l

0.21

241

1896

Maternal care for known or suspected fetal abnormality and damage

521

0.88

0.40

1.1

1.2

80.32

58.99

u/l

0.49

481

Secondary parkinsonism+Parkinsonism in other disease

102

0.68

0.39

1.4

1.3

75.29

51.10

u/l

—

Other disorders of central nervous system

1.43

0.39

1.4

1.3

85.60

58.22

u/l

—

Glucosamine medication

272

2291

0.95

0.38

1.2

58.06

61.15

u/l

0.42

231

1999

Long labour

919

0.91

0.38

1.3

1.2

54.22

60.74

u/l

1.00

816

Appendicitis, broad definition

422

3624

1.04

0.38

1.2

56.74

63.39

u/l

1.62

373

3198

Torsion of ovary, ovarian pedicle and fallopian tube

1.37

0.38

1.1

49.89

55.85

u/l

—

Benign neoplasm: Cerebral meninges

438

1.14

0.38

1.3

1.2

64.03

57.24

u/l

0.58

388

Alzheimer disease, excluding more controls

567

0.90

0.38

1.1

1.2

62.86

71.69

u/l

0.34

490

Endometriosis ASRM stages 1,2

832

0.90

0.38

1.2

56.67

57.84

u/l

0.09

744

Other and unspecified nerve root and plexus disorders, also in other diseases

999

0.91

0.38

1.2

53.77

60.98

u/l

0.91

868

Acute appendicitis

394

3498

1.05

0.37

1.2

56.92

63.56

u/l

1.52

345

3086

Conductive and sensorineural hearing loss

497

3170

1.04

0.37

1.2

58.06

62.64

u/l

0.86

451

2778

Impacted maxillary molar

147

0.75

0.37

1.3

1.2

87.82

63.96

u/l

0.50

131

Other melanin hyperpigmentation

1.39

0.37

1.3

1.2

41.70

49.63

u/l

—

Gestational diabetes (for exclusion)

165

1060

1.07

0.36

1.2

52.57

58.50

u/l

1.26

149

953

Intracranial and intraspinal abscess and granuloma

1.43

0.35

1.5

1.2

57.50

50.94

u/l

—

Malignant neoplasm of ovary

190

0.79

0.35

1.2

59.60

59.55

u/l

0.00

165

Viral meningitis, including avohilmo

126

1.27

0.35

1.3

1.2

77.88

56.98

u/l

0.68

116

Malignant neoplasm of testis, including Hilmo

1.40

0.35

1.3

1.2

56.50

46.66

u/l

—

Other benign neoplasms of connective and other soft tissue

395

1.14

0.34

1.4

1.2

62.77

63.39

u/l

0.02

355

Injury of muscle and tendon at wrist and hand level

547

1.12

0.34

1.3

1.2

67.80

61.91

u/l

0.31

480

Benign leiomyoma with endometriosis

867

0.91

0.34

1.2

59.74

59.41

u/l

0.03

751

Juvenile osteochondrosis

100

1.30

0.33

1.4

1.2

114.85

55.90

u/l

0.75

Use of ropinirole

133

0.75

0.33

1.3

1.2

42.80

53.45

u/l

—

118

Polycystic ovarian syndrome

118

1.27

0.33

1.3

1.1

50.86

62.57

u/l

0.48

111

Brain glioblastoma and astrocytoma

1.31

0.33

1.3

1.2

59.00

51.54

u/l

—

Shoulder region

1.28

0.32

1.7

1.3

79.83

48.94

u/l

—

Other vitreous opacities

154

0.78

0.32

1.1

1.2

47.08

54.92

u/l

0.46

138

Parkinson's disease, including avohilmo

717

0.91

0.31

1.3

1.2

59.26

67.55

u/l

0.92

621

Injury of muscle and tendon at lower leg level

608

1.10

0.31

1.4

1.2

82.21

65.30

u/l

0.56

533

Lichen sclerosus et atrophicus

599

1.10

0.31

1.1

1.2

57.93

58.78

u/l

0.06

516

Congenital malformations of the respiratory system

1.32

0.31

1.3

47.43

68.60

u/l

—

Schizoaffective disorder

258

1.16

0.31

1.2

68.76

58.57

u/l

0.30

228

Injury of muscle and tendon at shoulder and upper arm level

176

1862

0.94

0.30

1.2

54.78

62.52

u/l

1.04

158

1614

Chromosomal abnormalities, not elsewhere classified

1.30

0.30

1.1

1.2

66.14

140.94

u/l

—

Prolapse and hernia of ovary and fallopian tube

151

0.78

0.30

1.2

59.17

60.75

u/l

0.10

126

Viral meningitis

120

1.25

0.30

1.3

1.2

81.27

57.38

u/l

0.77

110

All dysplastic lesions of the cervix uteri

121

1112

1.07

0.30

1.2

69.21

57.85

u/l

0.56

108

999

Primary open-angle glaucoma, strict

152

1427

1.06

0.30

1.2

62.08

61.83

u/l

0.01

132

1236

Supervision of high-risk pregnancy

567

0.92

0.29

1.2

68.19

58.50

u/l

0.33

513

Primary open-angle glaucoma

185

1688

1.05

0.28

1.2

58.68

61.65

u/l

0.19

158

1469

Myopia

489

1.11

0.27

1.3

1.2

137.40

63.63

u/l

0.46

438

Laparoscopic left hemicolectomy

1.23

0.27

1.1

1.2

43.63

52.03

u/l

—

Male infertility

128

0.78

0.26

1.3

1.2

45.60

67.01

u/l

—

110

Acute appendicitis, with complications

926

0.93

0.26

1.2

48.79

65.20

u/l

3.92

809

Benign neoplasm: Skin of eyelid, including canthus

760

0.92

0.26

1.3

1.2

54.71

62.45

u/l

1.00

665

Malignant neoplasm of oesophagus

0.70

0.26

1.0

1.1

50.00

45.53

u/l

—

malignant neoplasm of female genital organs

706

1.08

0.26

1.3

1.2

57.02

58.27

u/l

0.13

607

Impingement syndrome of shoulder

124

1168

1.06

0.25

1.2

67.01

62.38

u/l

0.23

113

1021

Additional codes for the location of defect, injury or illness

216

1.16

0.25

1.2

61.65

68.50

u/l

0.20

197

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

254

1.14

0.24

1.1

1.2

52.41

61.40

u/l

0.78

229

Use of disulfiram, acamprosate or naltrexone

321

1.12

0.24

1.3

1.2

56.71

57.29

u/l

0.03

285

Cerebral aneurysm, nonruptured

369

1.11

0.24

1.2

50.34

55.39

u/l

0.43

335

Mandibular retrognathia AND surgery (BSSO)

0.72

0.24

1.0

1.2

70.83

54.30

u/l

—

Exposure to smoke, fire and flames

0.71

0.24

1.0

1.3

58.83

56.28

u/l

—

Epiphora

0.70

0.24

1.2

1.3

57.67

60.09

u/l

—

Malignant neoplasm of ovary, including Hilmo

265

0.87

0.24

1.3

1.2

57.09

59.62

u/l

0.17

227

Ethmoidectomy

542

1.09

0.24

1.1

1.2

58.56

59.27

u/l

0.04

475

Cauda equina syndrome

1.32

0.23

4.2

1.4

55.40

54.78

u/l

—

Exposure to other and unspecified animate mechanical forces

1.24

0.23

1.1

1.2

63.36

59.56

u/l

0.16

HSIL lesion of the cervix uteri, vagina or vulva

863

1.07

0.22

1.2

57.69

55.97

u/l

0.12

774

Glaucoma suspect

220

2113

1.04

0.22

1.2

57.46

62.39

u/l

0.74

187

1842

Other congenital malformations of face and neck

0.75

0.22

1.0

1.2

39.71

54.65

u/l

—

Parkinson's disease, strict definition

628

0.92

0.22

1.3

1.2

58.68

65.60

u/l

0.68

548

Pedal cyclist injured in transport accident

1030

0.94

0.22

1.3

1.2

65.88

64.69

u/l

0.05

905

Dentofacial anomalies [including malocclusion]

408

3102

1.03

0.21

1.2

67.49

63.50

u/l

0.40

358

2751

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.21

0.0

1.1

—

281.33

—

Burn and corrosion of trunk

102

0.78

0.21

1.3

53.75

54.46

u/l

—

Parkinson's disease

688

0.93

0.21

1.3

1.2

59.58

66.72

u/l

0.73

598

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

0.21

0.0

1.1

—

293.92

—

Female infertility, cervical, vaginal, other or unspecified origin

129

867

0.95

0.20

1.2

51.61

58.32

u/l

1.25

117

770

Cervical polyps

547

1.08

0.20

1.2

59.44

56.77

u/l

0.19

481

Female infertility

140

880

0.95

0.20

1.2

52.85

58.38

u/l

0.72

124

781

Other spirochaetal diseases

193

1856

1.04

0.20

1.2

52.55

63.29

u/l

3.91

173

1618

Patellar tendinitis

1.23

0.20

1.3

1.2

49.67

49.35

u/l

—

Vascular dementia

370

1.10

0.20

1.1

1.2

64.00

63.19

u/l

0.03

333

Malignant neoplasm of other and unspecified female genital organs

1.18

0.19

1.2

51.83

55.44

u/l

—

Lyme disease

191

1839

1.04

0.19

1.2

52.98

63.07

u/l

3.51

171

1603

Lyme disease, including avohilmo

191

1839

1.04

0.19

1.2

52.98

63.07

u/l

3.51

171

1603

Endometriosis ASRM stages 3,4

118

1124

1.05

0.19

1.2

56.51

57.65

u/l

0.10

105

985

Schizophrenia

637

1.07

0.18

1.0

1.2

53.96

59.45

u/l

0.56

564

Parkinson's disease, excluding more controls

550

1.07

0.18

1.3

1.2

59.58

72.83

u/l

0.91

477

Other sexually transmitted chlamydial diseases, including avohilmo

251

1.12

0.18

1.1

1.2

58.10

60.97

u/l

0.08

229

Anomalies of dental arch relationship, including avohilmo

761

1.06

0.18

1.3

1.2

82.93

67.75

u/l

0.69

673

Pyogenic granuloma

1.19

0.18

1.6

1.2

50.00

52.76

u/l

—

Sensorineural hearing loss

467

3042

1.02

0.18

1.3

1.2

57.30

63.06

u/l

1.12

424

2661

Other degenerative diseases of the nervous system

148

1035

1.04

0.17

1.2

61.27

66.40

u/l

0.34

121

916

Spirochaetal infections, other/unspecified, including avohilmo

191

1846

1.04

0.17

1.2

52.98

63.04

u/l

3.50

171

1609

Certain zoonotic bacterial diseases

1.18

0.16

1.0

1.3

91.25

49.09

u/l

—

Major anomalies of jaw size

101

1.19

0.16

1.1

1.2

49.58

56.35

u/l

0.50

Other spirochaetal diseases, including avohilmo

194

1877

1.03

0.16

1.2

52.57

64.52

u/l

3.94

174

1638

Traumatic amputation of wrist and hand

141

0.85

0.16

1.1

1.2

60.25

59.27

u/l

0.02

125

FESS (DNB20)

525

1.07

0.16

1.1

1.2

59.65

59.57

u/l

0.00

461

Tooth agenesis EXCLUDE clefts and syndromes

1.19

0.15

1.1

1.2

363.18

87.92

u/l

0.43

Circumscribed brain atrophy

0.79

0.15

1.3

103.83

47.15

u/l

—

Mental and behavioural disorders due to cannabinoids

1.13

0.15

1.0

1.2

67.89

58.28

u/l

—

Normotensive glaucoma

410

0.93

0.15

1.1

1.2

61.73

62.46

u/l

0.03

360

Cyst of Bartholin Gland

131

1.15

0.14

1.1

1.2

63.35

61.11

u/l

—

121

Complications predominantly related to the puerperium

123

1277

0.96

0.14

1.3

1.2

53.56

57.71

u/l

0.62

112

1135

Aneurysms, operations, SAH

787

0.95

0.13

1.2

48.63

61.04

u/l

2.48

682

Parkinson's disease, strict definition, excluding more controls

511

1.06

0.13

1.3

1.2

58.68

66.03

u/l

0.68

443

Triptan medication for migraine, min. 3 purchases

299

2284

0.98

0.13

1.2

54.06

59.33

u/l

1.60

268

2025

Use of levodopa decarboxylase inhibitor

627

1.05

0.13

1.3

1.2

67.83

66.06

u/l

0.08

542

Tinnitus

129

1248

1.03

0.12

1.2

58.34

63.15

u/l

0.31

111

1074

Deviated nasal septum

159

1542

1.03

0.12

1.3

1.2

59.26

65.50

u/l

0.84

146

1343

HSIL lesion of the cervix uteri

728

1.04

0.12

1.3

1.2

60.75

56.36

u/l

0.30

651

Noninflammatory disorders of female genital tract

210

1080

0.98

0.11

1.2

77.52

60.19

u/l

0.49

189

948

Hydrocephalus

289

1.07

0.11

1.1

1.3

77.50

66.09

u/l

0.24

255

Inguinal or femoral hernia, bilateral

416

1.06

0.11

1.4

1.2

65.57

67.49

u/l

0.07

352

Chronic suppurative otitis media

221

1.09

0.10

1.5

1.2

65.12

82.37

u/l

0.56

201

Cervical disc disorders

190

1856

1.02

0.10

1.2

54.49

63.01

u/l

1.24

172

1622

Retained placenta and membranes, without haemorrhage

617

0.96

0.10

1.2

56.16

58.83

u/l

0.22

548

Inguinal hernia, bilateral

407

1.06

0.10

1.4

1.2

66.48

65.75

u/l

0.02

345

Lateral epicondylitis

633

1.04

0.10

1.2

53.93

58.55

u/l

0.47

558

Other menopausal disorders

170

924

1.03

0.10

1.2

62.23

57.71

u/l

0.26

151

811

Tuberculosis, IBD comorbidity

242

1.08

0.09

1.2

46.05

66.62

u/l

1.40

214

Oral lichen planus, including avohilmo , including avohilmo

340

1.06

0.09

1.3

1.2

46.47

58.77

u/l

1.15

301

Fall on and from ladder

272

1.07

0.09

1.2

1.3

51.14

64.11

u/l

0.83

244

Other specified and unspecified disorders of eyelid

1.07

0.08

1.0

1.2

40.17

48.75

u/l

—

Pedal cyclist injured in noncollision transport accidents

461

0.95

0.08

1.1

1.2

52.74

60.06

u/l

0.76

411

Dysplasia of cervi uteri

122

836

1.03

0.08

1.2

66.81

58.59

u/l

0.37

108

738

Failed induction of labour

146

1.10

0.08

1.1

1.3

60.69

63.37

u/l

0.09

134

Infections of breast associated with childbirth

1.12

0.07

1.1

1.2

52.82

60.12

u/l

0.41

Tularaemia, including avohilmo

0.81

0.07

1.0

1.1

97.17

53.14

u/l

—

Medical treatment for female infertility

779

1.03

0.07

1.3

1.2

62.40

56.65

u/l

0.73

703

Glaucoma, exfoliation

489

0.96

0.07

1.2

39.50

64.69

u/l

7.49

427

Pedestrian injured in collision with car, pick-up truck or van

0.84

0.07

1.1

1.2

69.86

51.65

u/l

—

Endometriosis

183

1045

1.02

0.07

1.2

54.08

58.64

u/l

0.83

165

920

Propionic acid derivatives

137

703

0.98

0.06

1.2

74.46

72.29

u/l

0.07

121

636

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

1.11

0.06

1.1

1.2

56.36

57.11

u/l

0.03

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.11

0.06

1.5

1.2

76.00

59.12

u/l

0.32

Obstructed labour due to malposition and malpresentation of fetus

928

0.98

0.06

1.2

54.81

60.54

u/l

0.78

829

Non-allergic asthma

315

1.05

0.06

1.1

1.2

57.29

73.90

u/l

0.78

281

Deep bite

372

1.04

0.06

1.1

1.2

83.58

85.94

u/l

0.04

329

Cervicobrachial syndrome

108

1102

0.98

0.06

1.1

1.2

51.76

61.75

u/l

2.31

965

Puerperal sepsis

718

0.97

0.05

1.2

53.71

59.27

u/l

0.52

632

Later onset COPD

144

1138

1.02

0.05

1.2

54.03

64.53

u/l

1.59

125

990

Benign neoplasm of other and unspecified sites

130

0.92

0.04

1.3

58.36

49.84

u/l

0.39

120

Chronic diseases of tonsils and adenoids

439

2748

1.01

0.04

1.3

1.2

62.26

67.66

u/l

0.54

397

2413

Dislocation, sprain and strain of joints and ligaments of knee

317

2887

0.99

0.04

1.2

54.23

64.67

u/l

2.83

284

2545

Nasal polyp

858

1.01

0.02

1.2

54.92

66.51

u/l

1.70

745

Other acquired deformities of musculoskeletal system and connective tissue

162

1.05

0.02

1.3

1.2

53.34

55.72

u/l

0.08

149

Gestational [pregnancy-induced] hypertension

112

1129

0.99

0.02

1.1

1.2

59.35

58.14

u/l

0.11

997

Tuberculosis, wide

262

1.03

0.02

1.2

44.59

65.76

u/l

1.55

233

Preterm labour and delivery

137

1380

0.99

0.01

1.3

1.2

61.29

58.52

u/l

0.32

125

1219

Benign neoplasm: Skin of ear and external auricular canal

137

0.95

0.01

1.5

1.3

64.00

60.75

u/l

0.10

123

Benign mammary dysplasia

752

1.01

0.01

1.3

1.2

59.44

60.86

u/l

0.09

655

Chondromalacia

106

0.94

0.01

1.0

1.3

49.30

49.78

u/l

—

Non-invasive ventilation

765

0.99

0.00

1.2

53.32

67.94

u/l

2.10

683

Tuberculosis, wide, including avohilmo

264

1.02

0.00

1.2

44.59

65.76

u/l

1.55

233

Pregnancy with abortive outcome

394

2048

1.00

0.00

1.2

54.48

59.66

u/l

1.59

354

1796

Female genital prolapse

173

965

1.00

0.00

1.1

1.2

59.64

57.66

u/l

0.21

151

848

Contraceptive management

217

1512

1.00

0.00

1.3

1.2

65.30

59.22

u/l

0.69

196

1341

Pedal cyclist injured in other and unspecified transport accidents

438

1.00

0.00

1.4

1.2

87.21

60.11

u/l

0.87

390

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

335

0.98

0.00

1.2

71.88

59.47

u/l

0.53

299

Benign neoplasm of ovary

975

0.99

0.00

1.2

55.52

59.07

u/l

0.34

848

Malignant neoplasm of oesophagus, including Hilmo

1.04

0.00

1.0

1.2

49.80

50.60

u/l

—

Blepharochalasis

171

1715

1.00

0.00

1.2

60.80

61.61

u/l

0.07

151

1502

Occupational exposure to risk-factors

115

0.96

0.00

1.3

43.55

52.45

u/l

0.69

104

Contact with other hot metals

1.02

0.00

1.4

1.2

46.60

55.12

u/l

—

Hypospadias

0.00

0.0

1.4

—

98.88

—

Balanced rearrangements and structural markers, not elsewhere classified

0.00

0.0

1.5

—

83.17

—

Vertigo of central origin

0.85

-0.00

1.0

1.2

80.40

42.37

u/l

—

Traumatic amputation of lower leg

0.00

-0.00

0.0

1.0

—

31.60

—

Anomalies of pupillary function

0.99

-0.00

1.4

1.2

56.43

51.48

u/l

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.0

—

580.71

—

Other and unspecified syphilis

0.00

-0.00

0.0

1.5

—

53.83

—

Maxillary retrognathism

0.93

-0.00

1.8

1.2

69.40

84.45

u/l

—

Other and unspecified syphilis, including avohilmo

0.00

-0.00

0.0

1.4

—

48.00

—

Congenital malformations of great veins

0.00

-0.00

0.0

1.0

—

509.86

—

Injury of muscle and tendon at forearm level

0.89

-0.00

1.0

1.2

42.20

49.13

u/l

—

Bilateral cryptorchidism (undescended testicles)

0.00

-0.00

0.0

1.6

—

125.80

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.4

—

59.13

—

Pityriasis lichenoides chronica

0.00

-0.00

0.0

1.0

—

92.57

—

Rheumatic heart disease, other

0.00

-0.00

0.0

1.0

—

45.60

—

Assault by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.0

—

116.20

—

Constitutional tall stature

0.00

-0.00

0.0

1.0

—

154.67

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.2

—

44.33

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.4

—

43.57

—

Acne keloid

0.00

-0.00

0.0

1.0

—

60.22

—

Pseudosarcomatous fibromatosis

0.00

-0.00

0.0

1.0

—

37.00

—

0.00

-0.00

0.0

1.0

—

439.75

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS